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ABSTRACT
The NADPH-dependent lipid peroxidation in rat liver microsomal membrane was studied by 
using an effective and sensitive "reconstituted lipid peroxidation assay", which closely 
resembled the microsomal system. The NADPH-dependent lipid peroxidation was monitored 
by Thiobarbituric Acid Reactive Substances (TEARS) formation in the reconstituted assay 
system, initially using a î.2%-0.4% (w/v) differentially cholate solubilized fraction (CCMs), 
which had a 3-fold increase in relative specific activity compared to microsomes.
The lipid peroxidation activity in the reconstituted assay was demonstrated to be dependent 
on the presence of NADPH, NADPH-Cytochrome P-450 reductase enzyme, CCMs and 
extracted microsomal membrane phospholipids. The optimal concentrations of these reagents 
in the reconstituted assay, were determined. It was shown that the factor supporting NADPH- 
lipid peroxidation activity was heat labile, lending support to the possible protein nature of 
this factor. By using Gas Chromatography, it was demonstrated that arachidonate and 
docosahexanoate fatty acids were the preferred substrates in the assay. Both phosphate and 
cholate detergent inhibited lipid peroxidation activity. The lipid peroxidation active fraction 
was extremely labile. Solubilization with alternative detergents such as 3-[(3- 
Cholamidopropyl) dimethylammonio]-l-propanesulfonate (CHAPS), or addition of protease 
inhibitors such as phenylmethylsulfonylfluoride, did not improve its labile nature. However, 
addition of bovine serum albumin did improve stability but then further purification steps 
were required.
Nevertheless, some degree of purification of the lipid peroxidation activity was achieved. An 
11-, 10-, 5- and 4- fold purification was achieved (compared to microsomes) using 75%-45% 
(w/v) ammonium sulphate precipitation method, diethylaminoethyl-, hydroxyapatite- and 
laurate-sepharose- chromatographies, respectively. All the post chromatography eluate 
fractions with measurable lipid peroxidation activity, had an increased level of “background” 
TEARS. This resulted in an overall decrease in their lipid peroxidation activity.
Although an electrophoretically homogeneous preparation was not produced, partial progress 
has been made, providing a basis for future purification and characterisation of this enzyme 
system.
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CHAPTER 1: INTRODUCTION
Lipid peroxidation has been implicated in many diseases and pathological conditions.
These include inflammation, carcinogenesis, atiierogenesis, toxic cell injury, ischaemia and 
reperfusion of organs (Dargel, 1992), the toxicity of environmental pollutants (Saito, 1990) 
and the acute and chronic consequences df traumas (Sadrzadeh & Eaton, 1988). Some of 
these diseases are discussed in more detail later on, in respect to their relevance to lipid 
peroxidation (Halliwell & Chirico, 1993).
Although the mechanism underlying lipid peroxidation is uncertain, it is accepted that due to 
“spin barriers”, direct reaction of molecular oxygen with polyunsaturated fatty acids (PUFAs) 
is forbidden (Minotti & Aust, 1989), It is also generally accepted that transition metals, such 
as iron and copper, play an important role in catalysing lipid peroxidation. Transition metals 
readily “oscillate” between oxidised and reduced states, hence they can disturb the redox 
balance of biological systems including membranes (Minotti, 1993). However it is far from 
clear, whether the intermediates formed as a result of interaction of transition metals with 
molecular oxygen and PUFAs, promote lipid peroxidation directly or indirectly (Minotti & 
Aust, 1989). There is also general agreement that so called “initiating species” are required. 
Below I define what is meant by an initiating species and review their nature and then discuss 
the proposed mechanisms of lipid peroxidation.
1.1) PROPOSED MECHANISMS OF LIPH) PEROXIDATION
The lipid peroxidation process can be divided into three steps: Initiation, propagation and 
termination. It is the initiating step, and especially the “initiating species”, which has 
stimulated most interest. This interest is partially fuelled by the possibility that identification 
and characterisation of the initiating species, could lead to effective therapeutic methods for 
the treatment of diseases in which lipid peroxidation plays a key role.
An initiating species can be defined as “any chemical species with sufficient reactivity to 
overcome the dissociation energy of an allylic C-H bond of a PUFA, and to abstract a 
hydrogen atom” (Halliwell & Gutteridge, 1989). This results in the formation of the 
corresponding lipid alkyl radical and initiates a series of further reactions which result in the 
formation of various products of lipid peroxidation. This has been referred to as the "first 
chain initiation" by Halliwell & Gutteridge (1989) to distinguish it from the propagation stage 
of lipid peroxidation in which "further" abstraction of hydrogen atoms occurs.
1.1.1) LEPID HYDROPEROXIDE DEPENDENT & INDEPENDENT 
LIPID PEROXIDATION
lipid peroxidation can be defined as the process by which lipid hydroperoxides (LOOH) are 
formed from unsaturated lipids (LH) (Minotti, 1993). Minotti and Aust (1992) reported that
the presence of lipid hydroperoxides in either commercial or isolated lipid fractions, 
significantly affects the mechanism of lipid peroxidation. These lipid hydroperoxides are 
easily formed as a result of oxidation of lipids due to cellular disruption and manipulation. 
These investigators proposed different mechanisms by which lipid peroxidation proceeds in 
vitro dependent on the concentration of lipid hydroperoxides already present.
They proposed that in the absence of LOOH or the presence of very low concentrations of 
LOOH, the initiation of lipid peroxidation occurs predominantly via an “LOOH-independent” 
mechanism (Rgure 1.1). Under such conditions, the peroxidation is initiated via a “reactive 
species” (designated as X*). The nature of this reactive species is discussed in further detail in 
section 1.1.2, however one strong candidate is the hydroxyl radical (OH*) which can be 
produced in the presence of ferrous ions and hydrogen peroxide (hydrogen peroxide is 
produced as a result of dismutation of superoxide).
Fe"+ + H2O2 —  > Fe"" + OH + OH*
This highly reactive hydroxyl radical is capable of abstracting a hydrogen atom from an 
“allylic methylene group” in the lipid and hence results in the formation of another reactive 
species, lipid alkyl radical (L*).
OH* + LH ----------> H2O + L"
The lipid alkyl radical can then react with molecular oxygen to form the corresponding lipid 
peroxy radical (LOO*) which can subsequently abstract further hydrogen atoms from adjacent 
allylic methylene groups, resulting in the formation of so called the “1st generation” of 
LOOH. However, if LOOH are abundant in the lipid fraction, the initiation of lipid 
peroxidation has been proposed to proceed via another mechanism, called the “LOOH- 
dependent” mechanism (see Figure 1.1). Pre formed LOOH, in the presence of ferrous ions, is 
converted to highly reactive lipid alkoxy radicals (LO*), which are themselves capable of 
abstracting hydrogen atoms from a neighbouring “allylic methylene group” and hence 
initiating lipid peroxidation.
Fe "^ + LOOH --------- > Fe"" + OH + LO*
LO* + LH ----------> LOH + L*
The "propagation" stage of lipid peroxidation is veiy similar to the “LOOH-dependent” 
initiation stage of lipid peroxidation. This stage consists of decomposition of LOOH formed 
from either mechanism of initiation. The resultant LOOH, in a similar fashion to the 
described LOOH-dependent initiation, gives rise to LO* which subsequently abstracts a 
hydrogen atom from the adjacent LH and once again the reactive L* is reproduced.
(H202 Fe2+) XH
LODH INDEPENDENT INITIBTiON
JLOOLH
\ /
L O H^LO - LH
LOOH DEPEHDEhfr INITIATION
L O O H  ^
FIGURE 1.1: Lipid hydroperoxide independent & dependent peroxidatioii and
radical, L G - Lipid alkoxy radical, LOO = Lipid peroxyl radical (Adapted from 
Minotti, 1%!^,
As demonstrated in figure L2, the highly reactive LOO* which contributes to the propagation 
of the lipid peroxidation process, can also fold on itself to form cyclic pero^des and 
endoperoxides. These products then undergo fragmentation which results in the formation and 
release of soluble aldehydes such as malondialdehyde (MDA), a compound which is 
commonly used as a measure of the lipid peroxidation process. Another such aldehyde is 4- 
hydroxynonenal (4-HNE) which will be discussed in more detail in section 1.2.2.
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FIGURE 1.2.: Schematic representation of lipid peroxidation of
arachidonic acid, representing first chain initiation, propagation and 
fragmentation resulting in formation of some soluble aldehydes, as by­
products of lipid peroxidation (Halliwell & Gutteridge, 1989). LH refers to 
a polyunsaturated fatty acid.
Finally, in the “termination stage” of the lipid peroxidation process, either two of these highly 
reactive species which contribute towards initiation and propagation, react with each other 
and consequently “neutralise” each other by forming a relatively un-reactive by-product. 
Alternatively, radical scavengers are capable of terminating the propagation of lipid 
peroxidation by reducing these highly reactive species. The presence of such scavengers is 
vital to the cell’s survival. They can be enzymatic or non-enzymatic in nature, such as 
glutathione peroxidase and a-tocopherol. They terminate the lipid peroxidation process by 
donating hydrogen atoms or a reducing equivalent and scavenging the chain propagating 
radicals (Buttriss & Diplock, 1984).
Another very important matter which needs especial attention, is the requirement for Fe^  ^in 
both LOOH-dependent and independent initiation of lipid (Fig 1.1). However, it has been 
demonstrated experimentally that Fe^ can fulfil this role in the presence of certain reductants 
which reduce it to Fe^  ^(Saito, 1990), The nature of these reductants is highly dependent upon 
the chelator used to keep the Fe^ soluble and accessible for participation in lipid 
peroxidation. For instance, it has been reported that cytochrome P450 reductase is capable of 
reducing Fe^ to Fe^ % if EDTA is used as the chelator of F e^  (Morehouse et aL, 1984), 
whereas when ADP is used as the chelator, cytochrome P450 can reduce Fe^ to Fe^ 
(Morehouse & Aust, 1988).
The role of iron in lipid peroxidation is made more complicated by the proposals that the 
resultant Fe^^-chelate formed as a result of reduction of Fe^-chelate, must be able to partition 
in to the site where the allylic bonds are situated, i.e. the hydrophobic compartments (Minotti, 
1992; Schaich & Borg, 1988). There is also evidence suggesting an optimum Fe^7 Fe^ ratio 
is required for lipid peroxidation to occur (Bucher et aZ., 1983; Minotti & Aust, 1987; Minotti 
& Aust 1989), since excess of Fe^  ^ions would result in the depletion of OH* whereas excess 
Fe^  ^may cause the “displacement of Fe^^’ from the hydrophobic sites where lipid oxidation 
occurs (Minotti, 1992). This evidence has raised the possibility that there may be a Fe^ :^ Fe^: 
dioxygen complex which may be acting as the initiator of the lipid peroxidation process 
(Bucher et aL, 1983; Braughler et aL, 1986; Minotti & Aust, 1989; Schaich & Borg, 1988; 
Minotti, 1992). These matter are further discussed in section 1.1.2.2.
1.1.2) PROPOSED MECHANISMS FOR INITIATION OF LIPID 
PEROXTOATION
1.1.2.1) OH AS A POSSIBLE INITIATOR FOR LIPID PEROXIDATION
In 1934, Haber and Weiss postulated that hydroxyl radicals are produced as a result of the 
reaction of hydrogen peroxide with superoxide (O2 ’) (Halliwell & Gutteridge, 1989). This is 
now widely known as the "Haber-Weiss” reaction :
0 2 ' + H2O2  -> 02 + OH + OH- (#1)
However, it was later shown that the above reaction does not proceed at any significant rate in 
the absence of transition metals such as iron^ copper and perhaps cobalt (McCord & Day,
1978). The Haber-Weiss reactions would therefore be more appropriately re-written as 
follows:
Fe^ + O2 -  -> + O2 (#2)
Fe=* + H2O2 ---------- -> Fe^ + OH + OH- (#3)
The above sequence of reactions has been named as the “Iron catalysed Haber-Weiss 
reaction" or more correctly: the "Superoxide dependent Fenton reaction". In these reactions, 
iron is a representative of any transition metal or “redox active metal” that functions as 
electron-acceptor from superoxide and electron donor for hydrogen peroxide, thereby 
undergoing continuous reduction-oxidation cycling (Halliwell & Gutteridge, 1989).
The formation of OH- via die above sequence of reactions has been detected and reported by 
a number of investigators (Heikkila et aL, 1976; Halliwell, 1978; Rosen & Rauckman, 1984). 
It is possible to test the role played by OH- in the initiation of lipid peroxidation, by either 
limiting its production by addition of SOD, or by removing any H2O2 produced by addition of 
catalase or by quenching any OH - produced before it can participate in the initiation of lipid 
peroxidation, by the addition of OH- scavengers. These possibilities are explored further in 
the following sections 1.1.2,1 A-C.
1.I.2.1.A) THE EFFECT OF SOD
Morehouse and his collaborators used a highly modified cytochrome c preparation, with a 
minimal tendency for direct enzymatic reduction, to investigate the role of superoxide 
generated by intact microsomes. However, their results demonstrated that NADPH-dependent 
lipid peroxidation by microsomes was not inhibited by SOD (Morehouse et aL, 1984), a 
finding which was later confirmed by Kostner & Slee (1986) who used ferritin as the source 
of iron instead of chelated ferric ions. It was proposed that the lack of inhibition by SOD 
could be due to “inaccessibility” of SOD to the site of superoxide production i.e. the 
hydrophobic sites where superoxide is released by cytochrome P450 reductase and 
cytochrome P450s. In addition, other studies demonstrated that superoxide is only generated 
very slowly by microsomal membranes and cytochrome P450 reductase (Schaich & Borg, 
1988). It has been shown that the participation of cytochrome P450 in NADPH-dependent 
lipid peroxidation is restricted to the propagation step i.e., to the breakdown of previously
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formed LOOH (Minotti & Aust, 1989). Thus, lack of inhibition of lipid peroxidation by SOD 
implies that Fe^ i^s reduced in a superoxide-independent manner.
1.1.2.1.B) THE EFFECT OF CATALASE
The effect of catalase in different in vitro systems is often used to determine if OH* 
participates in the initiation of lipid peroxidation via the superoxide dependent Fenton 
reaction. Although there are numerous contradictory results in the literature in regard to the 
effect of catalase on lipid peroxidation, a review by Minotti and Aust has effectively and 
clearly tackled this matter (Minotti & Aust, 1989). They have blamed the inconsistency of the 
results on two very important factors.
(1) Contamination of many commercial preparation of catalase with thymol, a stabilising 
agent which is also a potent antioxidant, which can effectively inhibit lipid peroxidation. So it 
is very important to make sure that the catalase used is thymol free.
(2) If one aims to study the effect of the exogenous addition of catalase, it is important that 
the microsomal fraction does not contain any endogenous catalase. Unfortunately, unless the 
microsomes have been chromatographed or subjected to repeated washing, they are 
contaminated with significant amounts of endogenous catalase, which would effectively 
invalidate the results obtained by addition of exogenous catalase.
However, by restricting their review to those investigations carried out under the above 
conditions, they demonstrate a lack of inhibition by thymol free, exogenously added catalase 
to an endogenously catalase free microsomal fraction ( Morehouse et ah, 1983; Thomas et aL, 
1985), or to an extracted microsomal lipid (Thomas et aL, 1985; Minotti & Aust, 1987). 
Collectively, these results suggest that the formation of H^O  ^ via NADPH-supported 
microsomal electron transport and oxygen reduction was not required for iron catalysed lipid 
peroxidation, thus providing further evidence against the involvement of OH* as the initiating 
species in the LOOH-independent peroxidation.
1.1.2.1.C) THE EFFECT OF OH* SCAVENGERS
The use of specific hydroxyl radical scavengers seems to be a useful approach in investigating 
the involvement of OH* in lipid peroxidation. This approach has been attempted by a number 
of investigators with mixed results. Some investigators have claimed OH* to be involved in 
the lipid peroxidation process (Iba & Mannering, 1987). In their system the formation of the 
by-product of lipid peroxidation, malondialdehyde (MDA), was almost completely inhibited! 
by the hydroxyl free radical trapping agents: sodium benzoate, mannitol and thiourea. 
However, their results are questionable since in their system they did not add exogenous 
chelators and claimed that "the phosphate ion in their buffer is a good iron chelator”. Their 
results have been confirmed by other investigators under different experimental conditions
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(Lai & Piette, 1977; Cohen & Cederbaum, 1980). On the other hand other investigators have 
ruled out the involvement of OH* due to tiie lack of inhibition by hydroxyl radical traps in 
systems where chelators are added with iron (Morehouse et aL, 1983). It has been suggested 
by some investigators that there may be “multiple mechanisms” via which the lipid 
peroxidation process proceeds under different experimental conditions, hence giving rise to 
contradictory results obtained by different investigators (Iba & Mannering, 1987).
Considering that adenosine is frequently used as a chelator of iron to keep ferric ions soluble, 
ADP-Fe^^ is commonly used for the lipid peroxidation assay (Tien et aL, 1981). It has been 
shown by Scholes and his collaborators that adenosine is a very effective scavenger of OH* 
(Scholes et a/., 1960). These results strongly argue against the involvement of OH* as the 
initiator of the lipid peroxidation.
Further argument against the participation of OH* as the initiating species in the lipid 
peroxidation process, stems from the fact that OH* is a very reactive radical species with a 
very short life span. Due to this “diffusion limited reactivity”, it would seem unlikely for it to 
migrate from an aqueous site where it is generated to the hydrophobic membrane site, where 
it would abstract a hydrogen atom from the membrane phospholipids, without reacting with 
other organic biomolecules.
1.1.2.2) Fe^ - Fe^ COMPLEX AS THE INITIATOR OF PEROXIDATION
Since OH* is unlikely to be an initiator of lipid peroxidation (see section 1.1.2.L), I shall now 
discuss the evidence for the initiation of lipid peroxidation by a complex of Fe^  ^and Fe^\
The first convincing evidence regarding involvement of a ferrous-ferric complex was 
provided by the study carried out by Bucher and his collaborators (1983). In their 
investigation they studied the peroxidation of phospholipid liposomes with ADP-Fe^^ and 
noted that there was a lag phase between addition of ADP-Fe^^ and the initiation of lipid 
peroxidation. In further studies, they observed that this lag phase was not effected by SOD, 
catalase, or OH* traps, however upon addition of ADP-FeP  ^ it was completely eliminated. 
From these observations they concluded that the lag phase is a result of the autoxidation of 
Fe^  ^to Fe^ to form a certain complex of Fe^  ^- Fe^  ^ with dioxygen which would act as the 
initiating species. These conclusions were supported by Minotti and Aust who proposed a 
Fe^  ^- Fe^ complex formed as a result of oxidation of inactive Fe^\ or reduction of Fe^, to 
form the Fe^^- Fe^  ^complex which was active, i.e. able to initiate lipid peroxidation. This is 
illustrated in Fig. 1.3. It is apparent from this diagrammatic representation that either 
complete oxidation of Fe^  ^ or complete reduction of Fe^  ^ would result in inhibition of 
peroxidation since the ingredients for the initiating species, Fe^  ^- Fe^ complex, would not be 
at hand (Minotti & Aust, 1987).
Direct evidence that both Fe^  ^ and Fe^ are involved in lipid peroxidation, has also been 
obtained by incubating phospholipid liposomes with mixtures of the two forms of iron.
Maximal rates of lipid peroxidation have been observed by including approximately equal 
amounts of Fe^  ^ and Fe^  ^ (Halliwell, 1978; Braughler et 1986). Stadtman and Beriet 
(1991) have suggested that a critical Fe^  ^ : Fe^ ratio may dominate the oxidation of 
biomolecules other than lipids such as amino acids.
Affected by: 
Chelation, pH
Oxidation OxidationReduction
F e 2 +
Inactive
F e 3 +
Inactive
INITIATION OF LIPID PEROXIDATION
FIGURE 1.3; Schematic representation of the proposed role of iron in lipid 
peroxidation and the effect of pH. chelation oxidation and redaction, (after 
Minotti and Anst. 1987).
The involvement of such an initiating species has been challenged because of lack of 
experimental observation or isolation of the Fe^  ^-dioxygen- Fe^  ^complex which undermines 
their existence and role in the initiation of lipid peroxidation. Indeed, Aruoma and his 
collaborators (1989) have provided sound evidence against the involvement of a F^^ - Fe^ 
complex. They concluded that since the action of Fe^  ^can be replaced by other metal ions 
(AF^ or Pb^ )^, a critical 1:1 Fe^  ^: Fe^  ^ratio or a specific Fe^  ^-dioxygen- Fe^ complex, is not 
required for the initiation of lipid peroxidation.
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1.1.3) A FACTOR IN RAT LIVER MICROSOMES THAT PROMOTES 
NADPH-DEPENDENT LIPID PEROXIDATION
The first report of an enzymatic system in microsomes which upon oxidation of NADPH 
results in the peroxidation of microsomal membrane fatty acids was published by Hochstein 
and Emster in 1963. Their pioneering work started a whole new interest in lipid peroxidation 
which had previously been considered to be a non-specific and self propagating non- 
enzymatic process.
Further studies indicated that MDA, which is a common indicator used to monitor lipid 
peroxidation, only accounted for 15% of fatty adds consumed in the process of the 
peroxidation of membrane fatty adds. There was no preference for the consumption of fatty 
adds from either phosphatidyl choline or phosphatidyl ethanolamine. However, there was a 
significant decrease in the levels of arachidonate (20:4) and docosahexanoate (22:6) fatty 
adds by the NADPH-lipid peroxidation of microsomes, which indicated that these fatty acids 
may be the source of MDA produced as a result of peroxidation (May & McCay, 1968). In 
agreement with these authors, Hogberg and his collaborators (1973) reported "with increasing 
peroxidation, microsomal phospholipids revealed decreasing concentration of 20:4 and 22:6 
fatty acids". Interestingly, they also showed that this was accompanied by observable changes 
in the membrane structure and integrity which they concluded were responsible for marked 
changes in some membrane enzyme activities. Niehaus and Samuelsson (1968) concluded 
that the MDA is derived either directly or indirectly from phospholipid bound arachidonate by 
demonstrating that ^-labelled MDA is produced from tritiated arachidonyl phosphatidyl 
choline. Further evidence in favour of the above claims were provided by Lokesh and his 
collaborators (1980) who reported that “fortification” of rat liver microsomes with 
diarachidonyl phosphatidyl choline resulted in increased MDA production. Jordan and 
Schenkman (1982) demonstrated that when the rates of individual PUFA consumption were 
compared with MDA formation in microsomes from the same species or different species, 
only 20:4 demonstrated a linear relationship as a result of the NADPH-dependent lipid 
peroxidation. Other PUFAs were also consumed but their consumption showed no 
relationship to MDA formation. They concluded that the 20:4 is the “sole” precursor of 
enzymatic fonnation of MDA, and although the ratio of 20:4 breakdown to MDA formed was 
3 to 1, they postulated that other 20:4 catabolic pathways may also exist which do not lead to 
MDA formation.
Davis and his group (1986), used [U - 't]  arachidonate labelled rat hepatic microsomal lipids, 
peroxidized by an NADPH-dependent iron pyrophosphate system and quantified the extent of 
peroxidation, by MDA production and arachidonate disappearance. They centrifuged 
microsomes following peroxidation, and extracted the oxidative products from the 
supernatant. Their results demonstrated a linear correlation between MDA production and 
radioactivity in the supernatant. The microsomal pellet was treated with phospholipase A^  to
II
cleave peroxidized products from the phospholipids. The de-esterified lipid products from the 
pellet were extracted and the fragments from &e supernatant ^ d  die hydrolysed pellet were 
separated by reverse phase HPLC. Several differently labelled polar compounds which co­
eluted with carbonyl-containing compounds were found in both the supernatant and the pellet 
In addition, many other carbonyl compounds were found which were not arachidonate- 
derived. The important point is that the elution pattern of the fragments after 2 and 15 min of 
peroxidation were "quantitatively identical i.e. no product-precursor relationship" was seen. 
Furthermore, when the supply of NADPH was rapidly depleted by the addition of a- 
ketoglutarate glutamic acid dehydrogenase system, lipid peroxidation also ceased. They 
concluded from their results that in their system, there was an absence of propagation and the 
peroxidation was most probably the result of a specific enzymatic reaction rather than a non­
specific chain reaction.
It had previously been shown that the NADPH-supported lipid peroxidation was inhibited by 
90% with the use of antibodies to cytochrome P450 reductase (Pederson et ah, 1973). Hence 
the presence of cytochrome P450 reductase in this enzymatic process was established as an 
essential component in this enzymatic system. Its role being to accept electrons from NADPH 
and passing the reducing equivalents to another component which promotes peroxidation of 
membrane phospholipids or more specifically, MDA production from arachidonate. 
Subsequently, in the search for this factor in rat liver microsomes, Yonaha and his 
collaborators (1992) managed to partially purify a heat labile and tiypsin sensitive fraction 
which supported NADPH-dependent lipid peroxidation in the presence of ferric chelate and 
cytochrome P450 reductase.
Other investigators have since reported attempts in purification of this component and have 
indicated that it is "probably a protein distinct from cytochrome P450 which is associated 
with iron reduction responsible for lipid peroxidation in microsomes" (Tampo & Yonaha, 
1995).
1.2) PRODUCTS OF LIPID PEROXIDATION
There are numerous diseases and pathogenic conditions which have been linked with lipid 
peroxidation. However it is rather difficult at times to determine whether the condition is a 
direct result of the lipid peroxidation process or is indirectly due to the by-products of lipid 
peroxidation. Additional problems arise from the limited knowledge of the lipid peroxidation 
products, since without detailed knowledge of their chemical structure or a method of 
preparing a relatively pure and biologically active compound, it is not possible to study the 
biological and also the toxicological effects of such products of lipid peroxidation. However, 
two by-products of lipid peroxidation have been extensively studied due to the relative ease of 
chemical synthesis of pure forms of these compounds, namely MDA and 4-HNE. The 
biological and toxicological effects of these two compounds are considered below, although
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one must hear in mind that th§se are only two of the soluble aldehydes and ketones produced 
as a result of peroxidation, a^d much further research is required to isolate and purify other 
by-products of lipid peroxidation and study these potentially very important compounds.
1.2 .n  IN VITRO & IN VIVO STUDIES WITH LIPID PEROXIDATION 
PRODUCTS
The discovery of 4-HNE as the most cytotoxic aldehyde formed directly as a result of 
NADPH-dependent microsomal lipid peroxidation by Benedetti and his collaborators in 1980, 
led to an increased interest and further investigation of the biological role of this compound 
(Esterbauer et éd., 1991). The concentration of this compound in the human plasma is in the 
range of 0 r 0.7 pmol/L, with an average concentration of 0.28 pmol/L. It is important to 
point out that even at low concentrations of 4-HNE, which can be reached in vivo when 
certain cells undergo oxidative stress (0.1 - 1 pM), it can have a pathological and possibly 
also a physiological significance. Among these effects are stimulation of phospholipase C and 
consequently protein kinase C and also the adenylate cyclase cascade (Esterbauer et éd., 
1991). It has also been reported that at this concentration range, and even at a concentrations 
as low as 0.01 pmol/L, 4-HNE causes a reduction in gap junction communication in cultured 
endothelial cells which is responsible for cell-cell communication. An interruption in such a 
mechanism has been strongly linked with uncontrolled cell proliferation (Radu & Moldovan, 
1991).
Interestingly, direct evidence in support of the possible involvement of the lipid peroxidation 
products in vivo, has been obtained. 4-HNE fonned as a result of peroxidation of low density 
lipoproteins in vivo, has been found to bind to apolipoprotein-B moiety of the LDLs, hence 
causing these peroxidized LDLs to be taken up by the special scavenger receptors on the 
surface of macrophages, leading to the formation of foam cells. Additionally, from plasma of 
rabbits and humans, auto-antibodies against proteins modified by 4-HNE have been isolated 
(Steinberg et a l, 1989; Esterbauer et a l, 1991; Esterbauer, 1993).
It has been established by some investigators that increased concentrations of MDA and 
TBARS in human serum, contribute significantly to the development of certain 
pathophysiological conditions such as atherosclerosis, diabetes and reperfusion injuiy (Janero, 
1990; Dargel, 1992).
Although MDA, formaldehyde and acetaldehyde all exhibited relatively low toxicity, MDA 
has been reported to cause changes in the cell morphology and also reduce protein synthesis 
(Janero, 1990; Esterbauer et a l, 1990; Esterbauer et a l, 1991; Kubow, 1992; Esterbauer, 
1993).
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understanding of physiological conditions and diseases which have been linked to lipid 
peroxidation.
1.3) LIPID PEROXIDATION AND DISEASE
An important question that arises in diseases with an established link to lipid peroxidation, is 
whether lipid peroxidation is the cause of the disease or a mere side-effect. It thus becomes 
important to establish if lipid peroxidation occurred after the onset of the disease or as a later 
event It was proposed that the release of transition metals into the extra cellular membrane 
due to cell damage could stimulate lipid peroxidation and in combination with dilution of the 
cellular antioxidant defence, this could cause increased lipid peroxidation which only occurs 
AFTER the onset of the disease which initiated the cellular damage (Halliwell & Gutteridge, 
1989; Halliwell & Chirico, 1993). This was supported by such observations as simple 
homogenisation of brain tissue which results in stimulation of lipid peroxidation (Stocks et 
al, 1974).
However, it must be emphasised that these observations are highly dependent on the disease 
concerned. For instance, in some diseases, such as atherosclerosis and ischaemic brain 
damage, it has been clearly demonstrated that lipid peroxidation does actually contribute to 
the progress and worsening of the disease. Whilst the administration of antioxidants, control, 
and to some extent reduce further progress and worsening of the disease (see sections 13.1.1 
and 13.1.2). However, in other diseases such as multiple sclerosis and muscular dystrophy, 
administration of antioxidants is of no significant benefit in the control of the disease, even 
though increased levels of lipid peroxidation have been documented in these diseases 
(Halliwell & Gutteridge, 1989). Hence, it seems that the extent of the role played by lipid 
peroxidation depends on the particular disease. In some diseases and pathophysiological 
conditions, such as atherosclerosis and ischaemic brain damage, lipid peroxidation plays a 
major role in the increased cell damage which leads to further progress of the disease and in 
short it can be said that it acts as one of the contributing causes in the disease. However, in 
other diseases such as multiple sclerosis and muscular dystrophy, lipid peroxidation is merely 
a consequence of the disease and it does not significantly contribute to the progress of the 
disease. It has to be emphasised that administration of antioxidants is an effective method of 
determining the role played by lipid peroxidation in the particular disease studied.
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1.3.1) LIPID PEROXIDATION AND DISEASE. A SELECTIVE 
REVIEW:
There are numerous diseases associated with lipid peroxidation some of which are listed in 
Table L  There has been a tremendous amount of research carried out to try to deteimine the 
exact role of lipid peroxidation in these diseases and a number of in depth revievv s have been 
published (Begin, 1987; Halliwell & Gutteridge, 1989; Dargel, 1992).
TABLE 1: LIST OF DISEASES LINKED WITH LIPID PEROXIDATION (HaUiweU & 
Gutteridge, 199d)
AIDS
Arthritis (Rheumatoid) 
Cataract rdrmatk® 
Hyperoxia 
Iron Overload
Malaria
Radiation Injur}' 
Sunburn
Alzheimer’s Disease
Atheroscelerosis
Dermatisis
Hypertension
Ischaemia/Reperfusion
Irgury
Muscular Dystrophy 
Retinopathy 
Thyroid Disease
Ageing
Cancer
Diabetes ^Wlitus 
Infertility
Keshan’s Syndrome
(Selenium Deficiency) 
Parkinson’s Disease 
Smoking
Vitmnin E Deficiency
1.3.1.1) ATHEROSCLEROSIS
Heart attacks (myocardial infarctions) and strokes are amongst the biggest causes of death in 
Western countries. They are induced as a result of occlusions of an essential arteiy to either 
the heart or the brain, respectively. The blockage of the Wood vessels has been attributed to 
plaque formation as a result of a phenomenon called atherosclerosis. The onset of these 
diseases has been associated with lipid peroxidation in a number of reviews (Halliwell & 
Gutteridge, 1%9; Dargel, 1992).
What initiates atherosclerosis is uncertain, however, it is believed to originate as a result of 
some kind of damage to the vascular endothelium wall. This results in attachment of 
macrojdiages which secrete hydrolytic enzymes and reactive oxygen species (Halliwell & 
Gutteridge, 1989). These oxidants are key intermediates in, and play a number of important 
roles in, the onset of atherosclerosis. One of the most important consequences is the lipid 
peroxidation, initiated by tlte macrophages and also the arterial endothelial cells, which has 
been documented to cause oxidative modification of low density lipoproteins (LDLs). LDL is 
a particle largely composed of lipid, including PUFAs and cholesteiyl esters, and is
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surrounded by cholesterol and the protein moiety apolipoprotein B-100. The normal 
physiological function of LDL is to provide tissues with lipids and cholesterol; and their 
uptake is controlled by negative feedback via the native LDL receptor (Brown and Goldstein, 
1976). However, if LDLs are oxidatively modified, their uptake by macrophages occurs via 
the scavenger receptor pathway (Steinberg et al., 1989). The mechanism, unlike the uptake of 
native LDL via the native LDL-receptor pathway, is not down regulated, and results in 
continuous endocytosis of oxidised LDL, ultimately leading to death of macrophages and 
their conversion to “foam cells”. Consequently, the contents of macrophages are laid down 
within the intima of the artery appearing as “fatty streaks”, the putative early atherosclerotic 
lesion. The fatty streaks may then progress to form “fibrous plaques”, leading to “complicated 
plaques”, which obstruct the lumen of arteries.
The oxidative modification of LDLs is widely implicated in the pathogenesis of 
atherosclerosis and it is not suiprising that it has been a topic of intense research. This 
oxidative modification can also be caused by products of lipid peroxidation such as MDA or 
4-HNE. As discussed earlier (section 1.2.2), auto-antibodies to 4-HNE modified LDLs have 
been reported to be present in plasma of rabbits and humans. Using immunochemical 
methods, 4-HNE modified LDLs have been observed in the atheroma of hyperlipidémie 
rabbits (Steinberg et a l,  1989; Esterbauer et al, 1991). Other important factors have been 
reported which further support the important role played by lipid peroxidation in the onset 
and progress of atherosclerosis. For instance, it has been suggested by Quinn et a l  (1988) that 
LDL lipid hydroperoxides may act as "chemotactics" for blood monocytes, attracting them to 
the site of the lesion and hence contributing to the progression of atherosclerosis.
So if lipid peroxidation is really responsible for the initiation and progression of 
atherosclerosis, according to the guidelines mentioned earlier (section 1.3), use of 
antioxidants should prove beneficial by diminishing its progression. Indeed, the "anti­
atherogenic" effect of probucol (a drug commonly prescribed to lower blood cholesterol), has 
been shown to be far greater than its cholesterol lowering effect in rabbits and has been 
attributed to its ability to inhibit lipid peroxidation of LDLs (Carew et a l, 1987). This is 
supported by the report that LDLs isolated from patients on probucol, are resistant to in vitro 
lipid peroxidation (Carew et a l, 1987; Halliwell & Gutteridge, 1989; Halliwell & Gutteridge, 
1990).
13.1.2) ISCHAEMIC BRAIN DAMAGE
Ischaemia can be defined as completely depriving a part of a tissue from oxygen (Halliwell & 
Gutteridge, 1989). This can occur as a result of atherosclerosis leading to occlusion of a major 
artery which supplies part of the brain with oxygen (leading to stroke). Reperfusion of the 
brain with oxygen rich blood can result in repair of the damage, depending on the length of 
the time ischaemia persisted. However, it was reported that this re-oxygenation may itself be
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the cause of further damage to the brain as a result of production of reactive oxygen species 
(McCord, 1987). The brain is especially susceptible to free radical attack and lipid 
peroxidation. This is because it is very rich in PUFAs, and also because it has low catalase 
and only moderate glutathione peroxidase and SOD activities. These facts, in combination 
with iron rich areas in the brain and high ascorbate concentration in other areas of the brain, 
make this organ prone to severe damage by lipid peroxidation. Upon injury, release of low 
molecular weight iron, either from as yet poorly characterised iron binding proteins of the 
brain, or breakdown of haemoglobin from bleeding, is believed to r^idly promote lipid 
peroxidation especially in the iron/ascorbate rich medium (Halliwell & Gutteridge, 1989). 
The ease by which brain homogenates undergo lipid peroxidation, has made it an ideal 
candidate for in vitro assays to measure antioxidant properties of various compounds. It has 
been shown that damage caused by ischaemic brain damage followed by reperfusion can be 
prevented by use of metal chelators, such as desferrioxamine, hence not only providing 
further evidence for involvement of iron mediated lipid peroxidation, but also fulfilling one of 
the requirements mentioned earlier (in section 1.3) about prevention of progress of the 
pathophysiological condition by the use of metal chelators or antioxidants. In regards to 
antioxidants, it has also been reported that administration of the chain breaking antioxidant, 
a-tocopherol, reduces the damage in models of ischaemic/traumatic brain injury (Halliwell & 
Gutteridge, 1989).
1.4) PROTECTIVE MECHANISMS AGAINST LIPID 
PEROXIDATION
It is vital for proper function of an organism, to be able to protect itself from inappropriate 
initiation of lipid peroxidation, and possess mechanisms by which it can effectively combat or 
remove its by-products.
There are a number of protective mechanisms which can generally be classified into three 
groups based on the mechanism by which they provide protection.
• Protection at a molecular level: Molecular removal or transformation of reactive oxygen 
species;
• Protection at a cellular level: Maintenance of membrane integrity;
• Protection at a systemic level: Transition metal quenchers;
These three mechanisms are considered in the following sections.
1.4.1) TRANSFORMATION OF REACTIVE OXYGEN SPECIES
Based on the number of different systems which fall within this category, transformation of 
reactive oxygen species to more inert by-products, is probably the most important mechanism
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in the protection against lipid peroxidation. This category can be further divided into two 
subgroups, as follows:
• Antioxidants: Systems designed to scavenge free radical species.
• Enzyme Systems: These catalyse the transformation of specific oxygen molecules.
1.4.1.1) ANTIOXIDANT CONTROL OF REACTIVE OXYGEN SPECIES
Chain breaking antioxidants donate a hydrogen atom to reactive oxygen species instead of 
PUFAs, hence protect the latter from oxidative attack and peroxidation. The resultant radical 
formed is relatively non-reactive and does not participate in the propagation of lipid 
peroxidation therefore terminating the reaction, hence their name as "chain-breaking". The 
most important lipophilic antioxidant, found primarily in the membrane of biological systems, 
is a-tocopherol which is more commonly known as vitamin E (Buttriss & Diplock, 1984). It 
can reduce the phospholipid peroxy radicals formed to hydroperoxides. There have been 
numerous reports on the adverse effects of vitamin E deficiency in diet, amongst which is the 
increased susceptibility of animals to acute paraquat toxicity (Block, 1979). Other lipophilic 
antioxidants include carotenoids, ubiquinone and ubiquinol (Sies et al., 1992). The cytosolic 
antioxidants include ascorbic acid, more commonly known as vitamin C, and also uric acid 
(Niki, 1987). It is interesting to note that ascorbate acts not only as a hydrophilic antioxidant, 
but it also acts synergisticaly in recycling and regeneration of a-tocopherol (Scarpa et al., 
1985). Under different experimental conditions it can also act as a pro-oxidant by stimulating 
non-enzymatic lipid peroxidation (section 13.1.2; Halliwell & Gutteridge, 1989).
1.4.13) ENZYMATIC REMOVAL OF REACTIVE OXYGEN SPECIES
There are some enzyme systems which catalyse the removal of reactive oxygen species. 
Amongst these are glutathione peroxidase, catalase and superoxide dismutase which are 
discussed very briefly here.
Glutathione peroxidase is a selenium containing cytosolic enzyme which reduces hydrogen 
peroxides produced in the endoplasmic reticulum or fatty acid hydroperoxides which are in 
lipid bilayers, to water or corresponding lipid hydroxides, respectively (Ursini & Bindolini, 
1987). This is carried out at the cost of oxidation of glutathione which itself is a good 
scavenger of OH- and superoxide. Oxidised glutathione is subsequently reduced by 
glutathione reductase as a result of oxidation of NADPH (Halliwell & Gutteridge, 1989). This 
is summarised in Fig 1,4.
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FIGURE 1.4: Réduction of lipid hydroperoxides (LOOH) by Glutathione 
Peroxidase enzyme system and its interaction with Glutathione Reductase.
Another very important intracellular enzyme involved in removal of reactive oxygen species 
is catalase which converts hydrogen peroxide to oxygen and water. Catalase is associated 
with organelles which have a high rate of peroxide formation, namely peroxisomes, which 
contain a variety of enzymes capable of producing hydrogen peroxide (Halliwell & 
Gutteridge, 1989). Although peroxisomes are not the only source of hydrogen peroxide, the 
presence of catalase plays an important part in protecting the cell by neutralising the 
potentially damaging effects of hydrogen peroxide, such as its possible role in lipid 
peroxidation by participating in the Haber-Weiss reaction (section 1.1.2).
As mentioned in earlier sections, there are many reports on the non-involvement of 
superoxide in the direct initiation of lipid peroxidation as SOD did not significantly inhibit 
this process (see section 1.1.2. LA for more detail and references). However, the release of 
superoxide and its effects are very important as it has been reported that superoxide can 
directly cause the release of iron from iron binding proteins such as ferritin (Minotti, 1992) 
and hence contribute to the progress, if not the initiation, of lipid peroxidation. SOD catalyses 
the dismutation of superoxide to hydrogen peroxide. Copper/zinc, manganese and iron 
containing SODs have been isolated from bacteria and all, except the iron containing form, 
have been isolated in mammals (Fridovich, 1986).
It has been suggested that the superoxide/SOD system plays an integral part in the celFs 
radical protection mechanism by allowing cells to respond by a general mechanism as free 
radical species donate electrons to oxygen and hence form superoxide which is then converted 
to hydrogen peroxide by the action of SOD (Winterboum, 1993).
1.4.2) MAINTENANCE OF MEMBRANE INTEGRITY
It is vital for a cell to maintain membrane integrity and hence essential for it to possess 
mechanisms to repair any damage. The adverse effects of lipid peroxidation on the structure
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and function of cell membranes is discussed in great detail in a number of reviews (Ritcher, 
1987; Dinis et a l,  1993). Here, the structural protection provided by the lipid bilayer needs to 
be considered. Physical shielding is provided from radical attack by the unsaturated fatty 
acids being held within the body of the membrane. This is supported by experimental 
evidence which has shown that the reaction of hydroxyl radicals with lipid micelles is an 
order of magnitude less than with monomeric PUFAs. a-Tocopherol scavenges lipid peroxy 
radicals formed within the membrane to produce non-radical hydroperoxides. Phospholipase 
A2 enzyme, whose activity has been shown to be stimulated as a result of peroxidation, 
cleaves the resultant hydroperoxides and peroxides from phospholipids, hence making them 
available for reduction by cytosolic enzymes such as glutathione peroxidase (Sevanian et al., 
1983).
The importance of maintenance of membrane integrity was further demonstrated when 
hepatocytes were exposed to carbon tetrachloride insult which resulted in failure of some 
membrane functions, such as maintenance of calcium homeostasis, and hepatocytes reached a 
"point of no return" where cell death became inevitable (Rechnagel & Glende, 1973; Schanne 
et a l, 1979; Ungemach, 1987). At this point the intracellular concentration of GSH is not 
significantly depleted (Krebs et a l, 1978) indicating that depletion of at least one biochemical 
protection system in the liver is not related to membrane failure. Hence the capacity of the 
cell to repair and maintain the integrity of its membrane is essential to the cell's survival.
The role of intracellular membranes in compartmentalising cells may have implications for 
the control of free radical processes in general and lipid peroxidation in particular. By 
compartmentalisation, not only are areas of the cell which have high peroxidation capabilities 
isolated, (such as mitochondria, peroxisomes and endoplasmic reticulum), but it may also 
allow the "fine tuning of mechanisms of protection against free radical damage" as seen by 
the compartmentalisation of catalase within peroxisomes, and the different pools of GSH 
found within the cell (Meredith & Reed, 1982).
1.43) TRANSITION METAL QUENCHERS
As discussed earlier, transition metals, such as iron, play an important role in catalysing the 
initiation and propagation of lipid peroxidation (section 1.1.1 & 1.1.2 ) and hence there is a 
need for a mechanism to avoid inappropriate release of these elements in order to avoid free 
radical damage. This is achieved by having a number of transport and storage molecules, 
which have been identified for iron and other transition elements. Transferrin and ferritin are 
proteins used for the transfer and storage of iron, respectively. Iron complexed with these 
proteins has been shown to be unable to catalyse peroxidation (Halliwell & Gutteridge, 1986). 
Similarly, ceruloplasmin sequesters 95% of human plasma copper, the rest being bound to 
histidine, albumin and small peptides (Halliwell & Gutteridge, 1990). These transition metal 
binding proteins ensure that very little free transition metals, such as iron or copper, are
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available to participate in catalysing reactive oxygen species production in vivo. Using the 
bleomycin assay, an assay used to measure bound iron in vivo, it has been documented that 
the concentration (rf "free iron" in normal human plasma is less than 0.5 pM (Gutteridge et 
al., 1982). One is reminded of the importance of these "sequestration proteins" in the body, 
when considering those tissues which only have low iron binding capacity, such as the central 
nervous system. As discussed previously (section 13.1.2), as a result of mechanical damage 
leading to the release of metal ions, peroxidation of PUFA rich tissue is initiated which 
contributes significantly to the progression of brain damage and ischaemic reperfusion injury 
(section 13.1.2).
1.5) ANALYTICAL METHODS FOR MEASUREMENT 
OF LIPID PEROXIDATION
1.5.1) GENERAL INTRODUCTION
Although many techniques are available to measure lipid peroxidation of fatty acids and 
biological membranes, the major problem is the absence of an accurate and sensitive assay. 
The techniques can be generally classified into two groups; the non-chromatographic, which 
are more general and non-specific and secondly, the more specific chromatographic 
techniques.
The classification of methods in this way, mirrors the two types of strategy employed for 
quantitative assessment of peroxidation. The most common approach is to view lipid 
peroxidation as a single coherent process and to try to measure the extent of this process by 
quantification of a general marker of peroxidation. Such an approach is imperfect in that lipid 
peroxidation is essentially a heterogeneous process. Results obtained by these methods may 
not accurately reflect the nature of the system being studied, particularly when the 
mechanisms of peroxidation are not well understood. The other approach is to accurately 
quantify a specific reaction product, or class of products, of peroxidation. This way of 
addressing the problem provides highly specific data for the particular analyte being studied, 
but may not provide information on the peroxidation process as a whole. This latter approach 
often requires extensive analytical expertise.
Consequently the choice of analytical method depends greatly on the objective of the 
experiment, and the nature of the lipid peroxidation system under study. It is often necessary 
to employ more than one method in order to be able to interpret experimental data correctly. 
A few commonly used methods are described below.
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1.5.2) SPECTROPHOTOMETRIC DETERMINATION
Spectrophotometric methods probably account for the vast majority of lipid peroxidation 
determinations. They include the thiobarbituric acid (TEA) test, which is used in almost all 
biologically related studies on lipid peroxidation, as well as the conjugated diene test and 
direct assay techniques for peroxide groups.
1.5.2.1) THE TfflOBARBITURIC ACID TTST
Small amounts of free MDA are produced by the peroxidation of most membrane systems, 
and a greater amount has been reported with the rat liver microsomal membrane system 
(Halliwell & Gutteridge, 1990). The TBA-assay is based on the reaction of 2 mol of 2- 
thiobarbituric acid with 1 mol of MDA under acid conditions, to form a pink chromagen 
product with an absorption peak at 532-535 nm (Slater, 1984). This reaction is summarised in 
Fig 1.5;
HS OH
OH
TBA
+
lOO^ C 
Acid pH
CHO
ÇH2
CHO
MDA
SHOH HO
0 —C=(/
OHOH
- j -  2 H2 0
PRODUCT
FIGURE 1^: Thiobarbituric acid assay as a measurement of lipid 
peroxidation (Halliwell & Gutteridge. 1989).
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The molar extinction coefficient of this TBA-MDA adduct is 154 L.mmol’l.cm’l at 532 nm. 
The adduct also fluoresces at 553 nm and is readily extractable into organic solvents such as 
butan-l-ol (Halliwell & Gutteridge, 19^).
The m^or problem associated with this assay, is its lack of specificity. Other endogenously 
formed aldehydes, beside MDA, and some carbohydrates have been reported to react with 
TBA and produce chromogens which could interfere with the assay (Moorhouse et al., 1985; 
Gutteridge, 1986). For this reason the majority of the papers published using this method, 
refer to TBA-reactive substances (TBARS) formed instead of MDA. Other authors have 
reported that the majority of die MDA which reacts with TBA is formed during the heating 
stage of the TBA assay and not as a result of the lipid peroxidation process (Gutteridge, 1986; 
Halliwell & Gutteridge, 1989).
The first point can be addressed by eidier measuring the fluorescence of the product at 553 
nm and hence, using that in combination with UV measurement at 532 nm, one can determine 
the amount of the MDA-TBA adduct formed. Alternatively, HPLC can be used to separate 
the TBA-MDA adduct specifically, prior to its quantification. Regarding the second point, a 
potent antioxidant such as BHT can be added during the heating stage to avoid formation of 
TBA reacting products.
However, the TBA assay continues to be a method of choice, mainly due to its ease of use 
and since it can be a reliable measurement of lipid peroxidation especially when used in 
conjunction with other procedures and methods. It has also been documented that in spite of 
difficulties mentioned earlier, it correlates well with other methods of lipid peroxidation 
measurement (Slater, 1984).
1^.2.2) MEASUREMENT OF CONJUGATED DIENES
The formation of conjugated diene groups in PUFAs which have undergone radical attack, 
has been widely used as a method of assessment for lipid peroxidation. This is based on the 
ultraviolet absorbance at 230-235 nm of conjugated diene groups in PUFAs (Slater, 1984; 
Halliwell & Gutteridge, 1989). The major problem with the measurement of conjugated 
dienes in biological samples is the potential of interference from endogenous materials at this 
wavelength. Analysis of conjugated dienes from lipid extracts at 234 nm involves the 
measurement of the required absorbance maxima as a small shoulder on a large background 
absorbance (Slater, 1984). The use of second derivative spectroscopy, allowing clearer 
discrimination of 235 nm absorbance against background, has assisted in improving the data 
in such assays (Corongiu & Milia, 1983). However, another difficulty with the technique is 
that some endogenous lipid conjugated dienes are demonstrably not fornied by free radical 
attack, for example, octadeca-9,11 ,dienoic acid, a fatty acid found in human serum 
(Dormandy & Wickens, 1987). The interference inherent in this approach, can be avoided by
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combining the technique with separation techniques such as HPLC (Dormandy & Wickens, 
1987) thus allowing the lipid dienes to be measured in isolation.
1,53) UTRIMETRTC ANALYSIS USING IQPOMFTRIC PEROXIDE 
MEASUREMENT
The measurement of the highly reactive peroxide group is an obvious strategy for assessment 
of lipid peroxidation and has the benefit of measuring the functional group which is central to 
the process. Techniques using reactions specific to the peroxide functional group have been 
available for many years, particularly for the assessment of levels of peroxidation in 
foodstuffs. Lipid hydroperoxides are capable of oxidising iodide ions (I") into iodine (12) in 
the iodometric assay (Halliwell & Gutteridge, 1989) in the following reaction:
ROOH +21 + 2H ----------- > 12 ROH + H2O
The iodine produced may be estimated titrametricaUy with sodium thiosulphate or by 
monitoring absorbance at 360 nm (Hicks & Gerbiki, 1979).
The major disadvantage of the method is that there is a significant tendency towards positive 
results due to the oxidation of the iodide ion by atmospheric oxygen and strict precautions 
must be taken to exclude oxygen from all reagents (Hicks & Gefbichi, 1979). In practice this 
is very difficult and the method has not been widely adopted for assessment of lipid 
peroxidation. It is primarily used to assess peroxide levels in lipid hydroperoxide preparations 
used as calibrants in other, less difficult assays. A stabilised reagent for the iodometric assay 
of lipid peroxides has been applied to the analysis of hydroperoxides in serum lipoproteins 
(H-Saadarin et a l, 1989). As a result, this method may be used more extensively in biological 
matrices.
Due to the presence of numerous oxidising agents in biological samples, such as hydrogen 
peroxide, which are capable of oxidising iodide to iodine, this method is not often used 
(Halliwell & Gutteridge, 1989).
1.5,4) MEASUREMENT OF HYDROCARBON GASES
Some minor end products of lipid peroxidation are hydrocarbon gases, such as ethane and 
pentane which can be measured in the expired breath, by the use of GC. Although this is 
potentially a simple and useful method for measuring lipid peroxidation in vivo, it is 
important to bear in mind that these products undergo metabolism by the liver and hence 
values in expired breath do not truly reflect the rate of lipid peroxidation. It has been reported 
by the same authors that vigorous exercise results in increased level of pentane in breath of 
human volunteers and if cumene hydroperoxide, a well known stimulator of lipid
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peroxidation, is injected into animals, increased ethane levels are measured in the expired 
breath (Halliwell & Gutteridge, 1989).
1.5.5) LOSS OF FATTY-ACIPS
Since the process of lipid peroxidation destroys the PUFAs, the loss of fatty acids has been 
used as a measure of the overall lipid peroxidation process. This is done by careful extraction 
of membrane lipids which have undergone peroxidation (usually under a nitrogen or argon 
blanket so they are not auto-oxidised) and their separation into different classes if a more 
detailed result is required. After hydrolysis to release the individual fatty acids and then 
estérification to make them volatile, they are separated and monitored by means of GC. This 
method is an accurate means of determining which individual fatty acids are consumed as the 
result of peroxidation and also for quantifying the overall lipid peroxidation.
1.5.6) CHEMILUMINESCENCE MEASUREMENT
Low level chemiluminescence at the whole organ, cellular and sub-cellular level is attributed 
to the peroxidation process in these systems and has been used as a direct measure of 
peroxidation (Boveris et ah, 1980; Ursini et ah, 1989). This method can be used to directly 
measure lipid peroxidation in vivo. The chemiluminescence response is stimulated by 
depletion of reduced glutathione and vitamin E (Ursini et ah, 1989). However, as the 
chemiluminescence also seems to be related to the activity of cycloxygenase and 
lipoxygenase (Schulte-Herbruggen & Cadenas, 1985) the specificity of the method for 
studying free radical mechanisms is in doubt
Chemiluminescence utilising the reaction of peroxides with luminol/haem reagents, has been 
used by a number of workers (Iwaoka & Tabata, 1984; Yamamoto & Ames, 1987). The 
method has the benefit of being specific for peroxide groups (Miyazawa et al., 1989) but 
specific groups have differing reaction rates with the reagents. Consequently, results from 
biological matrices may be difficult to interpret and other techniques have been used, such as 
HPLC, to increase specificity (Yamamoto & Ames, 1987; Miyazawa etah, 1989).
1.5.7) UPTAKE OF OXYGEN
As discussed earlier (section 1.1 and Fig 1.1), in the process of lipid peroxidation oxygen is 
taken up to form lipid peroxy radicals which after hydrogen abstraction results in the 
formation of the corresponding lipid hydroperoxides. Uptake of oxygen can be used as a 
measure of lipid peroxidation by monitoring the oxygen concentration of the atmosphere, 
above the closed chamber of the assay, using an oxygen electrode (Halliwell & Gutteridge, 
1989). It is interesting to note that historically, De Saussure pioneered studies of lipid
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peroxidation in 1820s using a similar method, although he did not have more than a simple 
mercury manometer available to him (cited by Halliwell & Gutteridge, 1989).
1.5.8) SUMMARY OF METHODS TO ASSESS LIPID PEROXmATION
It is apparent that a wide variety of methods for lipid peroxidation are available. However in 
every case, there is the potential for interference with the method which would lead to 
significant bias of the results under certain condition, particularly in the assay of tissue 
samples. In order to interpret results from such assays, it is extremely important to understand 
how the experimental conditions and nature of the assay sample will affect the results. While 
this is true of every analytical procedure, in the case of general methods of assessments of 
lipid peroxidation, tiie complexity of the system being studied, combined with the lack of 
selectivity of the available methods, exacerbate the problem.
1.6) AIMS OF THE PRO.TECT
A number of publications by various authors have reported an NADPH-dependent lipid 
peroxidation activity in rat liver microsomes and have suggested that the activity is enzymatic 
(Jordan & Schenkman, 1982; Davis etah, 1986; Yonaha e ta l, 1992).
Previous studies had reported that the microsomal membrane PUFAs, arachidonate and 
docosahexanoate, were the principal substrates for this NADPH-dependent lipid peroxidation 
in rat liver microsomes (Jordan & Schenkman, 1982). Yonaha and his collaborators (1992) 
reported partial purification of an enzymatic lipid peroxidation activity using a differential 
cholate solubilization method of rat liver microsomes. The initial aim of this study was to 
investigate whether the fraction obtained as a result of this differential cholate solubilization, 
is the same enzyme activity as in the microsomal fraction by determining the main fatty acids 
peroxidised by this fraction. Also the heat labile nature of the activity of this cholate 
solubilised fraction can be examined and compared.
Subsequently, the main objective of this project is to isolate and purify the enzyme 
responsible for NADPH-dependent lipid peroxidation. Since measurement of the lipid 
peroxidation activity is the only method available for monitoring the presence of the enzyme, 
the success and extent of purification achieved after each step, needs to be expressed as 
enzyme activity per total protein content.
A variety of purification methods have been successfully utilised in purification of other 
membrane enzymes, such as exclusion, ion-exchange and hydrophobic interaction 
chromatography. Their use will be assessed in this project
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CHAPTER 2: METHODS
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2.1) LIST OF MATERIALS A M )_ R EAGEN I  
SUPPLIERS
The fdlowing materials and reagents were obtained from Sigma Chemicals. St. Louis. 
Missouri. USA. :
Acetic acid (glacial),
Acryiamide: Bis-acryiamide 
(37.5:1 ratio).
Albumin (fatty acid free). 
Ammonium persulphate.
Ammonium sulphate,
Bromophenol blue,
Butylated hydroxytoluene.
Calcium chloride,
Coomassie brilliant blue, R250, 
Cytochrome c,
Diethylaminoethyl- Sepharose, 
Diethylaminoethyl- Sephadex, 
Dithionite,
Dithiothreitol,
Glucose-6 -phosphate, 
Glücose-6 -phosphate dehydrogenase, 
Glycerol,
Glycine,
Imidazole,
2-Mercaptoethanol,
Methanol,
Nicotinamide adenine dinucleotide, 
reduced form.
Nicotinamide adenine dinucleotide
phosphate, reduced form (type III), 
Phenylmethylsulfonylfluoride, 
Potassium acetate.
Potassium chloride.
Potassium phosphate,
Sephadex- G150,
Sephacryl S-3G0,
Sodium acetate.
Sodium chloride.
Sodium cholate.
Sodium dodecyl sulphate.
Sodium phosphate.
Sodium sulphate.
Sucrose,
TEMED(N,.N,N’,N ’- 
Tetramethylethylenediamine) 
Thiobarbituric acid,
Trizma™,
The following materials and reagents were obtained from Pharmacia. Alameda. CA. USA:
2*5'-ADP-Agarose gel,
• 2’-AMP,
• Carboxymethyl-Sepharose,
• CHAPS (3-[(3-cholamidopropyl) 
dimethylammonio]-l-propanesulfonate,
• Hydroxyapatite matrix,
• S-Sepharose gel,
29
The following reagents were obtained from the specified supplier:
• BCA lYotein assay kit,
• Centriprep^** 10/30 concentrators,
• Fatty acid esters,
• Iron pyrophosphate,
• n-hexane.
Pierce Company. Rockford. TL. USA: 
Amicon. Beverly. MA. USA:
Nu Chek Prep. Elvsian. MN.. USA:
K & K  laboratories. Plainview. NY. USA: 
Burdick & Jackson Laboratories. Inc.. 
Muskegon. ML USA.
All other laboratory reagents and solvents used were of the highest quality grade, that were 
commercially available.
2.2) PREPARATION OF MICROSOMES VIA A LOW 
SPEED CALCIUM AGGREGATION METHOD
Microsomes, despite their name, are not an organelle but are a sub-cellular fraction which 
consists of endoplasmic reticulum membranes. These form micelles due to the intrinsic 
behaviour of the membrane lipid bilayer when the cell is homogenised. Microsomes can be 
prepared using various methods, one of which is the Cinti & Schenkman calcium aggregation 
method which is described briefly below (Cinti etal., 1972).
Male Sprague-Dawley rats (Charles River, Wilmington, MA) weighing between 250-300 g, 
were killed by CCh suffocation, livers were removed, perfused with iced cold 0.9% (w/v) 
saline and homogenised in 10  volumes of 0.25 M sucrose containing 1 mM of 
phenylmethylsulfonylfluoride (PMSF), a serine protease inhibitor. The homogenate was 
centrifuged at 600 g for 10min at 4°C, and the sediment, which mainly consists of cell debris, 
nuclei, unbroken cells and remaining erythrocytes, was discarded. Lipids and triglycerides 
floating on the surface of the resultant supernatant were removed by first using suction and 
then passing the supernatant through a "cheesecloth". This supernatant was re-centrifuged at 
9000 g for 10 min to sediment mitochondria and the resultant supernatant was carefully 
separated from the pellet. After removing lipids and triglycerides, it was re-centrifuged for 10 
min at 17000 g to sediment light mitochondria and mitochondrial fragments. Then â 
calculated volume of 80 mM CaCl2  was added drop wise to die remaining supemaWt to 
achieve a final concentration of 8  mM. A tightly packed, pinkish, opalescent pellet was 
obtained by centrifugation at 2000 g for 10 min. This pellet was re-suspended in 10 mM Tris- 
HCl, 0.15 M KQ buffer, pH 7.5 and re-centrifuged to wash the microsomal pellet and remove 
any remaining haemoglobin and excess calcium from the microsomal pellet. The microsomal 
pellet was finally re-suspended in the desired buffer, 50 mM Tris-HCl buffer pH 7.5, for 
protein concentration determination, by the biuret protein assay method (refer to section
2.4.1).
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It has been reported (Thomas et al., 1985; Minotti & Aust, 1989) that contamination of 
microsomes with ferritin can be prevented using this calcium aggregation method for 
preparation of microsomes. Since ferritin is an iron storage protein that can contribute to 
membrane auto-oxidation under certain experimental conditions (Braughler et a l,  1986), its 
removal ensures that the microsomes are less susceptible to undesired auto-oxidation and 
hence damage to membrane phospholipids.
2.3) PREPARATION OF MICROSOMES VIA "ULTRA
CENTRIFUGATION" METHOD
As mentioned at the beginning of section 2.2, microsomes are micelles of endoplasmic 
reticulum membrane. Hence they can also be sedimented by differential centrifugation, 
without aggregation with calcium.
In this method, livers were removed, perfused with 0.9% (w/v) saline, homogenised and the 
same method of centrifugation was carried out as described earlier in section 2 .2 , up to the 
step when the 17000 g supernatant had been obtained.
The resultant supernatant, free of any nuclei, cell debris, mitochondria or mitochondria 
fragments was then centrifuged at a 105,000 g for 1 hour at 4“ C (ultra-speed centrifugation, 
hence the name). The clear supernatant fluid was decanted, the microsomal pellet removed, 
homogenised in half its volume of 10 mM Tris-HCl, 0.15 M KCl, 1 mM pyrophosphate, pH 
7.5, and re-centrifuged at 105000 g for 45 min. The clear, colourless supernatant was 
decanted from the microsomal pellet. This washing step removes some adsorbed proteins as 
well as haemoglobin from erythrocytes. If the resultant supernatant was not colourless, i.e. 
pinkish-red in colour, another washing step was necessary to ensure that the microsomal 
pellet was free of any contaminating haemoglobin. The reddish, translucent, jelly-like pellets 
were removed by overlaying with the desired buffer, and gently swirling the tubes. The 
microsomal pellet slid free, leaving a clear transparent pellet of glycogen on the bottom of the 
tube. These microsomal pellets were homogenised and the resultant microsomal suspension 
was translucent with a light pink colour.
 ERQIEM  ASSAYS & PURIFICATION 
PROCEDURES
2Æ1) METHODS USED IQ  DETERMINE PROTEIN 
CONCENTRATION
Preparation of the cholate cut solubilized microsomal fraction (CCMs) (see section 2.9) was 
first reported by Yonaha et a l  (1992). They used the biuret protein assay to determine the 
protein concentration. Therefore this assay was also used in the course of preparation of 
CCMs. The biuret assay was performed as described by Gomal et a l (1949), using a standard
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curve of 0-1.0 mg/ml of bovine serum albumin (BSA). Briefly, to a 0.5 ml set of samples at 
different dilutions, 2  drops of 10% (v/v) deoxycbolate detergent was added to make sure all 
the protein is solubilized. After vortexing to ensure mixing, 4.5 ml of biuret reagent (7.3 mM 
copper sulphate in sodium- and potassium-tartrate/ NaOH) was added, mixed and allowed to 
incubate for 5 minutes at room temperature prior to measuring absorbance at 540 nm. The 
results were compared to the standard curve obtained by plotting absorbance versus [BSA] 
standards, which were carried out simultanously.
However, the bicinchoninic acid (BCA) protein determination kit (Pierce Company, USA) 
was used for protein concentration determinaticm of all other fractions (such as eluate 
fractions post colunm chromatography). The BCA protein assay was chosen due to its higher 
sensitivity at lower protein concentrations and also since there is less interference by reagents 
commonly present in equilibrium buffers, such as Tris-HCl or DTT, at the concentrations 
used (Hinson & Webber, 1988). The BCA protein assay is based on a combination of biuret 
assay (reduction of cupric to cuprous ions by protein in an alkaline condition), with the highly 
sensitive and selective colorimetric detection of the cuprous cation when two molecules of 
bicinchoninic acid bind to a single cuprous ion to form a purple coloured complex which 
absorbs strongly at 562 nm. BCA protein assay, was also the assay of choice for the 
determination of percentage yield and fold purification as a result of purification steps. It was 
also used for the determination of the protein concentration of all the pooled eluate fractions.
It is important to mention that the protein concentration of eluate fractions obtained as a result 
of column chromatography, was generally estimated by measuring their relative absorbance 
(compared to buffer) at X= 280 nm, and then selected samples (such as those with lipid 
peroxidation activity) were subjected to BCA protein assay for a more accurate determination 
(rf protein content.
At times, the absorbance of the eluate fractions were also measured at 417 nm, to 
determine if these fractions contained any haem proteins.
2.4.2) SDS- PAGE TO DETERMINE THE EXTENT OF PURIFICATION
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) method was used 
to determine the purity of the fraction being examined, as judged from the number of bands 
and their intensity. This procedure was carried out as described in published literature 
(Matsudaira & Burgell, 1978) with slight modifications. Briefly, appropriate volumes of 
acryiamide: bis-acrylamide (37.5:1), separating buffer and water were mixed to obtain 6-12% 
separating gel which were de-gassed prior to addition of ammonium persulphate and 
TEMED, which initiate the polymerisation of the gel- The separating gel (6-12%, as required) 
was poured into the glass cast, using a Pasteur pipette, covered widi a layer of ethanol and 
allowed to set for at least half an hour prior to pouring the stacking gel. The stacking gel was 
allowed to polymerise, before the gels were inserted in to the electrophoresis tank. Fractions
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which had previously been incubated with an equal volume of the SDS-cocktail (consists of 
0.4 pM bromophenol blue, 0.7 M p-mercaptoethanol, 315 pM sucrose and 286 pM 
imidazole), were loaded into the designated wells, running buffer (0.21 M glycine, 3.7 mM 
SDS, and 27.5 mM Trizma) was added and gels run at constant v<^tage of 180 v for about 48 
minutes. Gels were then removed from the glass cast, rinsed throughly with distilled water 
before staining (with a mixture of 3 mM Coomassie Brilliant blue R250 in 50% (v/v) 
methanol and 10% (v/v) acetic acid) for at least 1 hour. The gds were then de-stained 
overnight whilst being shaken gently (destainer was 10% (v/v) acetic acid, 40% (v/v) 
methanol 2% (v/v) glycerol). Molecular weight bands were estimated by determining the 
Rf values (ratio of distance of the band from the beginning of the separating gel to distance 
travelled by the dye front) of each band and comparing it with R  ^values obtained from known 
molecular weight standards, run at the same time.
2.4J) SEPARATION. PURIFICATION AND CONCENTRATION BY
Ammonium sulphate is a commonly used reagent for“ salting-out” cytoplasmic proteins. It is 
an ideal salt since it is relatively inert and does not alter the functional activity of proteins and 
is easily removable by dialysis, Ammonium sulphate precipitation waa carried out as outlined 
below. Whilst a fraction was slowly stirred at 4°C, a pre-calculated amount of ammonium 
sulphate (to obtain the desired saturation level) was added in small aliquots and allowed to 
dissolve fully prior to further addition. When all the pre-calculated amount of ammonium 
sulphate had been added to the fraction, stirring was continued for a further 10 minutes. Then 
the fraction was centrifuged at 10000 g for 15 min in a swing bucket rotor. The precipitated 
proteins were removed and the resultant supernatant was carried forward , if desired, for 
further ammonium sulphate addition in order to precipitate other proteins at higher salt 
concentrations.
2.A4) CONCENTRATION USING CENTMPREF"- 10/ 30
Centriprep/** concentrator equipment, obtained Uom Amicpn Company, USA, is a container 
with a synthetic membrane with a set pore size, for instance in Çentriprep^**-fO, the cut-off 
point is 10 kDa, i.e. only solutes and proteins with molecular weight less than 10 kDa can 
cross the membrane. This container is held inside another tube which collects the solutes and 
components which cross the membrane. This diffusion through the membrane is facilitated by 
centrifuging the concentrator in a centrifuge under a low centrifugation force.
Centriprep 1050 (cut off point of either 10 kDa or 30 kDa) equipment were used as 
recommended by manufactures in order to concentrate fractions. This was done successfully 
without- loosing any lipid peroxidation activity as a direct result of the procedure. Briefly, 
samples were inserted in one chamber; and centrifuged at 4°C at 2000 g. Solutes and
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components with molecular weight below the cut-off point of the membrane passed through, 
leaving beMnd a more concentrated sample (Tsomides, 1993).
2.4.5) GEmRAL METBODSFOR COLUMN CMROMATOSRAPBY
A number of different matrixes were examined by column chromatography. The ratio of 
sample volume to bed volume, equilibrium buffer and elution buffers used are specified for 
each specific chromatography procedure in the results section. However, the general method 
for chromatography was similar and ean be summarised as follows:
All column chromatography procedures were carried out in a cold room at 4^C (except the 
final hydroxyapatite column in purificaticm erf cytochrome P-450 reductase, which was 
carried out at room temperature). Matrix was washed with at least 3 times its own volume of 
equilibrium buffer, 3/4 separate times. This repeated washing was carried out to remove any 
‘iine” particles, by allowing the matrix to precipitate to the bottom of the container after each 
wash prior to exchanging tire supernatant (containing the “fine” particles) with fresh 
equilibrium buffer Prior to loading the matrix into a column, tire matrix was suspended in 
about twice its own volume of buffer, and tire mixture was slowly poured into a clean, 
vertically positioned column, The column was usually packed under flow (i,e. the bottom 
column tap was kept open to allow buffer to elute through), and care was taken to avoid the 
matrix running dry. After the column was packed, at least 2-3 cm of clear buffer was Wt on 
top of the matrix, and then the reservoir containing the buffer was connected to the top of the 
cirfumn. The column was washed with at least another 3 times the bed volume erf matrix. The 
reservoir height was adjusted to obtain an optimum flow rate (between 150-250 pl/ml). The 
sample which was to be subjected to chromatography was usually loaded directly on top of 
the matrix under flow (although if the sample volume was large, it was loaded using the 
reservoir) after removing buffer on top of the matrix, to avoid dilution of the sample. Eluates 
were collected using an automatic fraction collector.
2.5> MICROSOMAL PHOSPHOLIPIDS
2.5.1)
liver microsomes were prepared from frozen rat livers, using the calcium aggregation method 
as described earlier in section 2 .2 , Microsomal phospholipids were extracted from liver 
microsomes using chloroform/methanol extraction procedure as described by Bligh and Dyer 
with slight modifications (Bligh & Dyer, 1959) as follows. Chloroform, water and also a 
chloroform/methanol mixture (ratio 1:2 ), were bubbled with nitrogen gas for 1 min to remove 
oxygen which may contribute to the auto-oxidation of membrane phospholipid. All
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procedures were carried out at 4°C in a separating flask covered by aluminium foil to protect 
t h ^  from light.
60 ml of chWoform/methanol (1 :2} mixtore was added to 15 ml of liver microsomes, 
adjusted to a protein concentration of 10 mg/ml in a 500 ml s^arating flask and shaken 
vigorously for 1 min. Then, 20 ml of chloroform was added, sh^en vigorously for 1 min, and 
allowed to settle. If the suspension was not monophasic, chloroform-methanol was added 
drop wise until it was. Subsequently, 25 ml of water was added, shaken for another minute 
and allowed to settle into layers (about 1 hour). The bottom, organic layer was poured off into 
a glass container, capped under an argon blanket and stored at 4“C in the dark. 40 ml of 
chloroform was then added to the separating flask, shaken vigorously and after separating into 
layers, the bottom organic layer was poured off into the same glass container. This extraction 
procedure was repeated three times. To the pooled chloroform extracts, a sufficient amount of 
sodium sulphate was added to remove water, and then it was left at 4“C overnight under 
argon. The chloroform extracts were then centrifuged at 2Q00 rpm for 2 min, any water 
droplets on the top removed and Ae clear chloroform solution transferred to another beaker, 
avoiding any contamination by sodium sulphate. Most of the chloroform was then evaporated 
by purging with nitrogen and then the highly concentrated lipid fraction in chloroform was 
transferred to a smaller pre-weighed container; All the chloroform was then evaporated by 
further nitrogen purging. The weight of the lipirf was determined by deducting the w ei^ t of 
the container from total weight. Extracted phospholipids were finally stored at 50 m^ml 
concentration in chloroform and under an argon blanket, at -20°C. The absolute spectrum of 
the lipid was examined (from 200-500 nm) to check qualitatively whether the lipid had been 
auto-oxidised (shoulder at 232 nm). This was done by taking an aliquot of lipid in chlorofcum 
and dissolving it in n-hexane and then the absolute spectrum was monitored.
2.6) CYTOCHROME P4S0 REDUCTASE
2.6.1) PURIFICATION OF NADPH-CYTQCHRQME P45« REDUCTASE
NADPH-cytochrome P450 reductase (EC.l .6.2.4) was purified from rat liver microsomes 
according to the method of Yasukochi & Masters (1976) with some modifications as follows: 
Microsomes were isolated using the ultra centrifugation method from frozen rat livers (see 
section 23). They were then solubilized with 10% (v/v) Bnulgen-911 and 5% (w/v) sodium 
cholate stock, to a final concentration of 1.3% (v/v) and 0.65% (w/v) respectively, by gentle 
stirring under an argon blanket for an hour at 4”C. After the npn-solubilized fractions were 
removed by ultra-centrifugation at 10,000 g for 45 minutes, the sample was loaded on a 
DEAE-Sepharose column, overnight. The column was then washed with the equilibrium 
buffw  ^ (25 mM Tris-HCl, 0;8% (v/v) Emulgen-911, 0.1% (w/v) sodium cholate^ 50 pM 
EDTA, 50 pM DTT, 25% (v/v) glycerol, pH 7.7) to remove unbound proteins and CYT P450;
and a second pool of CYT P450 was eluted by subsequently washing the column with a 
higher concentration of Tris-HCl equilibrium birffer (150mM Tris-HCl, 0.8% (v/v) Emulg^- 
911,0*1% (w/v) sodium cholate, 50 pM EDTA, 50 pM DTT, 25% (v/v) glycerol, pH 7.7) 
After the CYT F450 was eluted and cytochrome bsstartedto tafl off (measured by monitoring 
absorbance at 417 nm), the column was then subjected to a 0 -0 .,^  KCl gradient in the “high 
[Tris-HCl}” equilibrium buffer, to elute the bound proteins.
The cytochrome P450 reductase pool collected (based on activity as described in section 
2.6.2), was immediately loaded on to a 2',5-ADP agarose column for bio^iecific affinity 
chromatography, since cytochrome P450 reductase selectively binds to this column due to its 
affinity for its cofactor, NADPH, which is structurally related to 2’3 ’-ADP. An intense tight 
yellow band was observed at the top of the column, which after further washing of the column 
was eluted by the ^plication <rf 0.7 mM 2*-AMP* The resultant preparation was rendered free 
of detergent by loading it onto a hydroxyapatite (HA) column, to which cytochrome P45Q 
reductase binds, and then washed thoroughly with the equilibrium buffer, until the absorbance 
at28f> nm (detergents absorb at thia wavelength) of-the eluate dropped to zero. Subsequently, 
the cytochrome P450 reductase preparation was eluted with 325 mM potassium phosphate 
buffer, 20% (v/v) glycerol, pH 725 and immediately dialysed against 50 mM sodium 
phosphate buffer, 20% (v/v) glycerol, pH 7.25 and stored at--85“C. By recording the absolute 
spectrum (spectrum from 200-500 nm) of the cytochrome P450 reductase preparation, 
distinctive peaks were observed at 205, 277, 375 and 456 nm. Using the extinction coefficient 
of 214 mM‘^cm’1 at 456 nm, the concentration of cytochrome P450 reductase was calculated 
using the Beer-Lambert’s formula. An SDS-PAGE analysis of the purified cytochrome P450 
reductase is shown in figure 3.1.4.
2.6.2)
The cytochrome P450 reductase activity was measured by its ability to reduce cytochrome c, 
with NADPH as the electron donor. Assay components:
[STOCK]. VOLUME [FTNALJ
T m ^H C kp S T S 0*1 mM 23 ml 0*08niM
Cytochrome c 360 pM 0.5 ml 60 pM
FRACTION Diluted 25 pi Depends on Dilution
NADPH 5% (w/v) 
(53 mM)
25 pi 0.04% (w/v) 
(435 pM)
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The above samples were added in the order stated from top to bottom, to a 1 cm light path 
quartz cuvette, mixed and the cuvette inserted into a Shimadzu-spectrof^tometer. 
Immediately after the addition of NADPH, the rate of change in absorbance at 550-541 nm 
was measured at room temperature and recorded. Using the extinction coefficient of 19.6 
mM'^cm'ï the NADPH-cytochrome c reduction rate was.calculated.
Cytochrome P450 reductase was stOTed safely at -85°C for months without significant loss of 
activity. It was divided into small volume aliquots prior to freezing, to avoid repeated thawing 
which results in loss of enzyme acti vity .
2.7V MEASUREMENT OF CYTOCHROME P-450 AND 
CYTOCHROME k
Cytochrome P-450 content was measured spectrophotometrically as reported by Qmura and 
Sato (1964) using dithionite as the reducing agent. Briefly, difference spectra of fractions 
were measured as follows. Cuvetteacontaining the sample were placed in both the sample and 
reference compartments and they were botii reduced by the addition of dithionite. After 
recording the baseline, the cuvette in the reference compartment only, was saturated with 
carbon monoxide by carefully bubbling the gas through the cuvette for about 2 0  seconds. 
Difference spectra was recorded from 400-500 nm using a Shimadzu-spectrophotometer; By 
calculating the change in absorbance between 450-490 nm (corresponding with the distinctive 
450 nm peak, hence the name) and using the Beer-Lambert’s formula with the extinction 
coefficient of 91 mM 'cm \  the concentration erf CYT P450 in the sample was determined. 
Cytochrome b^  content was determined using the published method by Raw and Mahler 
(1959). Briefly, a difference spectra was recorded by placing cuvettes containing the sample 
in both the sample and reference compartments. After recording the baseline between 400- 
500 nm, using a Shimadzu-spectrophotometer, the sample cuvette (as opposed to the 
reference cuvette) was reduced by the addition erf dithionite. Difference spectra between the 
reduced and oxidised samples were recorded between 400-500 nm. By calculating the change 
in absorbance between 424-500 nm, and using the extinction coefficient of 112.1 mM'^cm'^ ; 
the concentration of CYT b^ was determined using the Beer-Lambert’s formula.
2.8V PREPARATION OF CHAPS SOLUBILIZED 
MICROSOMAL FRACTION
To a range of pre-calculated volumes of microsomes at 20 mg/ml protein concentration, a pre­
calculated volume of the Zwitterionic detergent, CHAPS, at a stock concentration of 10% 
(w/v) was added. This range covered a ratio of ‘Acrosomal proteimCHAPS detergent” 
concentration, from 6.3 to 33.5 (mg of protein/%w/v CHAPS), to determine the ideal ratio for 
preferential solubilization of the NADPH-dependent lipid peroxidation promoting factor.
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The additions were made in Eppendorf tubes, then incubated on ice for 15 minutes prior to 
centrifugation at 15000 rpm for 60 minutes in a desktop centrifuge, to sediment the insoluble 
proteins. The lipid peroxidation activity was determined in the reconstituted assay system, 
(2.10.2), and the protein concentration of each sample was determined using the BCA protein 
assay (2.4.1), and the specific activity was calculated.
2.9V PREPARATION OF CHOLATE-SOLUBILIZED
MICROSOMAL FRACTION
The differential solubilization of microsomes using cholate was carried out by the method of 
Yonaha and his collaborators (1992), with slight modifications, as follows. Microsomes were 
prepared and the protein concentration (biuret method) adjusted to 20 mg/ml, in 50 mM Tris- 
HCl buffer, pH 7.5 and were brought to 0.4% (w/v) final cholate concentration by tiie slow 
addition of a stock concentration of 2 0 % (w/v) sodium-cholate, gently homogenised, but not 
sonicated, and incubated for 15 minutes on ice. The suspension was centrifuged at 65000 g 
for 60 min, and the 0.4% (w/v) cholate solubilized supernatant was removed. The pellet 
obtained was suspended in the same volume of 50 mM Tris-HCl buffer, pH 7.5, and brought 
to 1.2 % (w/v) cholate concentration by the further addition of an appropriate volume of the 
20% (w/v) sodium cholate stock. The mixture was homogenised gently, incubated on ice for 
15 minutes and centrifuged at 65000 g for 60 minutes to remove the insoluble material. Lipids 
and triglycerides floating on the surface of the resultant supernatant were removed by first 
using suction and then by passing the supernatant through a "cheesecloth". The 1.2%- 0.4% 
(w/v) differentially solubilized supernatant fraction was designated as the cholate-cut 
microsomes (CCMs). It is important to note that although the sodium cholate detergent used 
for solubilization was obtained from Sigma Chemicals, USA and of high grade purity (99% 
purity), it was routinely washed with ethanol, prior to the stock preparations to remove yellow 
coloured bile impurities.
A more concentrated CCMs fraction was obtained by dialysing the sample against “50 mM 
Tris-HCl, 50 pM DTT, 1.2% (w/v) cholate, 20% (v/v) glycerol, pH 7.5 bufferi’, overnight. 
The presence of glycerol in the dialysis medium resulted in about 1.7-fold concentration of 
the CCMs fraction.
2.10V LIPID PEROXIDATION ASSAY SYSTEMS
Microsomal membranes are particularly susceptible to lipid peroxidation owing to the 
presence of high concentration of PUFAs. Pederson and his collaborators (1973) were the 
first to provide direct evidence for the involvement of cytochrome P450 reductase in the 
NADPH-dependent lipid peroxidation by demonstrating that an antibody to this microsomal 
flavoprotein, inhibited microsomal NADPH-dependent lijnd peroxidation by 90%.
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Furthermore, they demonstrated that a reconstituted lipid peroxide forming system composed 
of purified cytochrome P450 reductase, ferric ion chelated by both ADP and EDTA, and 
either isolated microsomal lipid or lipoprotein particles, promoted NADPH-dependent lipid 
peroxidation thus suggesting the invdvement of this^  enzyme in NADPH-dependent lifnd 
peroxidaticm (Pederscm et at., 1973).
2.10.0 MICROSOMAL LIPID PEROXIDATION ASSAY SYSTEM
The rate of lipid peroxidation of microsomes was monitored by the formation of TEARS 
using the TEA assay as follows: To a 30 ml conical flask,  ^the following reagents were added 
in the following order:
ORDER OF 
ADDITION
REAGENT [STOCK! [FINAL!
1 Tris-HCl 100 ndH 25 mM
BnffeTj pH 7.5
2 Ferric 225 pM 50 pM
Pyrophosphate
3 KCI 675 mM 150 mM
4 Microsomaf 20 mg/ml 0.5 mg/ml
Fraction
5 Distilkd Water To adjust the final volume
6 NADPH 5 mM 0.5 mM
The first five components of the mixture were incubated at room temperature for 30 minutes, 
prior to 2 min incubation at 3TC (this was done to be consistent with the reconstituted lipid 
peroxidation assay, where CCMs were present and a 30 minute incubation was introduced to 
allow equilibrium and possible liposomal formation in the presence of cytochrome P450 
reductase and exogenous phospholipids). Lipid peroxidation was initiated by the addition of 
NADPH to the mixture. Aliquots were taken fiom the assay mixture and added to an equal 
volume of 30% (v/v) trichloro-acetic acid (TCA)> vortexed and stored on ice until, the end of 
the assay. For a typical assay, 0.5 ml aliquots were taken at 0.5,15 and 30 minutes after the 
addition of NADPH and then added to 0,5 ml of 30% (v/v) TCA,
At the end of the assay, 0.5 ml of 0.75% (w/v) TEA reagent (which is 0.75% (w/v) TEA 
dissolved in 0.5% (w/v) sodium acetate), was added to all the test-tubes, vortexed and the 
tubes were heated in a boiling water bath, for 15 minutes. Test-tubes were allowed to cool on 
ice, centrifuged at 2000 rpm in a desk-top centrifuge to sediment the TCA-precipitated 
proteins, and then the absorbance of the pink supernatant was monitored at 532 nm in a quartz
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cuvette. Care was taken to avoid disturbing the protein pellet at the bottom of the test tube, 
and also to check that air bubWes were not formed on the interior wall of the quartz cuvette, 
both of which would result in a false increase in the absorbance values. The rate of specific 
NADPH-dependent lipid peroxidation was calculated by subtracting the absorbance of the 
sample obtained after 0.5 minutes of lijnd peroxidation, from the absorbance of the sample 
obtained after 30 minutes o f lipid peroxidaticm, {T (30-E.S min)}, hence TEARS formaticm 
can be attributed to NADPH-dependent lipid peroxidation during this time course, rather than 
TEARS previously presenL The non-specific auto-oxidation rate of the microsomal 
peroxidation was also examined by addition of water instead of NADPH, and monitoring the 
formation of the pink chromagen at 532 nm.
2.10.2Y THE RECONSTITUTED LIPID PER0XH>AT10N ASSAY 
SYSTEM
The reconstituted lipid peroxidation assay was essentially the same as die microsomal lipid 
peroxidation assay. However, in order to determine the activity of the cholate-cut fraction and 
the subsequently purified samples, it was important to be certain that the essential 
components of lipid peroxidation were present in the reconstituted system at a comparable 
activity to that in the microsomal lipid peroxidation system. Therefore in the reconstituted 
system, extracted microsomal membrane phospholipids and cytochrome P450 reductase were 
included together with the additional components of peroxidation, at a non limiting 
concentration, determined by experimental investigation. The final reconstituted lipid 
peroxidation assay system was as follows:
ORDER OF REAGENT [STOCK] [FINAL]
ADDITION
1 Membrane 50 mg/ml 0.5 mg/nd
phospholipid
2 Tris-HCLpH 100 mM 25^  mM
7.5; buffer
3 Sample / Desired
Fraction Concentration
4 CYT-F450 Dependent on 0.06 pM
reductase the [sample]
5 KCI 675 mM 150 mM
6 Ferric 225pM 50 pM
Pyrophosphate
7 Distilled water To adjust tiie final volume
8 NADPH 5 mM 0.5 mM
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A typical reconstituted lipid peroxidation assay was carried out as follows: To a 30 ml conical 
flask, 20 pi of 50 mg/ml membrane phospholipid (23.1) was added and purged with nitrogen 
gas to evaporate the chloroform. Then, 0.5 ml of Tris-HCl buffer , pH 7.5 was added, and 
sonicated under an argon blanket for 1 minute in a Branson Bath Sonicator. To the turbid, 
milky liposomes obtained, the required volume of the sample to be assayed (such as the 
CCMs fraction) was added, followed by the cytochrome P450 reductase and 0.675 M KCI 
and 225 pM FePPi. Distilled water was added to adjust the volume to 1.8 ml and the mixture 
was allowed to incubate at room temperature for 30 minutes. The conical flasks containing 
the above mixture were then inserted in a shaking water bath at 37“C, for 2 minutes prior to 
the addition of 200 pi of 5 mM NADPH to initiate the reaction. 0.5 ml aliquots were taken at 
0.5, 15 and 30 minute time periods and added to 0.5 ml of 30% (v/v) TCA, vortexed and 
incubated on ice until die end of the experiment The rest of the assay was essentially the 
same as for the microsomal lipid peroxidation assay (2 .1 0 .1).
2.11) ANALYSIS OF MICROSOMAL MEMBRANE 
PHOSPHOLIPIDS BY GAS-CHROMATOGRAPHY
Microsomal membrane phospholipids were extracted, before and/or after lipid peroxidation, 
as described in section 2.5.1. In order to separate the fatty-acids on a gas-chromatography 
column, it was essential to hydrolyse and esterify the fatty-acids, such that they were volatile 
enough to be separated using the fatty acid column. Extracted membrane phospholipids were 
hydrolysed and trans-methylated as indicated below. Methyl acetate was prepared as follows 
(Note: the reaction was carried out with care on ice due to the exothermic nature of the 
reaction);
CH3COCI + CH3OH —->  CH3COOCH3 + HCl
Incubation of the methyl-acetate with the phospholipids at 90“C for 2 hours, results in 
simultaneous hydrolysis and trans-methylation of the fatty-acids, as shown in figure 2 .1. 
Trans-methylated fatty acids were subsequently extracted with n-hexane and then dried using 
sodium sulphate. The transmethylated fatty acids were injected on to a Hewlett-Packard GC 
instrument to determine their composition. Separation of fatty acids was achieved on a 1 .8  m 
column, packed with 3% (w/v) Silar-lOC on Gas-Chrom Q (100-120 mesh) with helium as 
carrier gas at a flow rate of 15 ml/min. Maximum resolution of the fatty acids was 
accomplished by using a temperature program from 120-240°C at 10°C/min. The injection 
port was maintained at 240“C. The fatty acids were identified by their relative retention times 
compared with known standards (Nu Chek Prep, USA). Calculation of the microsomal fatty 
acid concentrations was based on the ratio of the area under each fatty acid peak to palmitic 
acid (16:0), a saturated fatty acid which was consistently unaffected as a result of lipid
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peroxidation or auto-oxidation as judged by the area under the curve, and thus acted as an 
internal standard. Subsequently, data were plotted as percentage fatty acid content compared 
to palmitate.
R2—
CH2
% C Rl
O CH + 2 CH3COOCH3
y
CH3—
CH2— PO4 — Base
0
O CH
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CH2 —  0
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R1 — I
R 2— '<
O
OCH3
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FIGURE 2.1; Simultaneous hydrolysis and trans-methylation of fatty acid 
side chains of a membrane phospholipid, by incubation with methyl acetate 
at yO°.C..for.2-hQBXS5
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CHAPTER 3: RESULTS
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3.1) THE RECONSTITUTED LIPID PEROXIDATION 
ASSAY SYSTEM
3.1.1) MICROSOMAL NADPH-DEPENDENT LIPID PEROXmATION & 
THE RECONSTITUTED LIPIP PEROXIDATION ASSAY SYSTEM
The methods commonly used, to determine the rate of lipid peroxidation including the 
NADPH-dependent lipid peroxidation, were given in section ZIO. As the main goal of my 
investigation was to purify the microsomal NADPH-dependent component responsible for the 
lipid peroxidation of phospholipids, it was vital to have a reliable lipid peroxidation assay 
system which closely resembled the microsomal NADKl-hpid peroxidation. To achieve this 
all the essential components responsible for this process were present in the reconstituted 
assay system (section 2.10.2). This enabled different microsomal fractions to be tested during 
the purificadon process to determine the extent of purification.
3.1.1.1) CHOLATE-SCÆUBILIZATION OF MICROSCHVfiES
A typical solubilisation result is presented in Table 2 . A 3-fold purification of lipid 
peroxidation activity was achieved by cholate solulnlizaticm.
FRACTION TOTAL PROTEIN Lipid peraxidation FOLD
ACTIVITY^ A (532y PURIFICATION 
MICROSOMES 300 mg (100%) 1.67(100%) 1
l,2%^4%CCMs^ 90 mg (30%) 1.47(88%) 3
TABLE 2: A TYPICAL PURIFICATION ACHIEVED AS A RESULT OF 
MICROSOMAL SOLUBILIZATION MIOCEDURE. (v/v) CCMs fraction
was prepared as described previousiy in section 2S^ Lipid peroxidation activity of each 
sample was determined at a concentration of 25 pFml by measnring change in
absorbance at 532 nm from 0.5 mm to 30 min% T(30-0,5 min). For experimental details in 
regards to lipid peroxidation assays and determination of TBARS formed, please refer 
to section 2.10.1. (for Microsomes) and section 2.10.2. (for Cholate solobilized fraction). 
Total protein content was determined by determination of samples' protein 
concentration usmg the commercial BCA-protein determination kit, as described in 
detail in section 2.4.1.
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The lipid peroxidation activity was measured by monitoring change of absorbance at 532 nm 
between T (30-0.5 min), which was due ta the ftmnation erf TBARS. As shown in figure 
3.1.1, almost all of the original lipid peroxidation activity of microsomal fraction, (A), is 
recovered in the CCMs fraction in the reconstituted systems, (B) and (C). (B) and (C) only 
differ in that (B) was dialysed against 20% (v/v) glycerol which concentrated the sample 
(section 2.9), whilst (C) was not dialysed. In this reconstituted assay system, lipid 
peroxidation activity measured is dependent on the presence of NADPH and CCMs fraction 
since in the absence of either of these fractions (D) and (E) respectively, negligible activity 
was observed. Experiment (E) was usually included in all lipid peroxidation assays as a 
measure of the auto-oxidation of the phospholipids in the reconstituted system and labelled as 
the "Blank**. Its T (30-0.5 min) value is deducted from aU other activities observed (in order to 
measure the true activity above the blank value).
FIGURE 3.1.1: H P I0  PEROXIDATION OF MICROSOMAL
vs RECONSTITUTED ASSAY SYSTEM
2.5
2 -
1.5 -
»
0.5 -
I
1 I
(A): Ms lipid peroxidation assay system at [0.5 mg/nd}^
(B): Reconstituted assay system, with 25 pl/ml (equivalent volume to 0.5 mg/nd of 
microsomes) of CCMs, post dialysis for 12 hrs against "50 mM Tris-HCl buffer, 50 pM 
DTT, 20% (v/v) glyeercrf, pH 7.5" buffer (rrier to section 2.9);
(C): Reconstituted assay system, with 25 pl/ral of CCMs (which was not dialysed);
(D): Reconstituted Assay system, without addition oi NADPH;
(£): Reconstituted assay system, in the absence of CCMs;
In (D) and (E), equal volume of water was added instead of NADPH and CCMs, 
respectively. For detailed ex{Kriment^ conditions, constituents and concentration of the 
Ms lipid peroxidation assay and reconstituted lipid peroxidation assays, please refer to 
section 2,19.1 and 2.10.2, respectively. n=5 experiments. Standard deviations (S.D.) are 
presented as error bars for each column.
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3.1.2) THE EFFECT OF HEAT ON LIPIP. PEROXIDATION ACTIVIIÏ 
OF THE CCMs FRACTION
As shown in figure 3.1.2, the lipid peroxidation activity in the CCMs fraction was heat labile, 
with 90% of the activity being lost on heating this fraction at 90°C for 5 minutes.
FIGURE 3.1.2: EFFECT OF HEAT ON LIPID  
PEROXIDATION ACTIVITY OF CCMs FRACTION
I
0.232
«uo
soL>«y
The activity of the CCMs fraction before and after heating at 90’C for 5 minutes. In 
order to maximise TBARS formation, the fractions were tested at 80 pl/ml 
concentration. The rest of the conditions were those in section 2.10.2. (n=3 experiments 
and error bars represent S.D.)
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3.13) THE RELATIONSHIP BETWEEN CCMs FRACTION 
CONCENTRATION AND THE LIPID PEROXIDATION ACTIVITY
The relationship between lipid peroxidation activity and the concentraticm of CCMs fraction 
is presented in the figure 3.13.
FIGURE 3.1.3! RELATIONSHIP BETWEEN CCMs 
CONCENTRATION AND LIPID PEROXIDATION 
ACTIVITY
2.5
I
1.5
s
I
0.5
S S
CCMs CONCENTTRATION (ul/ml)
For all concentrations except 5 & 10 pl/ml where only a single experiment was carried 
out, the vaines represent the mean ± SJ). of 8 determinations. For reconstituted assay 
experimental conditions, please refer to section 210.2.
Since the relationship was non-linear over the range studied, 25 pl/ml concentration of CCMs 
fraction in the reconstituted assay was the concentration of choice for the future work. This 
concentration was chosen as the control in all reconstituted lipid peroxidation assays; since it 
was the greatest concentration of CCMs fraction that could be used before a marked deviation 
from linearity occurred. At this concentration of CCMs in the reconstituted assay, a 
substantial activity above the background blank was observed which would permit sensitive 
measurement of lipid peroxidation activity. However, it is very important to note that the non- 
linearity of the relationship between CCMs fraction and lipid peroxidation activity, could 
translate to inaccurate estimation of the overall yield of the activity of the fraction studied.
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3.1.4) PURIFIED NADPH CYTOCHROME P450 REDUCTASE AND 
THE RELATIONSHIP BETWEEN ITS CONCENTRATION AND THE 
LIPID PEROXIDATION ACTIVITY
The NADPH Cytochrome P450 reductase was purified using multiple column 
chromatography procedures, as described in section 2.6.1. Typically, SDS-PAGE oi the 
sample obtained was performed to determine how pure was the final fraction. The SDS- 
PAGE in figure 3.1.4, demonstrates the purity of fractions eluted from the final purification 
step, hydroxyapatite column.
FIGURE 2AAl ^  SDS-PAGE OF NADPH- 
CYTOCHROME P450 REDUCTASE FRACTIONS
From left:
Lane 1: Standards [From top: 92 kDa, 69 kDa, 53 kDa, 40 kDa, 36 kDa and 12 kDa (which 
has not been separated from the dye front)].
Lane 2-8: 10 nmol of cytochrome P450 reductase fraction, eluted from the hydroxyapatite 
column.
77
LANE: 1 8
The lighter, lower molecular weight bands (estimated molecular weight of 60.5 kDa, based on 
Rf values) are the clipped forms of this protein, co-eluted with the intact enzyme (estimated 
molecular weight of 77 kDa) in the course of the purification steps.
48
The relationship between cytochrome P450 reductase concentration in the reconstituted 
assay, with the lipid peroxidation activity is presented in figure 3.1.5.
FIGURE 3.1.5! RELATIONSHIP BETWEEN LIPID 
PEROXIDATION ACTIVITY AND CYT-P450 
REDUCTASE CONCENTRATION
I
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IOOdM CYT P450 reductase 
60nM CYT P450 reductase 
19nM CYT P450 reductase
TIME/ minutes
The cytochrome P450 reductase content of CCMs faction was 19 nM, hence this 
represents activity in the absence of exogenously added cytochrome P450 reductase. 
Detei^ent solubilized purified cytochrome P450 reductase (as described in section 2.6.1) 
was added to other fractions to obtain final concentration of 60 and 100 nM of 
cytochrome P450 reductase. (Results are average of two separate experiments). For 
reconstituted assay experimental conditions, please refer to section 2.10.2.
Since in the process of preparation of CCMs, some cytochrome P450 reductase was also 
solubilized, the fraction invariably contained cytochrome P450 reductase as measured 
according to its ability to reduce cytochrome c. Hence in figure 3.1.5., the overall lipid 
peroxidation activity was monitored at different final concentrations of cytochrome P450 
reductase, by further addition of detergent-solubilized cytochrome P450 reductase to the 
reconstituted assay. Increasing the concentration of cytochrome P450 reductase in the assay 
also stimulates lipid peroxidation activity. This increase was not proportional to the 
concentration of cytochrome P450 reductase presenL Since a 1.7-fold increase in the 
cytochrome P450 reductase concentration, only gave a 6 % increase in activity, the final 
cytochrome P450 reductase concentration of 60 nM of cytochrome P450 reductase was
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chosen. This concentration was in agreement with previously reported concentration (Yonaha 
et al., 1992). This was done mainly for reasons of cost.
3.1.5) INVESTIGATION TO DETERMINE WHETHER THE 
CONCENTRATION OF NADPH IS A LIMITING FACTOR IN THE 
RECONSTITUTION ASSAY
As described previously, cytochrome P450 reductase has been shown to be an essential 
component of the reconstituted Upid peroxidation assay system. The cytochrome P450 
reductase accepts electrons from NADPH and transfers the reducing equivalents to either 
CYT P450 or other electron acceptor systems, such as the NADPH-dependent lipid 
peroxidation active fraction or a proposed "lipid peroxidase". It was initially reported by other 
investigators tiiat a 0.5 mM concentration of NADPH was sufficient to support microsomal 
NADPH-lipid peroxidation in the 30 minutes course of the assay (Yonaha et al., 1992). To 
confirm that NADPH does not become limiting in the 30 minutes course of the lipid 
peroxidation assay, an NADPH-regenerating system was added to the reconstituted system 
and its effect examined, at various cytochrome P450 reductase concentrations. This system 
regenerates NADPH from the oxidised NADP\ It consists of 5 mM glucose-6 -jAosphate in 
0.1 M Tris-HCl, pH 7.5 and 1 U/ml of glucose-6 -phosphate dehydrogenase. If NADPH is 
depleted in the course of the assay, it becomes a limiting factor and one would expect that the 
presence of a NADPH-regenerating system to contribute towards a sustained increase in the 
lipid peroxidation activity measured. The effect of the NADPH-regenerating system on the 
reconstituted system was tested at three different cytochrome P450 reductase concentrations 
and results are presented in figure 3.1.6.
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FIGURE 3.1.6; EFFECT OF NADPH-REGENERATING SYSTEM 
ON THE LIPID PEROXIDATION RECONSTITUTED SYSTEM 
AT VARIOUS CYT-P45a REDUCTASE CONCENTRATIONS
0 .5 -
+ Regenerating System 
W/O Regenerating System
[CVT-P450 reductase}
The effect of addition of the NADPH-regenerating system was examined at three 
different concentrations of cytochrome P450 reductase. The NADPH-regenerating 
system consists of 5 mM glucose-6-phosphate in 0.1 M Tris-HCl, pH 7.5 and lU / ml of 
glttcose-6-phosphate dehydrogenase. Reconstituted assay conditions were the same as 
reported in section 2.10.2. with CCMs fraction concentration at 25 pl/nd. The results are 
average of two separate experiments with S.D. of ± 3%.
It is clear from these results that at all three cytochrome P450 reductase concentrations, the 
presence of the NADPH-regenerating system did not enhance the lipid peroxidation activity, 
if anything the activity was decreased in the presence of the regenerating system. These 
results suggest that over the 30 minute course of the NADPH-lipid peroxidation assay in the 
reconstituted system, the 0.5 mM concentration of NADPH is probably sufficient and does 
not become a limiting factor under these experimental conditions. It is still possible that 
NADPH at 0.5 mM concentration is a limiting factor, and this question could had been 
tackled by simply increasing the concentration of NADPH in the assay. However, this 
possibility was not investigated and would be worth considering in future studies.
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3.1.6) THE CORRELATION BETWEEN THE MICROSOMAL
PHOSPHOLIPID CONCENTRATION Alfli IH E LIPID 
PEROXIDATION ACTIVITY
As the mechanism of lipid peroxidation has been thoroughly discussed in the introduction 
chapter, it should be quite clear that the PUFAs are the source of TBARS, formed as a result 
of peroxidation (section 1.1.1). Microsomal membrane phospholipids were chosen as they 
the actual substrate for the lipid peroxidation in vivo. Microsomal membrane phospholipids 
were extracted as described in section 25.1. TBARS formation was monitored at A (532) after 
addition of different concentration of pho^holipids to the reconstituted assay system and the 
reaction was started by either the addition of NADPH (to measure NADPH-dependent lipid 
peroxidation) or water (to measure auto-oxidation). Results are presented in figure 3.L7 
below;
FIGURE 3.1.7; RELATIONSHIP BETWEEN 
PHOSPHOLIPID CONCENTRATION AND LIPID 
PEROXmATION IN THE RECONSTITUTED system :
■  NADPH-LIPID PEROXIDATION ( 2  AUTOOXIDATION
1.5 -
<  0.5 -
[MEMBRANE PHOSPHOLIFÎD] ADDED TO REœNSTrrUTED SYSTEM 
(mg/ml)
Reconstituted lipid peroxidation assay was set-up as described in section 2.10.2 at 25 
pl/ml concentration of CCMs and various concentrations of exogenously added 
microsomal phospholipids (extracted as described in section 2.5.1). TBARS formation of 
samples was determined by monitoring A(532) of samples, 30 minutes after addition of 
either water (auto-oxidation) or NADPH (NADPH-dependent lipid peroxidation). n=l.
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It is apparent from figure 3.1.7 that there was minimal auto-catalytic breakdown of the 
phospholijnd in the reconstituted lipid peroxidation assay system and that it did not 
significantly contribute to the NADPH-dependent lipid peroxidation in the course of the 
assay.
However when the reaction was started by addition of NADPH to the CCMs fraction, 
significant amount of A(S32) was observed, even when no exogenous microsomal 
phospholipids were added (i.e. zero value on the x-axis). This is probably because although 
steps were taken to remove accessible lipid at every stage during the microsomal extraction 
and also differential cholate-solubüization, (removal by suction of the lipid and triglyceride 
layer floating on the surface of the supernatant fractions and also by passing samples through 
a few layers of "cheesecloth" after each centrifugation step), substantial amounts of 
phospholipids were still present in the CCMs to support lipid peroxidation in the absence of 
exogenously added phospholipids.
When extracted membrane phospholipids were added to the reconstituted lipid peroxidation 
assay system containing CCMs, there was an increase in the rate of TBARS formation up to 
addition of 0.5 mg/ml of exogenous phospholipid but there was no further significant 
influence on the lipid peroxidation activity by increasing the amount of exogenously added 
phospholipids to 1 mg/ml.
It is also worth mentioning that the presence of this phospholipid in the CCMs may cause an 
increase in the background of the samples, T (0.5 min), as seen in fractions obtained post 
column-chromatography. Although care was taken to remove jAospholipids from CCMs, the 
presence of contaminating phosjAolipids may have been responsible for the increase in the 
background and hence the decrease in the apparent lipid peroxidation activity, both post 
incubation and post chromatography of CCMs. This point must be taken into consideration 
upon future attempts to purify the lipid peroxidation active fraction which requires lengthy 
chromatography steps.
3J.71-THE -STABILITY OF IHE LIPID PEROXIDATION ACTIVITY 
OF THE CCMs FRACTION
In my experiments, the most important and difficult challenge in the purification of the lipid 
peroxidation active fraction was its instability. As shown in figure 3.1.8, lipid peroxidation 
activity was decreased to less than 30% of the original activity, simply by storing it at 4°C for 
120 hours. However, no substantial loss of lipid peroxidation activity was observed by storage 
of intact microsomes at 4"C for at least two weeks (data not shown). This loss of activity 
which is interrelated to the solubilization of microsomes, could to some extent be prevented 
by the addition of albumin (1 mg/ml) to the CCMs, but addition of various protease inhibitors 
such as PMSF, a serine protease inhibitor, did not appear to have any significant benefit as 
shown in figure 3.1.8.
53
FIGURE,3^.8: STABILITY OE_CCMsJLIPID 
PEROXIDATION ACTIVITY A T f C
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Reconstituted lipid peroxidation assay was performed as described in section 2.10.2. 
with CCMs fraction concentration at 25 pl/ml. (n= 5 ± S.D. for 24 hrs and 72 hrs, for 
odier time points, n=l).
The lack of effect of PMSF indicates that serine proteases are probably not responsible for the 
dénaturation of the lipid peroxidation activity. Protection of the lipid peroxidation loss of 
activity by albumin (fatty-acids free grade), could be either due to its “sacrificial antioxidant” 
function i.e. protecting the activity of the fraction by quenching the free radicals and reactive 
oxygen species as suggested by some investigators (Halliwell & Gutteridge, 1989) or due to 
its well known ability to sequester transition metals (binds copper tightly and iron weakly) 
and hence indirectly inhibiting various radical reactions which could result in loss of the lipid 
peroxidation activity (Halliwell & Gutteridge, 1986).
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3.1.8) THE EFFECT OF CARBON MONOXIDE ATMOSPHERE ON 
THE NADPH-DEPENDENT LIPID PEROXIDATION ACTIVITY OF 
THE CCMs FRACTION IN THE RECONSTITUTED ASSAY SYSTEM
To determine whether the cytochrcune P450s contribute in any way to the NADPH-dependent 
lipid peroxidation in the reconstituted assay system, the influence of a carbon monoxide 
atmosphere (which binds to the protoporphyrin IX moiety of cytochrome P450s and inhibits 
their activity) was examined. The results are presented in the figure 3.1.9.
FIGURE 3.1.9; RECONSTITUTED LIPID 
PEROXIDATION ASS AY WITH AIR. 80% CARBON 
MONOXIDE OR NITROGEN ATMOSPHERE
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ATMOSPHERE ABOVETHERBGONSTTTUTED ASSAY FLASK
The ^^ 100% VALUE” is the reconstitnted hpid peroxidation assay system wifli 25 pl/ml 
conc. of CCMs as described in section 2.10.2. The gas mixture atmosphere was achieved 
by inserting each flask individually in a distilled water tank and while held upside down, 
pre calculated volume of each gas was delivered to the inside of the flask which 
displaced tiie existing distilled water. The flasks were tiien capped before removing them 
from the tank and the reconstituted Hpid peroxidation assay components were 
"injected" through the plastic cap (n=l).
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Since it is generally accepted that CYT P450s are non-functional when bound to carbon 
mcmoxide, under reducing conditions (in the presence of NADPH & cytochrome P450 
reductase), it can be concluded from these results that cytochrome P450s in the CCMs 
fraction, do not contribute significantly to the TBARS formed as the result of the NADPH- 
dependent lipid peroxidation in the reconstituted assay system. Hence some other factor, 
which is not inhibited by the carbon monoxide atmosphere is responsible for this activity. 
However, this could have been tested by first of all measuring the total CYT P450 available in 
that particular CCMs fraction, (as described by Omura & Sato, 1964), and then comparing 
that value with the measurable carbon monoxide bound-CYT P450 in the sample with a 
sample taken from CCMs in the presence of 80% carbon monoxide atmosphere. From the 
above analysis, further evidence would have been provided to support the fact that all the 
CYT P450s present were carbon monoxide bound and hence rendered inactive.
In addition, another reconstituted system was prepared with a final concentration of 560 nM 
of detergent purified CYT-P450 2E1 (gift from Dr. A. Vosnezensky), but it did not exhibit 
any lipid peroxidation activity under similar conditions to the CCMs fraction (data not 
shown).
3.2) CHAPS AS AN ALTERNATIVE DETERGENT FOR
SOLUBILIZATION OF THE LIPID PEROXIDATION
ACTIVITY FROM MICROSOMES
Due to purification difficulties with the CCMs fraction, as discussed in sections 3.7. 
(primarily instability and also the behaviour (rf cholate containing equilibrium buffer in 
DEAE-anionic exchange column chromatography), CHAPS was considered as an alternative 
detergent to cholate due to its zwitterionic nature.
In an initial experiment, the ideal CHAPS detergent to protein ratio and its ability to 
solubilize lipid peroxidation activity was assessed. These results are shown in figure 32.1.
56
FIGURE 3.2.1! LIPID PEROXIDATION ACTIVITY OF 
CHAPS SOLUBILIZED MICROSOMES AT DIFFERENT 
PROTEIN TO DETERGENT RATIOS
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% UPED PEROXIDATION 
ACTIVITY COMPARED 
TO MICROSOMES ONLY
RATIO OF PROTHN: CHAPS (mg of protein : %w/v CHAPS)
Ratio of protein : [CHAPS] = Total protein (mg) : Final % (w/v) [CHAPS].
After addition of calculated amount of CHAPS to known amount of microsomal protein 
to achieve the desired ratio, fractions were incubated on ice for 15 minutes prior to 
centrifugation at 105000 g for 45 minutes. Supernatants were then separated and lipid 
peroxidation activity measured in the reconstituted assay system as described in section 
2.10.2. at 25 pl/ml conc. of fractions. 100% value = Microsomal lipid peroxidation in the 
absence of CHAPS (n=3 ± S.D.)
The data above suggests that the lipid peroxidation active fraction is solubilized to more or 
less the same extent at all the above protein to detergent ratios. Consequently, the stability of 
the CHAPS solubilized, lipid peroxidation activity was compared to the CCMs fraction, in 
the following time course.
57
FTGTTRE 3.2.2; STABILITY OF CHOLATE SOT.TJBILIZED 
vs CHAPS SOLUBILIZED MICROSOMAL FRACTION. 
LIPID PEROXIDATION ACTIVITY
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To 10 mg of microsomal protein, appropriate amounts of detergent were added to 
obtain 1.2% (w/v) concentration. "Ms + 1.2% (w/v) CHAPS" is equivalent to a 
Protein:CHAPS ratio value of 8.3 in the x-axis of figure 3.2.1. Lipid peroxidation 
activity measured in the reconstituted assay system as described in section 2.10.2. at 25 
{ll/ml conc. of fractions. Note: Testing "Ms + 1.2% (w/v) Cholate" fraction at 25 pl/ml 
conc. in the reconstituted assay system results in a final cholate concentration of 0.03% 
(w/v) in the assay (cf. Figure 33.1). It is also important to emphasise that the "Ms + 
1.2% (w/v) Cholate" fraction is different from ‘‘1.2%-0.4% (w/v) CCMs” fraction, since 
in the former, the 0.4% (w/v) cholate solubilized fraction has not been removed by 
centrifugation (n=l).
Further results showed that dialysis of CCMs fraction with equilibrium buffer containing 1% 
(w/v) CHAPS (necessary to equilibrate the fraction prior to loading on the column) resulted 
in 67% loss of lipid peroxidation activity (results not included). Alternatively, CCMs fraction 
was diluted 1:5 with equilibrium buffer containing CHAPS detergent (instead of dialysis). 
This simple dilution, resulted in the loss of activity by 30% compared to control (CCMs 
fraction diluted 1:5 with equilibrium buffer not containing CHAPS detergent).
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Since the stability of the CHAPS solubilized fraction did not improve much beyond that of 
CCMs fraction, solubilization using cholate detergent was continued based on the beneficial 
3-fold purification achieved as a result of 1.2%-0.4% (w/v) differential solubilization.
3.3) EFFECTS OF DIFFERENT REAGENTS ON THE 
LIPID PEROXIDATION ACTIVITY IN THE
RECONSTITUTED ASSAY SYSTEM
33.1) EFFECT OF SODIUM-CHOLATE DETERGENT ON THE 
RECONSTITUTION ASSAY SYSTEM
Sodium-cholate proved to be an inhibitor of the lipid peroxidation activity in the reconstituted 
system at concentrations of, and greater than 0.24% (w/v), as shown in figure 3.3.1.
FIGURE 3.3.1; EFFECT OF CHOLATE DETERGENT 
ON THE LIPID PEROXIDATION ACTIVITY 
OF THE RECONSTITUTED SYSTEM
i
I
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9
FINAL [CHOLATE]/
% (w/v)
Lipid peroxidation activity measured in the reconstituted assay system as described in 
section 2.10.2. using 25 pJ/ml concentration of fractions in the presence of different final 
cholate concentrations. Addition of 200 pJ/ml of either 1.2 % (w/v) or 1.4 % (w/v) 
cholate stock solution to the reconstituted assay system, resulted in the final cholate 
concentrations of 0.24 % (w/v) or 0.28% (w/v), respectively. (Results are average of 2 
separate experiments).
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3.3.2) EFFECT OF EMULGEN-911 ON THE LIPID PEROXIDATION 
ACTIVITY OF CCMs FRACTION IN THE RECONSTITUTED ASSAY 
SYSTEM
Emulgen-911 detergent was examined as a possible detergent for solubilization erf the lipid 
peroxidation active fraction. The data below shows that even at a concentration of 0.14% 
(w/v) of Emulgen-911, there is an extensive inhibitory effects on the lipid peroxidation 
activity in the reconstituted assay system.
FIGURE 3.3.2; INHIBITORY EFFECT OF EMULGEN 
DETERGENT ON THE LIPID PEROXIDATION 
ACTIVITY IN THE RECONSTITUTED SYSTEM
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Lipid peroxidation activity was measured in the reconstituted assay system as described 
in section 2.10.2. at 25 pl/ml conc. of fractions. Final conc. of Emulgen-911 at 0.02% 
(v/v) and 0.14% (v/v) was achieved by addition of appropriate volume of 0.7% (v/v) 
stock Emulgen-911 (n=l).
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3.33) EFFECT OF PHOSPHATE BUFFER ON THE T.TPTD
PEROXIDATION ACTIVITY ÛE THE CCMs IN THE
RECONSTITUTED ASSAY SYSTEM
Phosphate buffer was also examined as an alternative buffer for purification purposes, since it 
is the buffer of choice in numerous chromatography procedures, especially in the 
hydroxyapatite column chromatography. Results shown in figure 3 3 3 , indicate that 
phosphate inhibits the lipid peroxidation activity in the reconstituted assay system, and if 
phosphate containing buffer is to be used, its concentration will have to be decreased to a 
level where the inhibitoiy effects are minimal.
FIGURE 3.3.3; EFFECT OF PHOSPHATE BUFFER 
QN-THE LIPID PEROXIDATION ACTIVITY OF 
THE RECONSTITUTED SYSTEM
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Lipid peroxidation activity measured in the reconstituted assay system as described in 
section 2.10.2. at 25 pi/ml conc. of CCMs fraction. Effect of phosphate buffer was 
investigated by addition of either 350 pi of 5 mM sodium phosphate buffer to 2 ml of 
reconstituted assay (to achieve final phosphate concentration of 875 pM) or 350 pi of 
325 mM potassium phosphate buffer, pH 7.5, to 2 ml of reconstituted assay (to achieve 
final phosphate concentration of 57 mM). NOTE: Other reagents and conditions in the 
reconstituted assay were the same as described in section 2.102. (n=l).
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3.3.4) EFFECT OF GLYCEROL ON THE LIPiD PEROXIDATION 
ACTIVITY OF THE CCMs IN THE RECONSTITUTED ASSAY 
SYSTEM
Glycerol, a commonly used component in numerous column chromatography and purification 
procedures was not included in the early column chromatography purification as a precaution 
due to its antioxidant properties! However, as shown in figure 33.4, it was demonstrated that 
glycerol used at a concentration of up to 2 0 % (v/v) in the purification buffers (giving rise to 
3.5% (v/v) final concentration in the reconstituted assay) does not inhibit the lipid 
peroxidation activity and hence it was included in all the following column chromatography 
buffers. It is also important to mention that Dithiothreitol (DTT), a reagent commonly used to 
prevent auto-oxidation of proteins and enzymes, was without an effect on the lipid 
peroxidation activity and hence was included in the equilibrium buffer at 50 pM 
concentration (data not included).
FIGURE 3.3.4; EFFECT OF GLYCEROL ON 
THE LIPID PEROXIDATION ACTIVITY OF 
THE RECONSTITUTED SYSTEM
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Lipid peroxidation activity measured in the reconstituted assay system as described in 
section 2.10.2. at 25 pl/ml conc. of fractions. Final glycerol concentration was achieved 
by addition of an appropriate volume of 20% (v/v) stock (n=l).
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3.3.5) IHE EFFECT OF ADDITION OF BHT. IN THE HEATING 
STAGE OF THE TBA-ASSAY
As described earlier (in section 1.5.2.1), it had been reported by some investigators that the 
majority of TBARS are formed during the heating stage of the TBA-assay, and hence 
measurement of the pink chromagen, A (532)* is not an accurate method for measurement of 
the lipid peroxidation activity of the fraction (Gutteridge, 1986). This question was addressed 
by including the potent antioxidant, BHT, during the heating stage of TBA-assay and 
comparing the lipid peroxidation activity to the same sample in the absence of BHT. 
Although any fraction with substantial lipid peroxidation activity could potentially be used to 
determine if the heating stage of TBA-assay contributes to the TBARS formation, the DEAE- 
(1) *^ 03 M KCI + 0.4% (w/v) Cholate” eluate pool fraction (section 3.7.1) was used at the 
same time as when its activity was to be determined, in the following experiment represented 
in figure 3 3 3 .
These results clearly indicate no difference in the level of TBARS formation in the presence 
or absence of BHT, suggesting that the TBA-reactive substances are not formed during the 
heating stage, since otherwise there would be a substantial decrease in the TBARS formation 
in the presence of BHT in the heating stage of the TBA-assay.
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FIGURE 3.3.5; COMPARISON BETWEEN TEARS- 
FORMED.IN THE PRESENCE & ABSENCE OF BHT. 
DURING THE HEATING STAGE OF THE TBA-ASSAY
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Li{»d peroxidation activity was measnred at 25 pi/ml concentration "DEAE- (1) 0.5M 
KCl + 0.4% (w/v) cholate" elnate pool fraction (section 3.7.1), ± BHT in the heating 
stage of reconstituted lijnd peroxidation assay systan as described in section 2.10.2. 
100% value = A(S32) T (30-0.5 min) value for CCMs fraction. Final BHT 
concentration = 225 pM (Jordan & Schenkman, 1982)^  (n=l).
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SUMMARY OF THE RECONSTITUTED LIPID PEROXIDATION 
ASSAY RESULTS
An effective and specific reconstituted lipid peroxidation system was used which closely 
mimics the microsomal lipid peroxidation assay system. In this reconstituted assay, a 1.2%- 
0.4% (w/v) differential cholate cut microsomal fraction was used which retained about 90% 
of the lipid peroxidation activity but only 30% of the microsomal protein, hence a 3-fold 
increase in the specific activity was achieved. Hence in the reconstituted assay system, the 
majority of the lipid peroxidation activity was retained effectively by replacing microsomes 
with CCMs, extracted microsomal phospholipids, and cytochrome P450 reductase.
This activity was NADPH-dependent and a final concentration of 0.5 mM concentration was 
not a limiting factor in the 30 minute time course of the lipid peroxidation assay. This activity 
also appeared to be heat labile. The NADPH-dependent lipid peroxidation activity exhibited a 
non-linear relationship with CCMs concentration. The lipid peroxidation activity was 
dependent on the presence of the microsomal PUFAs and cytochrome P450 reductase. 
Unfortunately, the NADPH-dependent lipid peroxidation activity was not very stable, 25% 
loss of activity occurring in 24 hours when stored at 4°C. The stability was not improved by 
addition of serine protease inhibitor, PMSF. However, the addition of albumin at a 
concentration of 1 mg/ml did help, probably by acting as a "sacrificial protein". The use of 
CHAPS as an alternative detergent for solubilization, not only did not improve the stability of 
the activity, but the 3-fold increase in specific activity obtained by the use of the cholate 
detergent was lost by the use of CHAPS as the detergent.
The effects of certain reagents were examined in the reconstituted assay system. Phosphate 
buffer, cholate and Emulgen-911 detergents proved to be inhibitory of the lipid peroxidation 
activity in the reconstituted assay system, beyond a certain concentration, and hence it is 
important to either avoid such reagents or keep their concentration to a minimum during the 
lipid peroxidation assay. On the other hand glycerol, was not inhibitory over the concentration 
range examined. By addition of BHT to the sample prior to the TBA-assay, it was 
demonstrated that all of the TBARS measured were formed as a result of the lipid 
peroxidation active fraction in the assay, prior to the heating stage of the assay and the heating 
stage itself did not contribute towards further formation of TBARS.
In conclusion, the reconstituted lipid peroxidation assay system described, is comparable with 
the microsomal lipid peroxidation assay system. Also conditions and reagents which can be 
used to measure the lipid peroxidation activity of fractions post purification were determined.
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3.4  ^ GAS-CHROMATOGRAPHIC ANALYSIS OF
MEMBRANE FATTY-ACmS. AFTER A im h
OXIDATION & NADPH-DEPENDENT LIEID
PEROXIDATION
Many investigators have reported that arachidonic and docosahexanoic acids are the major 
fatty acids which are utilised as a result of NADPH-lipid peroxidation in microsomes 
(discussed in detail in section 1.13). The aim of this study was to determine whether the same 
fatty acids are utilised by CCMs fraction as a result of NADPH-dependent lipid peroxidation 
compared to auto-oxidation. The reconstituted assay was either initiated by addition of 
NADPH (NADEH-dependent lipid peroxidation) or addition of H^O (auto-oxidation) and 
after 30 minutes a sample was taken for lipid extraction (as described in section 2.5.1.) and 
then analysed on a GC fatty-acid column post hydrolysis and trans-methylation as described 
in section 2 .11 .
In figure 3.4.1, the effect of NADPH-dependent lipid peroxidation is compared with auto­
oxidation by CCMs fraction on membrane fatty-acids composition.
It is apparent that the biggest decrease in the microsomal membrane fatty acids due to the 
NADPH-dependent lipid peroxidation, are in the contents of arachidonic acid (20:4) and 
docosahexanoic acid (22:6); which decreased by 84% and 58%, respectively, relative to the 
auto-oxidative values.
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FIGURE 3.4.1; EFFECT OF NADPH-LIPID 
PEROXIDATION vs AUTO-OXIDATION ON 
MEMBRANE FATTY-ACID COMPOSITION
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Samples were taken after 30 min of either anto-oxidation or NADPH-lipid peroxidation 
by CCMs fraction. Phospholipids were extracted, hydrolysed and transmethylated as 
described in section 2.11. Trans-methylated fatfy-acids were then dissolved in 10 pi of n- 
hexane and 2 pi was injected to a Hewlett-Packard GC instrument with the mjection 
port maintained at 240'C and helinm as carrier gas at a flow rate of 15 ml/min, 
equipped with a fatty-acid separating colunm (as described in section 2.11). Fatty acids 
were separated by using a temperature gradient from 120-240*C at lO'C/min and fatty 
acids identified by their relative retention time compared to known standards. Fatty 
acid content was determined by auto-integration of areas under the curve, which were 
then represented as percentage value compared to palmitate.
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3.5  ^ PURIFICATION OF LIPID PEROXIDATION 
ACTIVITY BY AMMONDJM SULPHATE
PRECIPITATION
This procedure was successfully used to achieve between 9- to 11-fold purification of lipid 
peroxidation activity prior to any column chromatography purification steps. In figure 3.5.1 
below, an anunonium sulphate precipitation which was typical of the results is presented.
FIGURE 3.5.1: PURIFICATION BY AMMONIUM 
SULPHATE PRECIPITATION
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Lipid peroxidation activity measured in the reconstituted assay system as described in 
section 2.10.2. at 25 pl/ml conc. of fractions. Protein concentration was measured using 
BCA method as described in section 2.4.1. Ammonium sulphate precipitate fraction [75- 
45% (w/v)] was prepared as described in section 2.4.3. and then dialysed, (n=l).
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FIGURE 3.5.2: 9% SDS-PAGE OF THE AMMONIUM 
SULPHATE PRECIPITATED FRACTIONS;
All fractions were dilated to the same volume as the starting material (microsomes), 
Equal volumes of each fraction were loaded in each lane.
From left to right:
Lane 1: Standards [From top: 69 kDa, 53 kDa, 40 kDa, 36 kDa and 12 kDa (which has not 
been separated from the dye front)].
Lane 2: Microsomes.
Lane 3: CCMs after dialysis.
Lane 4 :30-0% (w/v) Ammonium Sulphate precipitate.
Lane 5:45-30% (w/v) Ammonium Sulphate precipitate.
Lane 6 : 75-45% (w/v) Ammonium Sulphate precipitate.
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The 75%-45% ammonium sulphate precipitate fraction which exhibited good lipid 
peroxidation activity, contained a prominent band at around 53 kDa region. This band was 
also present in lipid peroxidation active fractions, CCMs, and absent in the 30%-0% 
ammonium sulphate fraction which exhibited no lipid peroxidation activity. However, the 
presence of this band in the 45%-30% ammonium sulphate fraction, which had little lipid 
peroxidation activity, diminished the possibility of this band being the protein responsible for 
lipid peroxidation activity. Please note that other fainter bands were also present in the 75%- 
45% ammonium sulphate fraction.
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FIGURE 3.5.3; RELATIVE PURIFICATION OF 
LIPID PEROXIDASE BY 75%-45% AMMONIUM 
SUT.PHATE PRECIPITATION
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Relative specific activity of CCMs firaction post dialysis (against 50 mM Tris-HCl, 50 
pM DTT, pH 7.5, 20% (v/v) glycerol, to remove cholate), and subsequent 75-45% (w/v) 
ammonium sulphate precipitation.
Unfortunately, since cholate detergent also precipitates along with proteins (results not 
shown), it was essential to decrease its concentration to a minimum, by means of dialysis, so 
that it does not interfere with the selective protein purification procedure. This dialysis 
procedure alone, proved to render the sample more susceptible to loss of activity (data not 
shown), hence upon further treatment of such sample, such as column chromatography, the 
lipid peroxidation activity would be reduced in such a manner that the eluted samples could 
not be carried over for further purification steps (section 3.6). As a result, although it is 
possible to obtain an 11-fold purification by this purification step, it was decided to save this 
step for use further up in the purification ladder where a decrease in the lipid peroxidation 
activity would not be as vital as in the initial steps where many chromatographic steps are yet
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to follow. It is also worth mentioning that at times, when dealing with large volumes, 
ammonium sulphate precipitation was also used as a tool for concentrating the desired lipid 
peroxidation activity (section 3.7.2).
3 m PTTRTFTCATTON OF LIPID PEROXIDATION
ACTIVITY BY EXCLUSIQN-CHROMATOGRAPHY
Several exclusion- or gel-chromatographic procedures were carried out in order to achieve 
separation of the lipid peroxidation active fraction from other proteins. For this purpose 
Sephacryl-8300 & Sephadex G-150 matrix were most commonly used. An effective 
separation of lipid peroxidation active fractions was achieved using Sephadex G-150 gel 
filtration column. The presence of detergent in the equilibrium buffer proved to be essential in 
order to achieve good separation. However, due to inhibitory effects of cholate (discussed 
earlier in section 3.3.1) concentration of cholate in the eluate fractions had to be reduced prior 
to measurement of the lipid peroxidation activity. In figure 3.6.1, a successful 
chromatography of 75%-45% (w/v) ammonium sulphate precipitate fraction is demonstrated. 
In this chromatography, 1.2% (w/v) cholate was included in the equilibrium buffer which 
resulted in good separation of proteins. Judging from the elution profile, three distinguished 
peaks of proteins (monitored by absorbance at 280 nm) were separated and eluted, in the 
order of decreasing molecular weight. Judged from absorbance at 417 nm, a haem-protein 
was eluted off between fractions number 60-75. To determine if any lipid peroxidation 
activity remained post chromatography, at this instance all the eluate fractions were pooled 
together and dialysed to reduce cholate concentration to 0.015% (w/v). This was necessary in 
light of the experiment in which cholate concentrations as low as 0 .0 2 % (w/v) shown to 
interfere with ammonium sulphate precipitation by directly interacting with ammonium 
sulphate, probably by forming insoluble micelles, which precipitate out of solution (section 
3.5). This fraction was then subjected to ammonium sulphate precipitation to concentrate the 
sample and estimate percentage yield. The lipid peroxidation activity of resultant fraction, 
T(30-o.5>» was reduced due to numerous described steps and yield was only 14%. However in 
this chromatography, it was demonstrated that not only separation can be achieved by 
exclusion chromatography, but also activity can be recovered. But since the lipid peroxidation 
activity of 75%-45% (w/v) ammonium sulphate precipitate sample loaded itself is reduced by 
about half, and also chromatography, dialysis and further ammonium sulphate precipitation 
all resulted in further increase in the background, T (0.5 min), of eluate fractions, hence the 
resultant lipid peroxidation activity, T (30-0.5 min), was not sufficient to be carried forward 
for further purification steps.
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75%-45% AMMONIUM SULPHATE PRECIPITATE 
FRACTION ON SEPHADEX G-150 COLUMN____
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Sample loaded on Sephadex G-150 column was prepared as follows: CCMs were 
prepared (as described in section 2.9) and dialysed against 50 mM Tris-HCl, pH 7.5, 50 
pM DTT, 20% (v/v) glycerol; to reduce cholate concentration. Ammonium sulphate 
precipitation was carried out (as described in section 2.4.3.) and to the 75%-45% (w/v) 
ammonium sulphate precipitate, cholate detei^ent was added to obtain a final 
concentration of 1.2% (w/v) prior to loading on the column.
Sample was loaded on the column at a sample to bed volume ratio of 1:57. 
Chromatography was carried out at an elution rate of about 200 pj/min with "50 mM 
Tris-HCl, 1.2% (w/v) cholate, pH 7.5, 50 pM DTT, 20% (v/v) glycerol" as the 
equilibrium buffer.
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Lipid peroxidation activity, and hence percentage yield of recoveiy of the lipid peroxidation 
activity, was increased when 1 mg/ml of fatty acid free albumin was added to the equilibrium 
buffer. It has been shown previously (section 3.1.7) that albumin protects the lipid 
peroxidation activity of the fractions. However, the presence of albumin itself introduced a 
further burden to purification (results not shown).
Considering the above, alongside the fact that the fraction obtained post exclusion 
chromatography, exhibited a considerable amount of "background” TBARS, T (0.5 min), 
makes this chromatographic procedure un-suitable to be used as the initial step for separation 
of the lipid peroxidation active fraction. It was therefore decided to use this chromatography 
step at later stages of purification.
3.7) PURIFICATION OF LIPID PEROXIDASE BY 
DEAE-CHROMATOGRAPHY
BRIEF INTRODUCTION TO ION-EXCHANGE CHROMATOGRAPHY
The principal feature underlying this type of chromatography, is the attraction between 
oppositely charged particles. Many biological compounds, such as amino acids and proteins, 
have ionisable groups and the fact that they may carry a net positive or negative charge, can 
be utilised in separating mixtures of such compounds. The net charge exhibited by such 
compounds is dependent on their pKa values and pH of the solution, in accordance to the 
Henderson-Hasselbalch equation.
Ion exchange separation is mainly carried out in columns packed with an ion-exchanger. 
There are two types of exchanger namely cation and anion exchangers. Cation exchangers 
contain negatively charged groups and these will attract positively charged molecules. Anion 
exchangers have positively charged groups which will attract negatively charged molecules. 
Cellulose is a high molecular weight compound which can be obtained in a very pure state. 
Chemically modified cellulose has been successfully employed for separation of biological 
materials. Carboxymethyl cellulose (CM-cellulose), where the -CH2OH group is converted to 
-CH2OCH2COOH, and diethylaminoethyl cellulose [DEAE-cellulose, 
CH2 0 CH2CH2N(CH2CH3)2] are examples of the main derivatives of practical value. Closely 
related to the cellulose based exchangers, are those of Sepharose type derived from cross- 
linked agarose. Both the Sephadex and Sepharose types are particularly valuable for the 
separation of high molecular weight proteins and nucleic acids. Since all tiiese exchangers are 
closely related to the materials used for exclusion chromatography and have a matrix 
structure, they all have exclusion limits so that it is probable that some molecular sieving 
accompanies the ion-exchange process which may help in the over all chromatography 
resolution. Here I have summarised some of the experimental results obtained.
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3.7.1) DEAE- g )  CHROMATOGRAPHY;
In DEAE (1), represented in figure 3.7.1; CCMs was chromatographed on DEAE-column in 
the absence of any cholate detergent in the equilibrium buffer.
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2.0 ml of CCMs were loaded on to a DEAE-column (Bed volume = 5.2 ml) pre­
equilibrated with equilibrium buffer [E.B. = 50 mM Tris-HCl, pH 7.5,50 pM DTT, 20% 
(v/v) glycerol], elution rate = 140 pl/min. Eluted peaks were obtained as a result of 
washing the column with "E.B" (wash peak = fractions #1-7 inclusive); "E.B + 0.2 M 
KCl" (ffactions #12-18 inclusive); "E.B. + 0.5 M KCl + 0.4% (w/v) Cholate" (fractions 
#25-30 inclusive) and finally wifi: "E.B. + 0.5 M KCl + 1.2% Cholate" (fractions #34-41 
inclusive).
The DEAE- column was equilibrated with “50 mM Tris-HCl buffer, 50 pM DTT, 20% (v/v) 
glycerol, pH 7.5’. CCMs fraction was loaded directly on top of the matrix, and after washing 
the column with the equilibrium buffer, a “wash peak” was eluted (fractions 1-7). After the
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absorbance of eluate fractions at 280 nm approached the base line, the column was washed 
with equilibrium buffer containing 0.2 M KCl salt. This resulted in elution of some bound 
proteins, which were collected in fractions 12-18. A third peak was eluted by washing the 
column with equilibrium buffer containing an increased KCl salt concentration of 0.5 M and 
also 0.4% (w/v) of cholate detergent. It is interesting to note that the ratio of haem protein 
(417 nm) to total protein (280 nm) in this 3rd peak, is about half that of the former two peaks. 
Finally, the column was washed with equilibrium buffer containing OS M KCl and also 1.2% 
(w/v) cholate to elute off any remaining proteins still bound to the column. This resulted in 
elution of small amounts of proteins, which were collected in fractions 34-41.
The lipid peroxidation activity of the pooled eluate fractions was determined using the 
reconstituted assay system. Only the eluate fraction pools, obtained as a result of washing 
with equilibrium buffer containing “0.2 M KCl” and “0.5 M KCl + 0.4% (w/v) cholate, had 
any measurable lipid peroxidation activity. Hence, their protein concentration was determined 
using the BCA protein assay (section 2.4.1). These results are summarised in figure 3.7.2.
75
FIGURE 3.7.2; SUMMARY OF___
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Percentage recovery of lipid peroxidation activity and protein of the pooled eluted peak 
fractions firom DEAE (l)-ccdumn chromatography are shown. Lipid peroxidation 
activity was determined at 25 pi/ml conc, of fraction in the reconstituted assay system as 
described in section 2.10.2 (n=l). BCA assay was used to estimate protein content of all 
fracticms as described in section 2.4.1 (n=3) and percentage values are compared te  total 
microsomal protein ccmtent.
Using the results shown in figure 3.7.2, relative specific activity of both pooled eluate peaks 
were determined and presented in figure 3.7.3. Considering that CCMs fraction has a 3-fold 
increase in relative specific activity compared to microsomes (section 3.1.1), it can be 
deduced that the "0.5M KCl + 0.4% (w/v) cholate" eluate fraction had an overall 10-fold 
increase in relative specific activity compared to microsomes.
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FIGURE 3.7.3: RELATIVE SPECIFIC ACTIVITY OF 
ELU AXES FROM DEAE ri>-CHROMATOGRAPHY. 
COMPARED TO CCMS
FRACTION
Relative specific activity of DEAE (l)-ehiate firactions compared to the starting material 
(CCMs).
Comparison of SDS-PAGE of the DEAE-eluate fractions with microsomes and CCMs, did 
not reveal any information, at this stage of purification, on the possible molecular weight of 
the lipid peroxidation active protein band. This is represented in figure 3.7.4;
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FIGURE 3.7.4: 9% SDS-PAGE OF THE DEAE 1 
ELUATE FRACTIONS:
From left to right:
Lane 1: Standards [From top: 69 kDa, 53 kDa, 40 kDa, 36 kDa (barely separated from the 
dye front) and 12 kDa (which has been “run-off^ the bottom of the gel) ].
Lane 2: Microsomes.
Lane 3: CCMs.
Lane 4: DEAE 1: "0.2 M KCl" eluate pool.
Lane 5: DEAE 1: "0.5 M KCl + 0.4% (w/v) Cholate" eluate pool.
(15 pg of protein were loaded in lanes 2-5)
LANE
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3J,2)JPEAE- (2) CHROMATOGRAPHY:
A tight yellowish colour band was observed on top of the DEAE-matrix columns whenever 
cholate detergent was included in the equilibrium buffer. By passing equilibrium buffer with 
or without cholate detergent through two identical columns, It was determined that this 
yellow band was due to binding of a bile contaminant from cholate, to the matrix (although 
cholate detergent was thoroughly washed with ethanol and dried prior to use, to remove 
yellow coloured bile pigments). It was thought necessary to remove this contamination from 
equilibrium buffer prior to chromatography, since presence of such contaminants could not 
only interfere with DEAE-chromatography by altering the elution profile but may also be 
eluted off with the desired fraction and even result in loss of the activity of that fraction. To 
avoid an unnecessary risk, this contaminant was removed by passing the cholate containing 
equilibrium buffer through a "cleaning" DEAE column, and then the resultant eluted buffer 
was used in subsequent DEAE- (2) chromatography. Also to enhance binding of CCMs 
fraction to the DEAE-column, the chromatography was carried out at higher pH of 8 .0  and 
low ionic strength (10 mM Tris-HCl). It had also been determined that 0.4% (w/v) of cholate 
is sufficient to keep the fraction soluble to achieve good separation on DEAE-column (results 
not included). In the following DEAE-chromatography (2), CCMs fraction was 
chromatographed using the conditions described (figure 3 .7 .5 ).
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FIGURE 3.7.5! PEAE-f2> CHROMATOGRAPHY; ELUTION PROFILE FROM 
DEAE-SEPHAROSE COLUMN EQUILIBRATED WITH 10 mM TRIS-HCl.
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39.0 ml of CCMs was loaded on DEAE-Sepharose column of bed volume = 127 ml 
(Sample:Bed volume ratio of 1:3.3), Equilibrium Buffer (E.B.): "10 mM Tris-HCl, pH 
8.0, 50 fiM DTT, 0.4% (w/v) cholate, 20% (v/v) glycerol", passed through an initial 
"cleaning" DEAE-column. Elution rate = 220-258 pl/min, "0-0.5 M KC1+ E.B." gradient 
was applied from fraction #65-#127, "0.5 M KC1+ E.B." from fraction #127-#152. Lipid 
peroxidation activity was measured at 75 pl/ml concentration using the reconstituted 
assay system as described in section 2.10.2. Eluate fractions then pooled as follows:
Pool A = Fraction # 105-116, inclusive. Total volume (Vp) = 63 ml.
Pool B = Fraction # 117-125, inclusive, ( V t )  = 51 ml.
Pool C = Fraction # 127-132, inclusive, (V t) = 36 ml.
Pool D = Fraction # 133-140, inclusive, (V t) = 50 ml.
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The absorbance at 280 nm, 417 nm and lipid peroxidation activity of eluate fractions along 
the elution profile were measured at 75 pl/ml concentration. Eluate fractions 105-116 
(inclusive) exhibited measurable lipid peroxidation activity and hence were pooled and named 
“Pool A”. Fractions 127-132 (inclusive) were pooled, “Pool C ’, according to absorbance at 
280 nm peak and also substantial measurable lipid peroxidation activity at 75 pi/ ml. The 
eluate fractions in between these two pooled samples, i.e. fractions 127-132, were also pooled 
and labelled as “Pool B”. Finally, fractions 133-140 (inclusive) were pooled, “Pool D”, 
according to their absorbance at 417 nm peak and also some lipid peroxidation activity at 75 
pi/nd. All the above pooled eluate fractions were dialysed twice against non-cholate 
containing equilibrium buffer to reduce the cholate concentration to below 0.005% (w/v), and 
then concentrated by 75% (w/v) ammonium sulphate precipitation. The resultant pellet (or 
pellicle, in case of “Pool C”) was re-dialysed to remove excess ammonium sulphate Finally, 
lipid peroxidation activity of these pooled fractions was initially determined at maximum 
concentration of 2 0 0  pl/ml, using the reconstituted assay system as described in section 
2.10.2. Pools B and D did not exhibit any substantial lipid peroxidation activity, however 
results obtained by pools A and C were more encouraging. Their protein concentration and 
also lipid peroxidation activity was determined at 25 pl/ml concentration and compared with 
Ms and CCMs fraction. These results are presented in figure 3.7.6. and the relative specific 
activity of these latter two pooled eluate peaks, were calculated and presented in figure 3.7.7.
81
EL6URE 3.7.6; COMPARISON BETWEEN TOTAL PROTEIN 
AND LIPID PEROXIDATION ACTIVITY OF Ms. CCMs A N D  
DEAE- (2) ELUTE POOL FRACTIONS A & C
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Total protein content was estimated using the BCA protein assay as described in section 
2.4.1 (n=3). For microsomal fraction, lipid peroxidation activity was measured at 0.5 
mg/ml concentration as described in section 2.10.1 (n=l). For other fractions, lipid 
peroxidation activity was measured at equivalent volume to microsomal fraction (25 
pl/ml), using tiie reconstituted lipid peroxidation assay as described in section 2.10.2 
(n=l).
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FIGURE 3.7.T: RELATIVE SFEOFJC ACTIVITY 
OF DEAE (2) ELUATE FRACTIONS
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Relative specific activity of DEAE- (2) elnate fraction pools and CCMs, compared to 
microsomes. Relative specific activity= “%Total Activity “divided by “%Total Protein” 
of each sample (values obtained from figure 3.7.6).
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DEAE- (2) pool C exhibited a 10-fold increase in relative specific activity compared to 
microsomes, and over 3-folds over CCMs fraction. Hence, to compare the extent of 
purification, equal amount of this fraction (107 pg of protein, based on protein concentration 
determined by the BCA method, section 2.4.1.) was run alongside 107 pg of CCMs fraction, 
on a SDS-PAGE. Although four prominent bands were observed on the SDS-PAGE of the 
DEAE- (2 ) pool C, however a few fainter bands were also present. Altogether at this stage, it 
was not possible to identify the molecular weight of the band responsible for the lipid 
peroxidase. These results are presented in figure 3.7.8.
FfCTTRE 3.7.S: 9% SDS-PAGE OF THE PEAK- (2) 
ELUATE FRACTION:
From left to right:
Lane 1: Standards [From top: 69 kDa, 53 kDa, 40 kDa, 36 kDa and 12 kDa (which has not 
been separated from the dye front)].
Lane 2  CCMs.
Lane 3: DEAE-2 pool C (refer to figure 3.7.6).
(107 pg of protein was loaded in lanes 2 and 3)
LANE:
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DEAE-(2) pool C fraction was subjected to 75-45% (w/v) ammonium sulphate precipitation, 
concentrated 2.5-fold using the Centriprep™ -10 instrument as described in section 2 .4 .4 ., and 
then carried forward for further purification on Sephadex G-150 exclusion chromatography 
column, under the conditions specified below (figure 3 .7 .9 ).
EXCLUSION CHROMATOGRAPHY OF DFAF, 
f2) JOOL C. ON SEPHADEX G-150 COLT
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EKj URE  3 7  9: Sample loaded: DEAE-(2) pool C ---- > Dialysis (vs. E.B. W/O
albumin or cholate) ——-> 75-45% (w/v) ammonium sulphate precipitation — > 
Centriprep™ 10 (2.5-fold conc.) => This sample was called "X-139" (referring to lab- 
book 10, page 139).
5.9 ml of this fraction (X-139) was loaded on Sephadex G-150 (Bed volume = 178 ml ), 
Chromatographed with the following equilibrium buffer = 50 mM Tris-HCl, 1 mg/ml of 
albumin, 0.4% (w/v) cholate, 50 pM DTT, 20% (v/v) glycerol, pH 7.5. Elution rate = 140 
pl/mL Lipid peroxidation activity was measured at 75 pl/ml using the reconstituted 
assay system as described in section 2.10.2.
85
The lipid peroxidation activity was not separated from the main protein peak as a result of gel 
filtration under these conditions and hence no further purification was achieved. Besides, the 
background, T (0.5 min), TBARS of the fraction loaded on Sephadex-G150 column, X-139, 
was substantially raised as demonstrated in figure 3.7.10. This increase in the background 
TBARS also persisted in the eluate fractions from the Sephadex-G150 which resulted in 
lower lipid peroxidation activity of eluate fractions, measured as T (30-0.5 min).
FIftURE 3.7.10! LIPID PEROXIDATION ACTIVITY QE 
FRACTION "X-139 ' COMPARED TO CCMs FRACTION
CCMs
Fraction "X-139"
BLANK1 . 5 -
0 . 5 -
TIME / (minutes)
Fraction ’’X-139" = [DEAE-(2) pool C > D ialysis > 75-45% (w/v) ammonium
sulphate precipitation - > Centriprep”* 10 (2.5-fold concentration)].
Lipid peroxidation activity of all fractions were measured at concentration of 75 pl/ml, 
using reconstituted assay system as described in section 2.10.2.
Note: In “Blank’ -  75 pl/ml of equilibrium buffer was used in the reconstituted assay.
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It is worth mentioning that DEAE-chromatography (2) was very reproducible. When it was 
repeated, a similar elution pattern was observed, and lipid peroxidation activity was in eluate 
fractions corresponding with DEAE-(2) pool C (results not shown). However similar 
obstacles were encountered, such as an increase in the background, T (0.5 min).
Another very important observation is that the precipitate from 75%-45% (w/v) ammonium 
sulphate fraction which exhibited substantial lipid peroxidation activity, was a "pellicle" 
rather than a "pellet" upon precipitation i.e. it floated on top of the resultant supernatant after 
centrifugation rather than precipitating at the bottom of the centrifugation tube. This effect 
suggests that the lipid peroxidation active fraction has a lower density than the 7 5 % (w/v) 
ammonium sulphate supernatant and lends support to the possibility that the lipid 
peroxidation active fraction is a "lipo-protein". This has been discussed in more detail in the 
discussion chapter.
CHAPS was also examined as an alternative detergent in DEAE-chromatography instead of 
cholate (due to problems encountered with cholate detergent, as described earlier). Although 
good separation and chromatography was achieved in the presence of 1% (w/v) CHAPS 
(results not included), however due to problems encountered with CHAPS-solubilized 
fraction (section 3.2), use of CHAPS as an alternative detergent was abandoned and its use 
did not prove beneficial in DEAE-chromatography.
3.8)JHYDROXYAPATITE CHROMATOGRAPHY
Hydroxyapatite (calcium phosphate), is a widely used matrix in adsorbent chromatography 
for separation of proteins. An adsorbent may be described as a solid which has the property of 
holding molecules at its surface, particularly when it is porous and finely divided. It differs 
from an ion-exchanger in that the attraction of molecules to the surface of the adsorbent, 
ideally, does not involve electrostatic forces. Adsorption can be fairly specific so that one 
solute may be adsorbed selectively from a mixture. Separation of components by this method 
depends upon differences both in the degree of adsorption by the adsorbent and solubility in 
the solvent used for separation. These features are of course governed by the molecular 
structure of the compound. Unlike most other adsorbents, hydroxyapatite has some ion- 
exchange properties which aids separation. Although commercial forms of the matrix are 
available, the matrix used in these experiments was prepared in our laboratory as there were 
experimental observations indicating differences in the binding properties compared to the 
commercially available material.
Results of the initial chromatography with hydroxyapatite column were promising since 36% 
of the lipid peroxidation activity was recovered as a result of one step elution with 325 mM 
phosphate buffer as shown in figure 3.8.1.
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FIGURE 3^ l! HYDROXYAPATITE CHROMATOGRAPHY m  
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CCMs fraction was first dialysed against "50 mM Tris-HCl, pH 7.5, 50 pM DTT, 20% 
(v/v) glycerol" buffer to remove cholate detergent and then centrifuged at 105000 g to 
remove the insoluble materials (these steps resulted in only 11% loss in lipid 
peroxidation activity compared to CCMs fraction). This sample was loaded on the 
hydroxyapatite column which was pre-equilihrated with "5 mM sodium phosphate, pH 
7.5, 20% (v/v) glycerol," buffer (1:2 ratio of sample to bed volume). After loading was 
completed, the column was washed with equilibrium buffer (twice the bed volume), and 
then bound proteins were eluted using one step elution with "325 mM potassium 
phosphate, 50 pM DTT, 20% (v/v) glycerol" buffer. Fractions pooled and labelled as 
follows: Pool A (Wash eluate): Fraction #5-10 (inclusive), Pool B (325 mM potassium 
phosphate eluate): Fraction #11-15 (inclusive).
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upon measurement of the lipid peroxidation activity of two pools, pool B had retained 36% 
of lipid peroxidation activity of sample loaded on the column (measured at 25 pl/ml 
concentration of fraction, using the reconstituted assay system as described in section 2 .1 0 .2 , 
results not shown).
It is important to note that in this chromatography, CCMs fraction was not pre-dialysed with 
the equilibrium buffer prior to loading. This could be the reason for relatively poor separation 
achieved as is apparent from above chromatography elution profile. However, this does not 
account for the surprisingly and puzzling high recovery of lipid peroxidation activity in the 
pool B fraction, since the final concentration of phosphate in the reconstituted assay was 
about 8  mM, which is expected to result in substantial inhibition of the lipid peroxidation 
activity, as demonstrated in section 3.33.
In order to over come the inhibitory effect of phosphate buffer on the lipid peroxidation assay, 
a set of experiments were carried out to determine if bound proteins on hydroxyapatite 
column could be eluted using alternative methods. Use of high salt concentration in low 
phosphate buffer (625 mM KCl in 5 mM sodium phosphate, pH 7.5, 20% (v/v) glycerol 
buffer) was examined as an alternative elution method. However, it proved unsuccessful since 
bound proteins were not eluted using this method (results not included). Also use of Tris-HCl 
buffer instead of phosphate buffer was also investigated. Although CCMs fractions did bind 
to the hydroxyapatite column using "50 mM Tris-HCl, 50 pM DTT, 20% (v/v) glycerol, pH 
7 .5 "; however veiy little protein (and no lipid peroxidation activity) was eluted even with "1 
M Tris-HCl, 50 pM DTT, 1.2% (w/v) cholate, 20% (v/v) glycerol, pH 7.5" buffer (results not 
included).
In subsequent hydroxyapatite chromatography (2), CCMs fraction was diluted 1:2 with the 
equilibrium buffer (instead of dialysis), and bound proteins were eluted using step elution 
with increasing concentration of phosphate buffer as described in figure 3.8.2.
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FIGURE 3.8.2: HYDROXYAPATITE CHROMATOGRAPHY_t2) 
OF CCMs AFTER 1 ;2 DILUTION WITH 5 mM SODIUM 
PHOSPHATE BUFFER. 20% (v/v) GLYCEROL. pH 7.5
2.5
POOLC POOLEA(280)
POOLD
2 -
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HYDROXYAPATITE (2) Fraction number
1.5 ml of CCMs fraction was dilated 1:2 with the eqoilibriam buffer (5 mM sodium 
phosphate, 50 pM DTT, 20% (v/v) glycerol, pH 7S) and loaded on a hydroxyapatite 
column (sample to bed volume ratio = 1:4.5). The column was then treated with the 
following reagents (elution rate about 60 pl/min) and subsequent eluates were pooled
and labelled accordingly.
Equilibrium buffer (E.B.)= Wash, Pool A: Fraction #1-4, Pool B: Fraction # 5-10,
E.B.+ O.IM Phosphate buffer = Nothing eluted;
E.B.+ 0.2M Phosphate buffer = Pool C: Fraction # 46-52;
E.B.+ 0.3M Phosphate buffer = Pool D: Fraction # 53-61 ;
E.B.+ 0.3M Phosphate buffer + 1.0% (w/v) Cholate = Pool E: Fraction # 63-67;
Above pooled fractions were concentrated to original volume oi  CCMs fraction loaded 
on the column, using the Centriprep™ 10 instrument, as described in section 2.4.4. 
Concentrated pooled fractions were then dialysed against "50 mM Tris-HCl, pH 7.5, 50 
pM DTT, 20% (v/v) glycerol" to decrease phosphate (and cholate for pool E, only)
concentration(s) to minimise there inhibitory effects.
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Lipid peroxidation activity was measured at 25 pl/mt concentration, using the reconstituted 
assay system as described in section 2 .10%  Lipid peroxidation activity erf above pooled 
fractions were as follows (expressed as percentage values of lipid peroxidation activity 
compared to the sample loaded on the column):
Pool A & B: Equilibrium buffer (E.B, Wash)= 1%;
Pool C: E.B.+ 0.2M Phosphate buffer = : 0%;
Pool D: E.B.+ 0;3M Phosphate buffer = 0%;
Pool E: E.B.+ 03M Phosphate buffer + 1,0% Cholate = 36%;
Since pool E contained significant amount of lipid peroxidation activity, the total protein 
content of pool E was determined using the BCA protein assay (as described in section 2.4.1.) 
and total lipid peroxidation activity was compared with total protein content in order to 
determine if any purification was achieved. The results are demonstrated in figure 3.8.3.
FIGURE 3.8.3: PROTEIN CONTENT AND LIPID 
PEROXIDATION ACTIVITY CW HA-ELÜATE (2)
POOL (E). POST CONCENTRATION & DIALYSIS
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Comparison between total protein content and total lipid peroxidation activity of 
"hydroxyapatite (2)-pool E" fraction and CCMs fraction. Protein content was estimated 
using BCA-protein assay as described in section 2.4.1. Lipid peroxidation activity of 
fractions were measured using the reconstituted assay system as described in section 
2.10.2.
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Judging from data in figure 3.8.3, there was not a substantial increase (only about 1.6-fold) in 
relative specific activity of "hydroxyapatite (2) pool E" compared to CCMs fraction (about 5- 
fold compared to microsomes). However, attempts were made to further purify this fraction 
using Laurate-Sepharose chromatography. Although, good separation of proteins were 
achieved under chromatographic conditions (results not shown), subsequent eluate fractions 
did not exhibit any significant lipid peroxidation activity due to loss of activity.
3.9) PURIFICATION OF LIPID PEROXIDATION 
ACTIVITY BY CATIONIC EXCHANGER
CHROMATOGRAPHY
The principals behind ion-exchange chromatography were mentioned in section 3.7. In this 
section are presented the results obtained by using cationic-exchange matrixes, namely 
"Carboxymethyl (CM)-Sepharose" and "S-Sepharose" as tools for purification of the protein 
responsible for the NADPHrdependent lipid peroxidation activity.
Although a variety of chromatographic conditions were examined to maximise binding to a 
cationic exchanger (such as low pH and ionic strength), almost all of the protein and over 
95% of lipid peroxidation activity was recovered in the "wash" eluate (non-binding eluate 
fraction) after passing CCMs fraction through CM-column. Figure 3.9.1. represents a typical 
chromatographic result obtained using CM-column.
Using a stronger cationic exchanger matrix, S-Sepharose, at even lower pH of 6.0 resulted in 
similar chromatographic elution pattern as Carboxymethyl-(l), with all the lipid peroxidation 
activity being eluted in the Wash eluate pool (results not shown). Addition of detergents such 
as cholate or CHAPS (1% w/v), did not enhance binding of proteins to the above cationic 
exchanger matrixes (results not shown).
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FIGURE 3.9.1; CHROMATOGRAPHY OF 
CCMs ON CARBOXY METHYL MATRIX
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CCMs fraction was dialysed against equilibrium buffer (5 mM Tris-HCl, 50 pM DTT, 
20% (v/v) glycerol, pH 6.5) without significant loss of lipid peroxidation activity. Post 
dialysis CCMs fraction was loaded on pre-equilibrated carboxymethyl column (sample 
to bed volume ratio of 1:2). Eluate pool A (wash pool) was obtained when the column 
was washed with equilibrium buffer. When no further protein filetions were eluted 
IA.(280) slope dropped close to zero], the column was subjected to 0.5 M KCl in 
equilibrium buffer, which resulted in elution of pool B. Lipid peroxidation activity of 
eluate pool fractions A & B, were 95% and 0% respectively, compared to original 
sample loaded on the column, measured at 25 pl/ml using the reconstituted lipid 
peroxidation assay as described in section 2.10.2.
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3.tOY PURIFICATION OF LIPIB PEROXIDATION
ACTTVTTY_______ BY_______ LAIJRATE-SEPHAROSE
CHROMATOGRAPHY
The hydrophobie affinity chromatography^ Laurate-Sepharose, is commonly used to isolate 
CYT-P450s (Gibson & Schenkman, 1978), As the earlier data suggests that the NADPH- 
dependent lipid peroxidation promoting enzyme^is not a CYT-P450 form (section 3.1.8), it 
seemed logical to attempt purification of the lipid peroxidation promoting enzcyme by 
separating this protein from the CYT- P450s, and other proteins which bind to this column.
In Laurate-Sepharose (1), CCMs fraction was first dialysed against the equilibrium buffer [5 
mM sodium phosphate, 1.4% (w/v), 50 pM DTT, 20% (v/v) glycerol] prior to loading on the 
Laurate-Sepharose column. Upon chromatography, some of the proteins did not bind and 
were eluted after washing the column with the equilibrium buffer (“wash eluate peak”, eluate 
fractions 1-15). The columns was then subjected to a 0-0.5 M NaCl in the equilibrium buffer 
gradient, to elute off the bound proteins from the matrix. The absorbance of eluate fractions at 
280 nm (as an estimate for total protein content), and at 417 nm (to estimate haem-protein 
content) were monitored. Also the lipid peroxidation activity of some fractions along the 
elution profile were measured to determine the whereabouts of the lipid peroxidase peak 
(eluate fractions with high lipid peroxidation activity). These results are summarised in figure 
3.10.1.
As it can be observed, some of the lipid peroxidation activity was eluted in the "wash" eluate. 
Fractions 1-9 were pooled, “Pool A”, which had retained 37% of the original lipid 
peroxidation activity compared to the sample loaded on the column (CCMs, post dialysis). 
About 7% of the lipid peroxidation activity was eluted at about 03  M NaCl concentration, in 
eluate fractions 57-63, “Fool ffactiou B”. Purification achieved as a result of this 
chromatographic procedure was examined by looking at the SDS-PAGE of selected eluate 
fractions. These results are presented in figures 3.10.2. and3.103.
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CHROMATOGRAPHY OF CCMs ON 
LAURATE-SEPHAROSE COLUMN
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FIG URE 3.10.1; Chromatography of CCMs fraction post dialysis against equilibrinm 
buffer (5 mM sodium phosphate, 1.4% (w/v) cholate, 50 pM DTT, 20% (v/v) glycerol, 
pH 7.5). This sample was then loaded on the column and first peak (fi*action #1-9) was 
eluted by washing the column with the equilibrium buffer (3-fold the bed volume). A 0- 
0.5 M NaCl gradient in the equilibrium buffer was started at fraction number 20 which 
resulted in elution of another protein peak (Auctions #57-63). Lipid peroxidation 
activity of Auctions were measured at the maximum concentration of 200 pl/ml using 
the reconstituted assay system, as described in section 2.10.2.
Judging from comparison of protein bands of the lipid peroxidation active fractions on the 
SDS-PAGE (figure 3.10.2 & 3.103), a significant level of purification was not achieved as 
the result of this chromatography. It is important to note that a substantial amount of the 
activity of the fraction was lost prior to loading on the Laurate-Sepharose column, due to 
dialysis of CCMs fraction with the equilibrium buffer used.
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FIGURE 3.ia.2: 9% SDS-PAGE OF THE LAURATE- 
SEPHAROSE (1) FRACTIONS;
(Equal volume of each fraction was added to each lane)
From left tur%ht:
Lane 1: Standards [From top: 92 kDa (barely visible), 69 kDa, 53 kDa, 40 kDa, 36 kDa and 
12 kDa (which has not been separated from the dye front)].
Lane 2  LS-l, fraction #1.
Lane 3: LS I, fraction #5.
Lane 4: LS I, pool A (fraction #1-9).
Lane 5: LS I, fraction # ^ .
KDa
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FIGURE 3.10.3: 9% SDS-PAGE OF THE LAURATE- 
SEPHAROSE (1) FRACTIONS;
(Equal volume of each fraction was loaded on each lane)
From left to right:
Lane 1: LS I, fraction # 58.
Lane 2  LS I, fraction #60.
Lane 3: LS I, fraction #62.
Lane 4: Standards [From top: 69 kDa, 53 kDa, 40 kDa, 36 kDa and 12 kDa (which has not 
been separated from the dye front)].
Lane 5: LS I, poot^, fraction #57-63.
kDa
LANE:
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A combination of Laurate-Sepharose and hydroxyapatite chromatography was attempted in 
order to achieve further purification as described below:
Laurate-Sepharose (2) Eluate pool-A (wash pool), contained 37% of lipid peroxidation 
activity (measured at 25 pl/ml concentration in the reconstituted assay as described in section
2.10.2). As a result of this chromatography, 8 6 % and 61% of CYT P450 and b5  (measured as 
described in section 2.7) remained bound to the column and hence were not eluted in this 
fraction. None of the subsequent eluate fractions had any substantial lipid peroxidation 
activity. These results are summarised in figure 3.10.4 and 3.10.5.
CHROMATOGRAPHY OF CCMs ON 
LAURATE-SEPHAROSE COLt
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FIGURE 3.10,4: 17 ml of CCMs was loaded on a Laurate-Sepharose column pre- 
equilibrated with "5 mM sodium phosphate, 50 pM DTT, pH 7.5, 20% (v/v) glycerol" 
buffer (sample to bed volume ratio of 1:8.6). The c o l u m n  was washed with equilibrium 
buffer at 173 pl/min elution rate, eluate fractions were pooled (Wash pool, Auction #12- 
16). Starting at fraction #38, the column was treated with 0.5 M KCl in the equilibrium 
buffer.
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FIGURE 3.10.5; CYT-P450 & bs CONTENT OF 
CCMs & ELUTE FRACTION AFTER LAURATE 
•SEPHAROSE (2) CHROMATOGRAPHY
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Comparison between total CYT P450, CYT bg content (measured as described in 
section 2.7) and lipid peroxidation activity (measured at 25 pl/ml as described in section
2.10.2) of CCMs fraction and Laurate-Sepharose (2) pool-A fraction. Numbers on top of 
each column indicates the actual content of CYT P450 and CYT bg for each fraction. 
The number for l^id peroxidation activity is the percentage value compared to CCMs 
Auction.
Laurate-Sepharose (2)-pool A (figure 3.10.4), was then subjected to hydroxyapatite 
chromatography as described in figure 3.10.6. It had a 1.3-fold increase in relative specific 
activity compared to CCMs (figure 3.10.7) or 3.9-fold compared to microsomes.
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HYDROXY APATITE CHROMATOGRAPHY 
OF LAURATE SEPHAROSE-(2) POOL A
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FIGURE 3,10,6: To Laurate-Sepharose (2) pool A, sufiBcient cholate d eta ^ n t was 
added to obtain a final concentration of 1.2% (w/v). 26 ml of this fraction was loaded on 
a hydroxyapatite column pre-equilibrated with ”5 mM sodium phosphate, 50 pM DTT, 
20% (v/v) glycerol, pH 7.5" (sample to bed volume of 1:1.1). The column was washed 
with equilibrium buffer at 37 pl/min rate and then subjected to the following increasing 
concentrations of phosphate buffer: 0.1 M Na-Phosphate buffer (Fraction #30); 0.2 M 
Na-Phosphate buffer (Fraction #42); 03  M Na-Phosphate buffer (Fraction #58); 0 3  M 
Na-Phosphate + 1% (w/v) cholate (Fraction #72); 03  M K-Phosphate buffer + 1% (w/v) 
cholate (Fraction #80). Fractions were then pooled and labelled as follows:
HA pool A: #51-55; HA pool B: #72-81; #86-90, HA pool D: #91-96.
1 0 0
The active fraction obtained post Laurate-Sepharose and hydroxyapatite chromatography, 
hydroxyapatite pool-(C), had just over a 3-fold increase in relative specific activity compared 
to CCMs (or 10-fold compared to Ms). The pwc^tage protein content and lipid peroxidation 
activity of pooled eluate fractions obtained as a result of these two chromatography steps, are 
shown in figure 3.10.7.
FIGURE 3.10.7; LIPID PEROXIDATION ACTIVITY & PROTEIN 
CONTENT OF FRACTIONS OBTAINED AFTER LAURATE. 
SEFHAROSE^ND HYDROXYAPETITE CHROMATOGRAPHY
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Comparison between lipid peroxidation activity and protein content of fractions 
obtained post Laurate-Sepharose and hydroxyapatite chromatography. Protein content 
was estimated using the BCA protein assay as described in section 2.4.1. Lipid 
peroxidation activity was measured at 25 pl/ml and 200 pl/ml using the reconstituted 
assay, as described in section 2.10.2.
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A very important point is the major difference in the lipid peroxidation activity of Pool C and 
D, although these pools were eluted right after each other (figure 3.10.6). SDS-PAGE of these 
fractions failed to reveal any major difference in protein bands (results not shown).
It is also important to note that the relatively low yield of lipid peroxidation activity, was 
partly due to the labile nature of the lipid peroxidation activity and also to the length of time 
taken (6  days) for the above two chromatographies and all the required measurements to be 
completed, which resulted in substantial loss of activity.
In a subsequent Laurate-Sepharose chromatography (3), the presence of 13% (w/v) cholate in 
the equilibrium buffer was examined (elution pattern not shown here, but was very similar to 
Laurate-Sepharose (2) elution pattern). This resulted in substantially improved binding of 
CTYT P450s and b5  to the column. Only 2% and 15% of original CYT b5  and P450,
respectively, were eluted in the "wash" (non-binding) eluate fiaction-A However, the 
presence of cholate also resulted in a lower yield of lipid peroxidation activity in the "wash" 
eluate pool. These results are presented in figure 3.10.8. There also appeared to be some 
correlation between total (TYT P450 content and the lipid peroxidation activity of eluate 
fractions, hence the role of CYT P450s in lipid peroxidation activity was further investigated 
in more details, as described in section 3.1.8.
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Lipid peroxidation activity, Cytochrome P450s and bg content of Laurate-Sepharose (3) 
pool A ("wash", non-binding pool) compared to microsomes and CCMs fraction  ^Lipid 
peroxidation activity was measured as described in section 2.10.1 for microsomes and as 
described in section 2.10.2 for other fractions. Cytochrome P450 and bg content was 
measured as described in section 2.7.
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CHAPTER 4: DISCUSSION
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GAS-ŒROMATQGRAPHIC ANALYSIS OF MEBsffiSANE FATTY- 
ACIDS POST AUTO-OXIDATION & NADPH-DEFENDENT LIPID 
PEROXIDATION BY CCMs FRACTION
By extraction and estedOcadon of microsomal membrane phospholipids, it is possible to 
analyse the effect of "NADPH-dependent lipid peroxidation" and compare it to the effect of 
"auto-oxidation". By means of Gas-chromatography, one can measure the content of 
individual trans-methylated fat^-acids, and hence determine which fatty-acids are 
preferentially utilised in each process. As described in more detail below, it has previously 
been demonstrated by several investigators that the enzymatic NADPH-dependent lipid 
peroxidation in microsomes, results in a major decrease in the level of PUFAs, especially 
arachidonate (20:4) and docosahexanoate (22:6) fatty acids.
To investigate this, the NADPH-dependent lipid peroxidation activity isolated by differential 
cholate soluHlization (CCMs) was studied using the reconstituted assay system and compared 
to auto-oxidation by the CCMs fraction. It was clearly demonstrated that arachidonate (20:4) 
and docosahexanoate (22:6), are the primary substrates of CCMs in the process of NADPH- 
dependent lipid peroxidation leading to the production of the TEARS. There was an 84% and 
58% reduction in the contents of these fatty acids respectively, in the course of 30 minutes of 
NADPH-initiated lipid peroxidation.
These results showed that CCMs gave similar results to those obtained by Jordan & 
Schenkman (1982), who examined the fatty-acid content of membrane phospholipids of 
"microsomes" which had undergone 30 minutes of incubation at 37“C with NADPH, in a 
number of different species. They found little or no change in the levels of saturated and 
mouoenoic fatty-acids. However, marked changes were noted in the polyenoic fatty acids 
with pronounced decreases in arachidonic (20:4) & docosahexanoic acid (2 2 :6 ). When they 
compared rates of individual PUFAs consumed with MDA formation (measured as TEARS), 
only arachidonic acid demonstrated a linear relationship. They suggested that the MDA 
produced by this enzymatic process, is solely from arachidonate. However, according to their 
data, the ratio of arachidonate utilisation to MDA formation was approximately 3 to 1, 
indicating that pathways of arachidonate breakdown, other than that yielding MDA, may also 
exist.
May & McCay (1968) also examined changes in fatty acid composition and noted a decrease 
in certain PUFAs, but primarily arachidonate and docosahexanoate. However, MDA 
production only accounted for 12% of the fatty-acid utilised. A similar decrease in 
phospholipid unsaturated fatty-acids were also noted by others (Hogberg et al., 1973).
More supporting data came when it was shown that the addition of tritiated arachidonyl 
phosphatidylcholine to liver microsomes, gave rise to tritiated MDA in correlation with the 
added arachidonate (Davis et al., 1986). As the experimental outcome has been described in
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more detail in section 1 .13 ,1 only emphasise here that they concluded that the phospholipid 
bound arachidonate was the precursor of the MDA formed.
Experimental evidence presented in the thesis, demonstrate that the enzymatic lipid 
peroxidation activity isolated in CCMs fraction, behaves in a similar manner to the reported 
literature for intact microsomes by utilising primarily arachidonate (and to some extent 
docosahexanoate) as the source of TEARS formed. Further investigations were carried out to 
purify this factor so that its relative specificity for arachidonate as a substrate, and its Km and 
also Vmax values could be determined upon purification.
THE NON-INVOLVEMENT OF CYTOCHROME P450 IN THE NADPH- 
DEPENDENT MICROSOMAL LIPID PEROXIDATION
The involvement of cytochrome P450s in the NADPH-dependent lipid peroxidation has long 
been a matter of debate. It has been claimed that superoxide, generated as a result of 
enzymatic reduction of CYT P450s in a reconstituted system consisting of feiric-ADP, 
phospholipid liposomes, CYT P450 and its reductase, is responsible for the NADPH- 
dependent lipid peroxidation (Minakami et al., 1988; Koga & Nakano, 1992). Although, the 
same authors did not observe similar inhibitory effects with SOD in the intact microsomes, 
they accounted for this discrepancy as being due to the "structural complexity of 
microsomes". Other investigators (Morehouse & Aust, 1988; Sevanian et al., 1990) proposed 
that CYT-P450s were involved in iron reduction accompanied by lipid peroxidation in 
microsomes. On the other hand some investigators, with whom my results agree, have 
dismissed the involvement of CYT P450s in the NADPH-dependent lipid peroxidation 
process. Yonaha and his collaborators modulated CYT P450s levels with glycerol by taking 
advantage of the fact that solubilized cytochrome P450 is protected against conversion to a 
denatured form, CYT P420, by glycerol (Ichikawa & Yamano, 1967). They reported 
correlation between the CYT P450 level and the NADPH-dependent lipid peroxidation 
activity since samples with very low CYT P450 content, still exhibited substantial lipid 
peroxidation activity (Yonaha et al., 1992). These results can be disputed, since it is 
theoretically possible that trace amounts of a particular isoform of CYT P450 could be 
responsible for the NADPH-dependent lipid peroxidation.
All CYT P450s in the reduced state are inhibited by the binding of carbon monoxide to the 
haem moiety which also results in their characteristic peak at 450 nm. Therefore, I examined 
lipid peroxidation activity of CCMs, under a high enough concentration of carbon monoxide 
atmosphere to inactivate all CYT P450s present in this fraction. Even under these conditions, 
the lipid peroxidation activity of CCMs fraction was 95% of that in the absence of carbon 
monoxide atmosphere. These results are in agreement with those of other investigators who 
reported that an 80% carbon monoxide atmosphere, which should bind to CYT-P450s and 
hence not allow them to participate in the NADPH-lipid peroxidation, do not inhibit the
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NADFH-dependent lipid peroxidation (Davis eî al., 1986; Yonaha et al., 1992; Tampo & 
Yonaha, 1995).
Interestingly, it has been reported by some investigators that lipid peroxides formed during 
lipid peroxidation rapidly destroy hepatic microsomal cytochrome P450 (Hrycay & O'Brien, 
1971 ‘ Jeffery et al, 1977; Neriand et a l, 1981). It has also been proposed by other 
investigators that the iron released by this destruction of CYT-P450 may contribute to the 
lipid peroxidation process (Brown et a l, 1978; Iba & Mannering, 1987).
Hammad's group (1990) established a strain of rats that exhibited marked resistance to the 
hepatotoxic and carcinogenic actions of 3'-methyl-4 dimethyl aminoazobenzene and other 
carcinogens. They compared lipid peroxidation in the livers of these carcinogen resistant (R) 
and the parental sensitive (S) strain. On stimulation of lipid peroxidation by exogenous 
addition of NADPH, the TEARS value of microsomes obtained from R rats was signifîeantly 
lower than that of microsomes obtained from S strain. Although the liver microsomal fraction 
of the R group contained lesser amount of PUFAs (specifically arachidonate), this decrease 
was not sufficient to account for this lower activity of the NADPIT-dependent lipid 
peroxidation. They also did not find any difference in the content of CYT P450s or the 
cytochrome P450 reductase. Neither were the contents of all the antioxidants and activities of 
all the scavenger enzymes examined in the liver of R rats higher than that in S rats. On the 
basis of these observations, they concluded that "S and R rats may be equally capable of 
generating reactive oxygen species, however, an as yet unidentified microsomal protection 
systems may be induced to protect the R strain against lipid peroxidation". On the same 
grounds of reasoning, it is equally plausible that in the R strain, the component which 
promotes the NADPH-dependent lipid peroxidation (possibly the same lipid peroxidase under 
investigation in this thesis), is either not active, not expressed or expressed at a lower level 
resulting in the lower lipid peroxidation levels observed!
EFFECT OF CHOLATE AND AMMONIUM SULPHATE 
PRECIPITATION
Bile salts are often used to solubilize and purify electron transfer components of 
mitochondria. The technique of bile salt fractionation was developed to a high degree of 
sophistication by Hattefi and his colleagues (1962). The most commonly used bile salts, 
cholate and deoxy-cholate, have a polar and an apolar side and hence are amphipathic i.e. able 
to form micelles in aqueous solvents and to interact with other polar and apolar compounds. 
Bile salt micelles differ from micelles of other detergents by being smaller (between 4-8 
molecules per micelle for cholate, the aggregation number is variable depending on 
temperature and salt concentration) (Hoffman & Small, 1967).
Cholate and deoxy-cholate can be purchased as sodium or potassium salts, or as the free 
acids. The sodium cholate salt was purchased from Sigma Chemicals, USA at 99% purity and
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subjected to extensive ethanol washing as suggested by others (Tzagoloff & Penefsky, 1971) 
to remove bile contaminants. Although a yellow coloured pigment was removed as a result of 
this washing, when cholate containing buffers were passed through DEAE-columns, a tight 
yellowish-brown band was observed on top of the columns. This indicated that cholate was 
probably not completely free of the contaminating bile pigments, which may also interfere 
with the purification procedure itself or even inhibit the lipid peroxidation activity of the 
eluate fractions. There is also the possibility that some of the negatively charged cholate 
detergent could bind to the positively charged DEAE-matrix, thereby rendering this detergent 
unsuitable for anionic exchange chromatography.
The inhibitory effect of cholate on the lipid peroxidation activity has been clearly documented 
in my results. This inhibitory effect is reversible since by removal of cholate by either dialysis 
or reduction of its concentration by dilution with a non-cholate containing buffer, the activity 
was recovered.
It is also important to emphasise the interfering role of cholate detergent in the ammonium 
sulphate purification step. Selective precipitation of proteins by salting-out can be a powerful 
purification tool. Ammonium sulphate is a particularly useful salt since it is very soluble and 
relatively inert as it does not have any harmful effects on the protein structure and it also can 
be obtained in a high degree of purity. Ammonium sulphate precipitation has been repeatedly 
used in the purification of various proteins, especially in the initial steps of purification. 
However, bile salts themselves are precipitated from aqueous solutions by high concentration 
of salts. According to published literature, \% (w/v) cholate detergent is precipitated at about 
40% (w/v) ammonium sulphate concentration (Tzagoloff & Penefsky, 1971). This is in 
agreement with my observations, as white precipitates were formed upon addition of 
ammonium sulphate salt to equilibrium buffer containing 1.2 % (w/v) cholate salt at about 
35% (w/v) ammonium sulphate saturation (results not included). Therefore it was also 
essential for the concentration of cholate detergent to be reduced to a minimum, by either 
dialysis, dilution or Centriprep’“ 10/30 concentration and subsequent dilution, so that the 
ammonium sulphate precipitation was practical without co-precipitation of interfering cholate 
detergent. This required carefully controlled dialysis, since complete removal of detergent 
could lead to the premature precipitation of proteins including the desired NADPH-lipid 
peroxidation promoting enzyme.
Between 9- to 11-fold of purification was achieved, using ammonium sulphate precipitation 
of the post dialysed CCMs fraction. Unfortunately, although this fraction had measurable 
lipid peroxidation activity, the total amount of activity was reduced due to an increase in the 
background TBARS, T (0.5 min), to such an extent that upon further column 
chromatography, or other purification steps, it would not be possible to distinguish activity 
from background. As a result of these findings, it was decided to leave this purification tool to 
a later stage, since after the ammonium sulphate precipitation the activity of the fractions 
were not recovered. Furthermore, even with 9-11 fold purification, it was not possible to
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identify a particular protein band on SDS-PAGE electrophoresis which corresponded with the 
lipid peroxidation activity. Theoretically, by running several lipid peroxidation active 
fractions side by side on SDS-PAGE, one should be able to identify the band(s) 
corresponding to the activity. This can only be achieved by adjusting the concentration of 
samples, such that they would all yield similar lipid peroxidation activity at that specific 
concentration. Although a number of different fractions obtained from different purification 
methods were examined, this method did not produce any convincing evidence on the 
possible molecular weight of the lipid peroxidase.
EFFECT OF PHOSPHATE BUFFER ON THE LDPID PEROXTOATION 
ACTIVITY IN THE RECONSTITUTED SYSTEM
It has long been established that phosphate is a strong chelator for transition metals including 
iron (Lai & Piette, 1977; Cohen & Cederbaum, 1980). It is therefore not surprising to observe 
an inhibition of the lipid peroxidation activity in the reconstituted system due to the presence 
of increasing concentration of phosphate, since it chelates the iron from the reconstitution 
assay and therefore make this essential component inaccessible to the lipid peroxidation 
active fraction. Phosphate is therefore essentially competing with the lipid peroxidation active 
fraction in the reconstituted system for the available iron and its concentration must be kept at 
a minimum so that sufficient iron is available to participate in the lipid peroxidation assay. It 
is important to note that the role of pyrophosphate (in the form of ferric pyrophosphate) in the 
reconstituted assay system was to keep F e^  ions in a soluble form so that they can participate 
in the lipid peroxidation process. An alternative approach to investigate the inhibitory effect 
of phosphate (which was not explored) is to increase the iron concentration in the lipid 
peroxidation assay, whenever there is high concentrations of phosphate present in the eluate 
fraction buffers. This might have eliminated the need for lengthy dialysis or "Centriprep™" 
centrifugation of the sample to decrease the phosphate concentration of the fraction prior to 
the lipid peroxidation assay,
CYTOCHROME P450 REDUCTASE CONCENTRATION AND LIPID 
PEROXIDATION ACTIVITY
In 1973, Bidlack et al. reported that since NADH does not support lipid peroxidation, and the 
NADH reduced cytochrome b5 was not oxidised by the ferric chelate, the peroxidizing 
system must occur prior to c)4ochrome b5 and most likely via the NADH-cytochrome b5 
reductase. At the time it was not established whether this enzyme was the same or different 
from the NADPH-cytochrome c (P450) reductase. But soon after, Pederson and his 
collaborators (1973) showed for the first time, that antibodies to cytochrome P450 reductase 
inhibited the NADPH-dependent lipid peroxidation of endogenous microsomal lipid by more
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than 90%, indicating that cytochrome P450 reductase is involved in NADPH-lipid 
peroxidation. These results have since been confirmed by other investigators (Jansson & 
Schenkman, 1977). It was also demonstrated that p-chloromercuribenzoate, an inhibitor of 
cytochrome P450 reductase, also inhibited the NADPH-dependent lipid peroxidation (Iba & 
Mannering, 1987).
In the lipid peroxidation reconstituted system used in this thesis, a final cytochrome P450 
reductase concentration of 60 nM was used which was the same concentration as that used by 
other investigators (Yonaha et ah, 19%; Tampo & Yonaha, 1995). At a higher concentration 
of 100 nM there was less than 10% increase in the lipid peroxidation activity observed. From 
the experimental data it was apparent that a cytochrome P450 reductase concentration of 60 
nM was close to the saturating level and seemed to be sufficient for optimum lipid 
peroxidation activity in the reconstituted assay system.
It was also demonstrated that purified cytochrome P450 reductase in the presence of extracted 
phospholipids, and NADPH alone could not reduce iron-pyrophosphate leading to lipid 
peroxidation, in agreement with other authors (Tampo & Yonaha, 1995) and also in 
agreement with the results described for the reduction of Fe^+ ADP by others (Tien et al., 
1981).
By addition of exogenous cytochrome P450 reductase to the reconstituted assay, it was made 
certain that this component was not the limiting factor in the assay and hence activity could 
be correlated to the method used and the extent of the purification of the subsequent fraction 
under investigation.
It has been reported by Emster & Nordenbrand (1982) that although lipid peroxidation results 
in inactivation of various enzymes such as glucose-6-phosphatase and CYT-P450s by its 
conversion to cytochrome P420, the cytochrome P450 reductase activity remains constant 
during the lipid peroxidation assay. This is in agreement with the hypothesis about the 
enzymatic nature of this lipid peroxidation reconstituted system, since cytochrome P450 
reductase being an important component of this system, remains intact during the lipid 
peroxidation process.
MICROSOMAL PHOSPHOLIPID
Microsomal phospholipids are included in the reconstituted assay at an optimal concentration 
in order to make sure that the lipid peroxidation activity can be correlated with the 
microsomal solubilized fraction. Since the microsomal lipid peroxidation activity is assayed 
at 0.5 mg/ml of protein concentration, then 0.5 mg/ml of extracted microsomal phospholipids 
should provide sufficient amounts of phospholipid for the lipid peroxidation assay. This was 
examined and as presented in the results, seems to be a sufficient concentration for optimal 
lipid peroxidation assay. These results were in agreement with the concentration used by 
other investigators (Yonaha et al., 1992; Tampo & Yonaha, 1995).
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NADPH & LIPID PEROXIDATION
The presence of a novel microsomal electron transport component, which is specifically 
reduced by cytochrome P450 reductase and is involved in promoting the NADPH-dependent 
peroxidation of microsomal lipid has been proposed by other authors (Pederson et al., 1973). 
In the reconstituted lipid peroxidation assay, a final concentration of 0.5 mM of NADPH 
proved not to be a limiting factor in the 30 minutes time course of the assay, as judged by the 
results obtained in the presence of a NADPH re-generating system. This is not surprising as 
the reported Km value for NADPH is 0.139 mM in the NADPH-dependent lipid peroxidation 
process (Yonaha & Ohbayashi, 1980).
IRON AND NADPH-DEPENDENT LIPID PEROXIDATION
Emster & Nordenbrand (1982) studied the effect of various iron chelates on the NADPH- 
dependent lipid peroxidation and compared them with the non-enzymatic ascorbate initiated 
lipid peroxidation. In their investigation, they reported various nucleoside di- and tri­
phosphates such as GDP, UDP, ATP and IDP, all activated NADPH-activated lipid 
peroxidation in a manner similar to ADP, but that nucleoside monophosphates were inactive. 
Maximal activities were reached at nucleotide concentration of 0.2-1 mM. Inorganic 
pyrophosphate (PPi), also activated the NADPH-dependent lipid peroxidation, but maximal 
activity occurred at about 50-100 pM, above which PPi was inhibitory. The concentration 
used in my reconstituted assay system, was 50 pM. They also reported that in all cases, Fe^+ 
and Fe^+ were equally efficient The Km for Fe^+ in the NADPH-dependent lipid peroxidation 
was reported to be 1.6 pM (Emster & Nordenbrand, 1967). FePPi was only active in the case 
of NADPH-dependent lipid peroxidation. In the case of ascorbate, PPi was inactive at eveiy 
concentration tested (7 pM- 1 mM) and it also inhibited ascorbate dependent lipid 
peroxidation as induced by other iron chelates (Emster & Nordenbrand, 1982).
EFFECT OF HEAT AND TRYPSIN DIGESTION ON CHOLATE 
SOLUBILIZED FRACTION AND LIPID PEROXIDATION ACTIVITY
Results presented here, clearly demonstrate that the enzymatic activity of the NADPH- 
dependent lipid peroxidation is heat labile since heating CCMs fraction at 90®C for 5 minutes 
abolished 90% of the NADPH-dependent lipid peroxidation activity. These results lend 
support to the proposition that the lipid peroxidation promoting factor may be a protein. These 
data support those obtained by Yonaha et al. (1992). They observed an extensive inhibition 
(86%) of the lipid peroxidation activity by heating the CCMs fraction at 90°C for 10 minutes. 
They also went one step further and demonstrated that this fraction is also sensitive to trypsin. 
Trypsin digestion of the lipid peroxidation active fraction resulted in complete loss of the
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NADPH-lipid peroxidation activity and this effect was abolished if a trypsin inhibitor was 
included. It was concluded that this effect was specifically due to the digestive action of 
trypsin.
Other investigators have .also obtained a fraction free from CYT-P450s and b^ (obtained as a 
result of Laurate-Sepharose chromatography), which supports NADPH-dependent lipid 
peroxidation. In agreement with the above results, they also reported that this fraction was 
heat-labile (Tampo & Yonaha, 1995).
Taken collectively these results support the hypothesis that the NADPH-dependent lipid 
peroxidation active fraction is probably a protein or more correctly, an enzyme.
STABILITY OF THE LBPH) PEROXIDATION ACTIVITY
The main problem with the purification of the lipid peroxidation active fraction was the labile 
nature of the activity. Even when stored at 4"C, the cholate solubilized fraction lost up to 35% 
of its original activity in 24 hrs and up to 55% in 72 hrs. It is obvious that with this labile 
nature of the activity, any attempts at purification are made extremely difficult since activity 
decreases rapidly to a level indistinguishable from the background auto-oxidation.
Other detergents were examined as possible alternatives to cholate. Emulgen-911 proved 
unsuitable due to its potent inhibitory effect on the lipid peroxidation activity. With the 
zwitterionic detergent, CHAPS, between 50-70% of total microsomal activity was solubilized 
over a range of 6.3-333 [total protein (mg): final % (w/v) CHAPS] protein to CHAPS ratio. 
The CHAPS solubilized fraction did not exhibit increased stability of the lipid peroxidation 
activity compared to CCMs. Further use of this detergent was abandoned in light of the 
observation that rimple dialysis or mere dilution of the CCMs fraction with 1% (w/v) CHAPS 
containing equilibrium buffer, resulted in 67% and 30% decrease in the lipid peroxidation 
activity, respectively, even prior to any chromatography!
A number of unsuccessful attempts were made to stabilise the enzyme activity by 
incorporating it into phospholipid vesicles, using phosphatidylcholine and CaCl2 , as 
suggested by other authors (Strittmatter et al., 1978).
The addition of various protease inhibitors such as the serine protease inhibitor, PMSF, did 
not improve the stability of the lipid peroxidation activity, suggesting that the presence of this 
class of proteases in the sample, may not be the major cause for this rapid loss of the lipid 
peroxidation activity.
Glycerol was shown not to inhibit the lipid peroxidation activity in the reconstituted assay at 
the concentration typically used for column-chromatography procedures, 20% (v/v), and 
hence was included in all equilibrium buffers since it has long been appreciated that polyols 
increase the stability of the membrane proteins by affecting the viscosity and density of the 
medium (Hjelmeland, 1990).
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Addition of fatty-acid free BSA to the lipid peroxidation active fractions dramatically 
improved the stability of the lipid peroxidation activity, probably by acting as a sacrificial 
antioxidant, i.e. being oxidised preferentially due to its high concentration in the fraction and 
subsequently protecting the enzyme. Protection provided by BSA, could also be due to its 
ability to sequester transition metals such as iron and copper ions present in the medium, and 
hence to inhibit the auto-oxidation promoted by the presence of these metals which can lead 
to deterioration of enzymatic activity (although this enzyme activity may be the peroxidation 
process!). Although the presence of BSA resulted in a more stable fraction, its addition 
caused a further problem in the purification of the NADPH-lipid peroxidation factor, since 
further purification steps were necessaiy in order to remove it from the active fraction.
COLUMN CHROMATOGRAPHY:
EXCLUSION CHROMATOGRAPHY
Yonaha and his collaborators (1992) first reported separation of the lipid peroxidation active 
fraction from the main protein peak by using exclusion column chromatography. They also 
separated the lipid peroxidation active fraction from cytochrome P450 reductase by passing 
the active fraction from the exclusion chromatography, through a 2'5'-ADP-Sepharose 
column. However, their final eluted fraction only had a specific activity about 4.5-fold higher 
than that of microsomes. Since about 3-fold purification is achieved as a result of CCMs 
fraction preparation, it can be concluded that the purification achieved as a result of their 
exclusion chromatography, was only a moderate 1.5-fold. This reflects the massive loss of 
lipid peroxidation activity and the labile nature of the activity of the eluate fractions since 
although the activity was separated from the main protein peak, the purification achieved was 
only 1.5-fold. I achieved a very similar pattern of purification by using a Sephacryl S-300 
matrix, although the lipid peroxidation activity of eluate fractions were not sufficiently above 
the background auto-oxidation level. Hence the fractions could not be pooled and carried 
forward for further purification steps (results are not included here). An additional problem, 
besides the labile nature of the lipid peroxidation activity, was the inhibitory effect of cholate 
detergent which was included in the equilibrium buffer to maintain solubilization and avoid 
aggregation of proteins during chromatography. Despite these problems, the most effective 
exclusion chromatography results. Exclusion chromatography (1), was obtained by 
chromatography of 75%-45% (w/v) ammonium sulphate precipitate on a Sephadex G-150 
column with "50 mM Tris-HCl, 1.2% (w/v) cholate, pH 7.5,50 jxM DTT, 20% (v/v) glycerol" 
as the equilibrium buffer (section 3.6). This fraction was well separated as a result of 
exclusion chromatography, however in order to observe the lipid peroxidation activity it was 
essential to decrease the concentration of cholate detergent to a level where it had minimal 
inhibitory effect on the lipid peroxidation activity. When all the fractions were pooled in order
113
to determine the percentage yield of activity, only 14% of the activity was recovered post 
exclusion chromatography. This was mainly due to diminished lipid peroxidation activity, T 
(30-0.5 min), due to an increase in the background, T (0.5 min), TEARS of lipid peroxidation 
active eluate fractions (i.e. the active fractions contained TEARS even prior to addition of 
NADPH in the lipid peroxidation assay). This suggests the possibility of lipids co-eluting 
with the active fractions which become auto-peroxidized in the course of the purification 
manipulations. It is also possible that the lipid peroxidation active fraction is a ’’lipoprotein", 
in other words the enzyme is covalently bound to phospholipids which are being peroxidized 
auto-catalytically during the course of the chromatography. These observations are consistent 
with data reported by other authors as to the possible lipoprotein nature of this fraction 
(Tzagoloff & Penefsky, 1971). This theory is further supported by the fact that the [75%-45% 
(w/v)} ammonium sulphate precipitate of the lipid peroxidation active fractions are 
consistently in a form of a “pellicle” instead of a pellet i.e. they float on top of the supernatant 
rather than precipitating at the bottom of the centrifugation tube. This suggests that the f75%- 
45% (w/v)] ammonium sulphate fraction has a lower density and hence may be covalently 
bound to some sort of lipid. Furthermore, the increase in the background lipid peroxidation is 
also observed with the ammonium sulphate fractions and other fractions eluted from other 
column chromatographies as shall be discussed.
In conclusion, for effective exclusion chromatography, the presence of 1.2% (w/v) cholate 
detergent proved necessary and since at this concentration of detergent it is not recommended 
to measure the lipid peroxidation activity of fractions (due to inhibitor)' effect of cholate), the 
concentration of cholate had to be decreased by such means as dialysis (which itself leads to a 
decrease in the lipid peroxidation activity due to the labile nature of the lipid peroxidase 
activity).
It was decided that if another suitable column was found, then the eluate fractions would be 
loaded directly on that column, hence avoiding dialysis and further manipulations which 
result in loss of lipid peroxidation activity. Hence chromatography on this 2nd column, in the 
absence of detergent, should yield eluate fractions which could be assayed directly. Also, 
these fractions could also be directly and immediately subjected to further purification, or 
concentrated by ammonium-sulphate precipitation, since cholate would be absent and hence 
would not co-precipitate with the desired protein. In the search for other suitable columns, the 
following matrices were examined.
DEAE-CHROMATOGRAPHY
Over 3-fold of purification was obtained compared to CCMs (or about 10-fold compared to 
microsomes) by chromatography of CCMs on a DEAE matrix with non-cholate containing 
equilibrium buffer [DEAE- (1)] (section 3.7.1), The active fraction had to be eluted off the 
matrix with "0.5 M KCl + 0,4% (w/v) cholate detergent" (in preliminaiy experiments,
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washing the column with 0.5 M KCl in equilibrium buffer was examined, however it did not 
result in elution of the lipid peroxidation active fraction; results not included). Although these 
results seemed very promising by allowing cholate containing fractions to be loaded on a non- 
cholate containing chromatography matrix, cholate was still necessary to eluate the fraction 
off the column. Also 10-fold increase in the relative ^ecific activity compared to microsomes 
was achieved at the cost of substantial increases in the background lipid peroxidation of the 
eluate fractions, T (0.5 min).
As noted earlier, the cholate detergent which was commonly used in the equilibrium for 
chromatographies such as DEAE-column chromatography, contained a yellowish colour bile 
pigment contaminant which would bind tightly to the top of the DEAE-column matrix. 
Although there was no direct evidence of interference of this contaminant with the 
chromatography, the fact that tiiis contaminant bound so tightly to the matrix was a matter of 
concern since it could potentially, not only interfere with the binding and the elution profile, 
but also, denature the enzymatic activity. Hence, in order to remove this bile contaminant, 
equilibrium buffers containing cholate detergent were initially passed through a small 
"cleaning" DEAE-column. The resulting equilibrium buffers were then used for 
chromatography of the lipid peroxidation activity.
In DEAE-2, where the equilibrium buffer used had been passed through a "cleaning" DEAE- 
column, all of the lipid peroxidation activity bound to the column (although this could be 
partly due to the large scale of the DEAE-chromatography carried out compared to all the 
previous small-scale DEAE-columns, where up to half of the lipid peroxidation activity were 
eluted in the "wash, non-binding" pool). The fractions eluted from DEAE-(2) were dialysed to 
reduce the cholate concentration and then subjected to ammonium sulphate precipitation and 
further dialysis to remove the milky coloration as a result of excess ammonium sulphate. The 
results demonstrated a 10-fold increase in the relative specific activity of the "DEAE (2)-pool 
C" fraction, which was then subjected to exclusion chromatography on Sephadex G-150. This 
latter column did not yield any further purification and the lipid peroxidation activity of this 
fraction was low due, once again, to an increase in the background lipid peroxidation of the 
fraction.
CHAPS was examined as an alternative detergent to cholate, but as discussed earlier did not 
provide further advantage.
In conclusion, DEAE-column chromatographies yielded 10-fold purification. However, the 
lipid peroxidation active eluted fractions obtained had an increased background TEARS 
content which made them unsuitable for further purification steps.
HYDROXYAPATITE CHROMATOGRAPHY
Hydroxyapatite chromatography has been used extensively as a step in the purification of 
various proteins and enzymes such as the cytochrome P450s, desaturase isoenzymes and
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cytochrome P450 reductase (Yasukochi & Masters, 1976). Attempts were made to purify the 
lipid peroxidation active fraction using hydroxyapatite chromatography. Unfortunately, as 
indicated earlier, phosphate buffer which is the buffer of choice for this chromatography 
procedure, exhibited some inhibitory effect at high concentrations, on the lipid peroxidation 
activity in the reconstituted assay system. By using Tris-HCl, as an alternative buffer, the 
lipid peroxidation active fraction could not be eluted off the hydroxyapatite matrix even with 
IM Tris-HCl buffer containing 1.2% (w/v) cholate, and it became apparent that phosphate 
buffer was necessary to eluate off the bound proteins off the column (data not included).
In the initial hydroxyapatite chromatography attempt, hydroxyapatite (1), over a third of the 
original activity of the fraction loaded was recovered using one step elution with high 
phosphate buffer concentration, however, good separation was not achieved since the fraction 
loaded had not been pre-equilibrated with the equilibrium buffer. In subsequent 
chromatography, hydroxyapatite (2), the fraction loaded was diluted 1:2 with the equilibrium 
buffer (instead of dialysis which resulted in loss of activity) and upon step elution, 36% of the 
loaded lipid peroxidation activity was recovered in the fraction eluted with "325 mM 
potassium phosphate + 1% (w/v) cholate" containing buffer. However, this did not result in a 
major increase in the relative specific activity of the fraction (only about 1.6-fold increase 
relative to CCMs fraction). This fraction was then subjected to Laurate-Sepharose 
chromatography for further purification by removal of CYT b5 and CYT P450s. However,
due to a substantial decrease in activity of eluted fractions post concentration and then 
dialysis (to decrease phosphate below its inhibitory concentration) no substantial lipid 
peroxidation activity was measured.
In conclusion, although hydroxyapatite column is a very effective column, especially in the 
purification of various haem-containing enzymes, it is not as effective in the purification of 
the lipid peroxidation activity (about 1.6-fold increase in the relative specific activity 
compared to CCMs and 5-fold compared to microsomes). This can partly be attributed to the 
inhibitory effect of the most suitable buffer for this matrix, phosphate, which as discussed 
earlier probably inhibits lipid peroxidation in the reconstituted system due to its metal 
chelating ability (quenching iron available for lipid peroxidation).
CATION EXCHANGER CHROMATOGRAPHY
Cationic exchange matrices are used to bind positively charged ions at a particular pH. 
Unfortunately, neither the "carboxymethyl" nor the stronger cationic exchanger matrix, "S- 
Sepharose", bound the lipid peroxidation active fraction. About 95% of the lipid peroxidation 
activity was recovered in the "wash, non binding" eluate fraction pool even at a pH as low as 
6.0, used to maximise the shift of the equilibrated fraction in the cationic form. However, 
dialysis of the lipid peroxidation active fraction at this pH, did not diminish the lipid 
peroxidation activity (results not shown), although the deterioration of lipid peroxidation
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activity of this post dialysis fraction followed a similar pattern to that of CCMs fraction as 
discussed in section 3.1.7.
From non-binding of the lipid peroxidation activity to the cationic exchanger columns at pH 
as low as 6.0, one can conclude that the "Isoionic point" of the lipid peroxidation active 
fraction is probably not above 7.0 and hence probably does not cany an overall positive 
charge at pH 6.0 to enable it to bind to the negatively charged cationic exchanger. This 
conclusion is further supported by binding of the lipid peroxidation activity to the anionic 
exchanger, DEAE, as described earlier in section 3.7.
At this pH, and under the chromatographic conditions described, there was no major binding 
of any other proteins to the column matrix. This was unfortunate, since if so, one could have 
taken advantage of this and obtain some "negative" purification by binding of un-wanted 
proteins to the column matrix, while the lipid peroxidation active fraction eluted right through 
the column). In conclusion, this column did not significantly contribute towards the 
purification of the lipid peroxidation active fraction.
LAURATE-SEPHAROSE CHROMATOGRAPHY
Laurate-Sepharose hydrophobic affinity column has been used on many occasions in the 
isolation and purification of various proteins such as microsomal CYT P450s (Gibson & 
Schenkman, 1978).
In section 3.1.8, experimental evidence was presented for the non-involvement of CYT P450s 
in the NADPH-dependent lipid peroxidation i.e. by performing the lipid peroxidation assay in 
the presence of an 80% carbon monoxide atmosphere. Here Laurate-Sepharose affinity 
column was used in order to bind the hydrophobic CYT P450s and CYT bg and exclude them 
from the lipid peroxidation active fraction, hence not only lending further support to the non­
involvement of CYT P450s, but also achieving some degree of purification.
Laurate-Sepharose chromatography of the CCMs fraction with equilibrium buffer containing 
1.4% (w/v) cholate detergent, resulted in recoveiy of only 7% of the lipid peroxidation 
activity, which eluted at about 03 M NaCl concentration, when the column was subjected to 
0-0.5 M NaCl gradient [Laurate-Sepharose (1)]. However, this low recovery of the activity 
was partly due to pre-dialysis of CCMs fraction which resulted in a marked decrease in lipid 
peroxidation of the loaded sample (and hence lower activity of eluted fraction). By examining 
the SDS-PAGE of the eluate fractions, it was concluded that chromatography under such 
conditions, did not yield significant purification.
In Laurate-Sepharose (2) chromatography, where no detergent was included in the 
equilibrium buffer, 37% of the lipid peroxidation activity was recovered, alongside 14% of 
CYT P450s and 29% CYT bg, in the "wash, non-binding" eluate pool fraction. This resulted 
in only 1.3-fold purification compared to CCMs (or 4-fold compared to microsomal fraction). 
This eluate fraction was subjected to further purification using hydroxyapatite column which
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led to separation of lipid peroxidation activity from other protein peaks and a recovery of 23% 
of the activity of the fraction loaded on the hydroxyapatite column (or 8.5% of the original 
activity loaded on the Laurate-Sepharose column). This combination chromatography, 
resulted in a moderate, about 3.3-fold, increase in relative specific activity compared to 
CCMs (or about 10-fold increase in relative specific activity when compared to microsomes). 
In Laurate-Sepharose (3), increased levels of CYT P450 and CYT b^ (98% and 85%, 
respectively) were bound to the column when 1.2% (w/v) cholate detergent was included in 
the equilibrium buffer, hence a more “CYT P450 and CYT b^ free” fraction was eluted. 
However, chromatography under such conditions, also led to a lower recovery of the lipid 
peroxidation activity (3%). Altogether, these results are in agreement with other authors 
(Tampo & Yonaha, 1995) who obtained an essentially CYT P450 and CYTb^ free fractions, 
which had retained 17% of the NADPH-lipid peroxidation activity, hence arguing against the 
involvement of CYT-P450 as suggested by others (Vile & Winterboum, 1988). This column 
is therefore another potentially useful tool in the separation of NADPH-dependent lipid 
peroxidation from CYT bs and CYT P 4^s, which compete with the former enzyme system 
for reducing equivalents from cytochrome P450 reductase.
In conclusion, numerous difficulties were encountered in the course of purification of the 
NADPH-dependent lipid peroxidation activity (some due to the inherent nature of the lipid 
peroxidation activity). Despite these difficulties, hurdles were overcome in purification and 
characterisation of this previously vaguely described enzymatic system, and substantial 
progress was made in purification, using column chromatography and other purification 
techniques, although an electrophoretically homogenous preparation was not produced.
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SUMMARY
An effective and sensitive reconstituted system was used to measure NADPH-dependent lipid 
peroxidation. Rat liver microsomes were differentially solubilized with cholate detergent 
resulting in a 3-fold increase in the relative specific activity of this fraction, labelled as 
"Cholate-Cut Microsomes" (CCMs). The NADPH-dependent lipid peroxidation was 
monitored by formation of thiobarbituric acid reactive substances (TEARS). In this 
reconstituted assay, TEARS formation was dependent on the presence of ferric- 
pyrophosphate, cytochromes P450 reductase, membrane phospholipids and NADPH. It was 
also demonstrated, by the addition of a potent antioxidant, butylated hydroxy toluene (BHT), 
that the TEARS are formed during the lipid peroxidation assay and not during the heating 
process of the TEA-assay, as suggested by some investigators (Gutteridge, 1986).
The microsomal NADPH-dependent lipid peroxidation, appeared to be an enzymatic process 
based on its heat labile nature and NADPH-dependence for the activity. Furthermore, other 
investigators have documented the trypsin sensitivity of the activity (Yonaha et ah, 1992) and 
others have reported "no product-precursor relationship" indicating the absence of 
propagation as a result of non-enzymatic chain reaction (Davis et a l, 1987). It was 
demonstrated with the use of gas chromatography that the NADPH-dependent lipid 
peroxidation of CCMs fraction, primarily peroxidized arachidonic and docosahexanoic fatty 
acids from the membrane phospholipids. This was in agreement with the previously reported 
effect of NADPH-dependent lipid peroxidation in microsomes (Jordan & Schenkman, 1982). 
The involvement of cytochrome P450s was ruled out since, in agreement with other 
investigators, an 80% carbon monoxide atmosphere failed to inhibit the lipid peroxidation in 
the reconstituted assay system (Yonaha et al., 1992; Tampo & Yonaha, 1995). Furthermore, 
chromatography of the lipid peroxidation active fractions on a Laurate-Sepharose column 
(which binds cytochromes P450s and bs) not only did not abolish the lipid peroxidation 
activity but also resulted in a 4-fold increase in relative specific activity of the lipid 
peroxidation activity compared to microsomes. Although I did not manage to obtain a 
completely CYT bs- and CYT P450-free fraction, in agreement with Tampo & Yonaha, 
(1995), an eluted fraction was obtained post Laurate-Sepharose chromatography (with low 
CYT bs and CYT P450 concentrations) which also had substantial lipid peroxidation activity. 
The reconstituted NADPH-lipid peroxidation assay was shown to be sensitive to inhibition by 
phosphate buffer. This could probably be due to phosphate's chelating ability, quenching the 
available iron and thereby making it unavailable to participate in the lipid peroxidation assay. 
The inhibitory effect of phosphate buffer, made hydroxyapatite chromatography less effective 
since it is the buffer of choice with this chromatography. However, despite this problem, a 5- 
fold increase in the relative specific activity, compared to microsomes, was achieved. Use of 
alternative buffers such as Tris-HCl with this column proved unsuccessful.
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Glycerol was without an inhibitory effect on the lipid peroxidation activity in the 
reconstituted assay system and was included in the majority of the buffers used in the course 
of purification.
Unfortunately, cholate, the detergent used for the solubilization of the lipid peroxidation 
fraction, also exhibited an extensive inhibitory effect in the lipid peroxidation assay at 
concentrations above 0.03% (w/v). Since a 1.2% (w/v) cholate concentration proved effective 
for the initial solubilization and chromatography steps, additional dilution, dialysis or 
concentration with Centriprep^“-10 or 30 instruments followed by dialysis, were necessary to 
decrease the cholate concentration below an inhibitory level so that the lipid peroxidation 
activity could be measured in the reconstituted assay system. Cholate also caused further 
difficulties with the anionic-exchanger chromatography column, DEAE-matrix. Sodium 
cholate detergent used was of 99% purity and was ethanol washed prior to use. However, it 
was discovered that some impurities were still present in cholate detergent, since a yellowish 
coloured bile pigment would bind tightly to the top of DEAE-column matrix, whenever 
cholate detergent was included in the equilibrium buffer for DEAE-chromatography. Despite 
these difficulties, a 10-fold purification was obtained by the use of DEAE-chromatography, 
compared to microsomes. Although the use of an alternative detergent, such as the 
zwitterionic detergent CHAPS, gave good separation on the DEAE column, the rapid loss of 
the lipid peroxidation activity with this detergent, made CHAPS unsuitable. Emulgen-911 
proved to be a potent inhibitor of the lipid peroxidation activity in the reconstituted system 
and hence was ruled out as an alternative detergent to cholate.
Although excellent recoveries were obtained (>90%) using the cationic exchanger columns 
such as Carboxymethyl- (CM) and S-Sepharose, neither of these columns contributed towards 
any significant purification, even under low pH and ionic strength conditions, with either 
cholate or CHAPS as detergents.
Inherent with the purification difficulties discussed so far, was the extra burden of the labile 
nature of the lipid peroxidation activity. Since the enzyme activity was the only tool available 
to "tag" the lipid peroxidation activity, the rapid loss of activity gave me limited time to 
complete purification studies. The purification of the fraction was complicated by the fact that 
the lipid peroxidation active fractions themselves rapidly lost activity, even when stored at 
4“C. This was not prevented by including protease inhibitors such as the serine protease 
inhibitor, PMSF. Neither did addition of phosphatidylcholine with CaCl2 increase the 
stability. Addition of BSA did protect the lipid peroxidation active fraction probably serving 
as a "sacrificial antioxidant" (Halliwell & Gutteridge, 1989), but its use did not prove 
practical for purification purposes since it increased the burden of purification. Furthermore, 
the lipid peroxidation active fraction's background, T (0.5 min), increased in the course of 
various chromatographic procedures as a result of the formation of TEARS. This could be 
due to peroxidation of lipid closely associated to this enzyme, either eluting alongside the 
active fractions, or more likely covalently bound to the lipid peroxidation active fractions i.e.
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the active fraction is possibly a "lipoprotein". This statement is based on the observation that 
in the eluate fractions, not only did the increased TEARS formation closely follow the lipid 
peroxidation activity, but also the ammonium sulphate precipitates, which had considerable 
lipid peroxidation activity, floated on top of the supernatant rather than precipitating at the 
bottom of the test tube i.e. they were a pellicle rather than a pellet. This indicated that the lipid 
peroxidation active fractions had a lower density than the supernatant, which could be due to 
their association with lipids. It is also possible that die lipid peroxidation active fraction can 
irreversibly inactivate itself by hydroperoxy lipids which are formed during the peroxidase 
reaction, as proposed in the case of 15-lipoxygenase (Schewe & Kuhn, 1991) evident by the 
TEARS formed alongside these fractions during chromatography, resulting in an increase in 
the background and consequent decrease and loss of measurable lipid peroxidation activity. 
The loss of activity was most prominentiy observed post ammonium sulphate salting out of 
the cholate solubilized fraction. Although the ammonium sulphate precipitation step yielded 
up to 11-fold increase in the relative specific activity over microsomes, lipid peroxidation 
activity of the ammonium sulphate precipitate was barely above the background and hence 
could not be carried forward for further purification steps. Consequently this step was saved 
for later stages in the chromatography, when further purification steps was not essential.
In conclusion, purification of the lipid peroxidation active fraction was hindered by numerous 
obstacles such as the labile nature of the activity, increase in the background TEARS as a 
result of exclusion chromatography and various other chromatography and purification steps 
such as ammonium sulphate precipitation. Taken collectively, the purification could not be 
continued after chromatography on two columns plus the ammonium sulphate precipitation 
step. This is mainly due to the decrease in the lipid peroxidation activity to an extent that 
upon further purification, activity of the eluates were not distinguishable from the background 
auto-oxidation of microsomal phospholipid membrane in the reconstituted assay.
It is important to note that despite the lack of isolation and identification of the protein band 
responsible for the NADPH-dependent lipid peroxidation, the purifications achieved using 
various chromatographic steps were greater than any results reported in the literature so far. 
Other investigators working on the same problem have also faced similar difficulties 
(Yonaha, 1996; personal communications) and there has not been any published report on 
activity achieved using more than a single column chromatography (Yonaha et a/., 1992) 
(Tampo & Yonaha, 1995).
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FUTURE WORK
By far, the most important factor which affected the purification of the factor promoting the 
NADPH-dependent lipid peroxidation activity, was the labile nature of the activity itself. This 
was especially pronounced post column chromatography, as the active eluted fractions rapidly 
lost activity and hence further purification steps would not yield any fractions with 
measurable activity. Although several methods were tried in order to decrease the rapid loss 
of lipid peroxidation activity, none of which proved successful. With the benefit of the 
hindsight, it seems most appropriate to determine conditions under which the lipid 
peroxidation activity would remain stable for a sufficient period of time to permit 
purification, or to find an appropriate component which would effectively stabilise the lipid 
peroxidation activity i.e. a "stabiliser", prior to further attempts at the purification. There is 
also the possibility that during the course of the purification, as other proteins are removed 
and the microsomal membrane components are separated, another vital component(s) 
responsible for maintenance of the activity is (are) removed; hence rendering the fraction 
more susceptible to loss in activity. It seems appropriate to examine this theoiy by addition of 
other eluate fractions to the active eluate fraction to determine if this stabilises activity.
Upon purification of the lipid peroxidase, it would certainly be very interesting to investigate 
the presence of this lipid peroxidation enzyme system in the rats resistant to the carcinogen 3’ 
methyl 4-dimethyl aminoazobenzene, as reported by Hammad et al. (1990). It is possible that 
the lack of NADPH-dependent lipid peroxidation activity in the liver microsomes of these 
resistant rats, could be explained by the lack of expression or expression of the active form of 
this lipid peroxidase enzyme system.
Another interesting observation was with rats fed a carbohydrate-rich, fat-free diet for a 
period of 4 hrs/day for 4 days after fasting. The hepatic microsomes from these rats, exhibited 
no NADPH-dependent lipid peroxidation activity at all, whereas a 10-20 fold elevation of the 
fatty-acid desaturase system and an approximately 40% reduction in mixed function oxidases 
levels were observed. Also like the cytochrome hs  level, the cytochrome b5 reductase content
of microsomes is decreased after the high carbohydrate regime, when desaturase activity was 
elevated 15-fold (Jansson & Schenkman, 1975; Jansson & Schenkman, 1977). Assuming 
purification of the lipid peroxidase to homogeneity, it would be interesting to raise antibodies 
against this protein and perform a western blot on microsomes obtained from fat-free diet 
animals to see if this enzyme is expressed or not and subsequently to determine the role of 
this enzyme and its relationship with diet. Other future work could investigate how this lipid 
peroxidation system interacts with the mixed function oxidase and the desaturase enzyme 
systems and finally, what iCs physiological roles are in health and disease?
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